a    O
disposable    O
infusion    B-Therapy100661091
set    I-Therapy100661091
,    O
including    O
a    O
cannula    O
for    O
subcutaneous    O
insertion    O
(    O
under    O
the    O
skin    O
)    O
and    O
a    O
tubing    O
system    O
to    O
interface    O
the    O
insulin    O
reservoir    O
to    O
the    O
cannula    O
.    O

There    O
are    O
three    O
pillars    O
of    O
the    O
religion    O
,    O
of    O
which    O
the    O
key    O
concept    O
is    O
johrei    B-Therapy100661091
,    O
claimed    O
to    O
be    O
a    O
method    O
of    O
channeling    O
divine    O
light    O
into    O
the    O
body    O
of    O
another    O
for    O
the    O
purposes    O
of    O
healing    O
.    O

Bee    B-Therapy100661091
sting    I-Therapy100661091
therapy    I-Therapy100661091

Honey    O
bee    O
products    O
are    O
used    O
medicinally    O
in    O
apitherapy    B-Therapy100661091
across    O
Asia    O
,    O
Europe    O
,    O
Africa    O
,    O
Australia    O
,    O
and    O
the    O
Americas    O
,    O
despite    O
the    O
fact    O
that    O
the    O
honey    O
bee    O
was    O
not    O
introduced    O
to    O
the    O
Americas    O
until    O
the    O
colonization    O
by    O
Spain    O
and    O
Portugal    O
.    O

An    O
American    O
inventor    O
Thomas    O
Galen    O
Hieronymus    O
built    O
a    O
machine    O
which    O
he    O
named    O
a    O
"    O
Hieronymus    B-Therapy100661091
machine    I-Therapy100661091
"    O
in    O
1949    O
.    O

They    O
were    O
opposed    O
to    O
the    O
use    O
of    O
coffee    O
,    O
sugar    O
,    O
salt    O
,    O
tobacco    O
,    O
alcohol    O
,    O
meat    O
,    O
dairy    O
products    O
,    O
cooked    O
food    O
,    O
and    O
refrigeration    O
,    O
and    O
promoted    O
massage    O
,    O
heliotherapy    O
,    O
iris    O
diagnosis    O
,    O
sun    B-Therapy100661091
gazing    I-Therapy100661091
,    O
barefoot    O
walking    O
,    O
and    O
naturism    O
.    O

Since    O
looking    B-Therapy100661091
directly    I-Therapy100661091
at    I-Therapy100661091
the    I-Therapy100661091
Sun    I-Therapy100661091
can    O
lead    O
to    O
permanent    O
eye    O
damage    O
or    O
blindness    O
,    O
special    O
eye    O
protection    O
or    O
indirect    O
viewing    O
techniques    O
are    O
used    O
when    O
viewing    O
a    O
solar    O
eclipse    O
.    O

by    O
internal    O
worms    O
:    O
helminthic    B-Therapy100661091
therapy    I-Therapy100661091

In    O
an    O
experimental    O
idea    O
called    O
helminthic    B-Therapy100661091
therapy    I-Therapy100661091
,    O
moderate    O
hookworm    O
infections    O
have    O
been    O
demonstrated    O
to    O
have    O
beneficial    O
effects    O
on    O
hosts    O
suffering    O
from    O
diseases    O
linked    O
to    O
overactive    O
immune    O
systems    O
.    O

"    O
T.    O
suis    O
"    O
is    O
also    O
used    O
in    O
helminthic    B-Therapy100661091
therapy    I-Therapy100661091
studies    O
.    O

Edward    O
Bach    O
(    O
;    O
24    O
September    O
1886    O
–    O
27    O
November    O
1936    O
)    O
was    O
an    O
English    O
doctor    O
,    O
homeopath    O
,    O
bacteriologist    O
and    O
spiritual    O
writer    O
,    O
best    O
known    O
for    O
developing    O
a    O
range    O
of    O
remedies    O
called    O
the    O
Bach    B-Therapy100661091
flower    I-Therapy100661091
remedies    I-Therapy100661091
,    O
a    O
form    O
of    O
alternative    O
medicine    O
inspired    O
by    O
classical    O
homeopathic    O
traditions    O
.    O

In    O
this    O
period    O
,    O
he    O
developed    O
seven    O
bacterial    O
nosodes    O
known    O
as    O
the    O
seven    O
Bach    B-Therapy100661091
nosodes    I-Therapy100661091
.    O

Bach    B-Therapy100661091
flower    I-Therapy100661091
remedies    I-Therapy100661091

The    O
number    O
of    O
Bach    B-Therapy100661091
flower    I-Therapy100661091
remedies    I-Therapy100661091

Sweet    O
chestnut    O
has    O
been    O
listed    O
as    O
one    O
of    O
the    O
38    O
substances    O
used    O
to    O
prepare    O
Bach    B-Therapy100661091
flower    I-Therapy100661091
remedies    I-Therapy100661091
,    O
a    O
kind    O
of    O
alternative    O
medicine    O
promoted    O
for    O
its    O
effect    O
on    O
health    O
.    O

Bach    B-Therapy100661091
flower    I-Therapy100661091
remedies    I-Therapy100661091

Severe    O
cases    O
can    O
lead    O
to    O
unconsciousness    O
and    O
must    O
be    O
treated    O
with    O
intravenous    O
glucose    O
or    O
injections    B-Therapy100661091
with    I-Therapy100661091
glucagon    I-Therapy100661091
.    O

In    O
the    O
early    O
1990s    O
it    O
was    O
hypothesized    O
that    O
casomorphin    O
can    O
cause    O
or    O
aggravate    O
autism    O
spectrum    O
disorders    O
,    O
and    O
casein-free    B-Therapy100661091
diets    I-Therapy100661091
are    O
widely    O
promoted    O
.    O

As    O
a    O
result    O
of    O
this    O
speculation    O
,    O
he    O
has    O
promoted    O
the    O
use    O
of    O
a    O
gluten-free,    B-Therapy100661091
casein-free    I-Therapy100661091
diet    I-Therapy100661091
to    O
ameliorate    O
the    O
symptoms    O
of    O
autism    O
,    O
a    O
theory    O
he    O
developed    O
along    O
with    O
Kalle    O
Reichelt    O
.    O

Work    O
has    O
been    O
reported    O
in    O
the    O
scientific    O
literature    O
into    O
the    O
incorporation    O
of    O
lispro    B-Therapy100661091
(    O
Humalog    B-Therapy100661091
rapidly    O
acting    O
insulin    B-Therapy100661091
analogues    I-Therapy100661091
,    O
and    O
the    O
glargine    B-Therapy100661091
(    O
Lantus    B-Therapy100661091
)    O
very    O
long    O
-    O
acting    O
insulin    O
analogue    O
,    O
into    O
the    O
freeware    O
diabetes    O
simulator    O
.    O

The    O
other    O
type    O
is    O
long    O
acting    O
insulin    O
;    O
the    O
first    O
of    O
these    O
was    O
Lantus    B-Therapy100661091
(    O
insulin    O
glargine    O
)    O
.    O

Long    O
-    O
acting    O
insulin    B-Therapy100661091
analog    I-Therapy100661091
such    O
as    O
insulin    B-Therapy100661091
glargine    I-Therapy100661091
(    O
brand    O
name    O
"    O
Lantus    O
"    O
,    O
made    O
by    O
Sanofi    O
-    O
Aventis    O
)    O
and    O
insulin    B-Therapy100661091
detemir    I-Therapy100661091
(    O
brand    O
name    O
"    O
Levemir    O
"    O
,    O
made    O
by    O
Novo    O
Nordisk    O
)    O
are    O
also    O
used    O
,    O
with    O
insulin    O
glargine    O
used    O
more    O
than    O
insulin    O
detemir    O
.    O

It    O
has    O
a    O
duration    O
of    O
action    O
that    O
lasts    O
up    O
to    O
42    O
hours    O
(    O
compared    O
to    O
18    O
to    O
26    O
hours    O
provided    O
by    O
other    O
marketed    O
long    O
-    O
acting    O
insulins    O
such    O
as    O
insulin    B-Therapy100661091
glargine    I-Therapy100661091
and    O
insulin    B-Therapy100661091
detemir    I-Therapy100661091
)    O
,    O
making    O
it    O
a    O
once    O
-    O
daily    O
basal    O
insulin    O
,    O
that    O
is    O
one    O
that    O
provides    O
a    O
base    O
insulin    O
level    O
,    O
as    O
opposed    O
to    O
the    O
fast    O
and    O
short    O
acting    O
bolus    O
insulins    O
.    O

The    O
institute    O
does    O
research    O
into    O
the    O
efficacy    O
of    O
alternative    O
medicine    O
,    O
such    O
as    O
on    O
the    O
effects    O
of    O
prayer    O
on    O
treating    O
disease    O
,    O
use    O
of    O
homeopathy    O
to    O
fight    O
bioterrorism    O
,    O
and    O
use    O
of    O
magnetic    B-Therapy100661091
healing    I-Therapy100661091
devices    O
on    O
orthopedic    O
injuries    O
,    O
with    O
Jonas    O
commenting    O
on    O
these    O
research    O
programs    O
,    O
"    O
There    O
is    O
a    O
good    O
case    O
for    O
looking    O
at    O
these    O
things    O
scientifically    O
,    O
because    O
we    O
do    O
n't    O
know    O
a    O
lot    O
about    O
them    O
"    O
.    O

Magnet    B-Therapy100661091
therapy    I-Therapy100661091

Although    O
a    O
highly    O
successful    O
merchant    O
and    O
diplomat    O
,    O
Baldwin    O
found    O
himself    O
a    O
subject    O
of    O
ridicule    O
on    O
his    O
return    O
to    O
Britain    O
for    O
his    O
belief    O
in    O
the    O
healing    B-Therapy100661091
power    I-Therapy100661091
of    I-Therapy100661091
magnets    I-Therapy100661091
,    O
then    O
widely    O
considered    O
a    O
pseudoscience    O
.    O

It    O
was    O
his    O
friendship    O
with    O
Cosway    O
that    O
led    O
to    O
his    O
introduction    O
into    O
the    O
field    O
of    O
magnetic    B-Therapy100661091
therapy    I-Therapy100661091
,    O
the    O
theory    O
that    O
megnetic    O
force    O
had    O
healing    O
powers    O
.    O

These    O
practitioners    O
may    O
use    O
unproven    O
,    O
disproven    O
,    O
or    O
questionable    O
methods    O
,    O
devices    O
,    O
and    O
products    O
such    O
as    O
adjusting    O
machines    O
,    O
applied    O
kinesiology    O
,    O
chelation    B-Therapy100661091
therapy    I-Therapy100661091
,    O
colonic    O
irrigation    O
,    O
computerized    O
nutrition    O
deficiency    O
tests    O
,    O
cranial    O
osteopathy    O
,    O
cytotoxic    O
food    O
allergy    O
testing    O
,    O
DMSO    O
,    O
Gerovital    O
,    O
glandular    O
therapy    O
,    O
hair    O
analysis    O
,    O
herbal    O
crystallization    O
analyses    O
,    O
homeopathy    O
,    O
internal    O
managements    O
,    O
iridology    O
,    O
laser    O
beam    O
acupuncture    O
,    O
laetrile    O
,    O
magnetic    B-Therapy100661091
therapy    I-Therapy100661091
,    O
and    O
so    O
forth    O
.    O

These    O
groups    O
have    O
some    O
overlap    O
,    O
and    O
distinguish    O
two    O
types    O
of    O
energy    O
medicine    O
:    O
"    O
veritable    O
"    O
which    O
involves    O
scientifically    O
observable    O
energy    O
(    O
including    O
magnet    B-Therapy100661091
therapy    I-Therapy100661091
,    O
colorpuncture    O
and    O
light    O
therapy    O
)    O
and    O
"    O
putative    O
"    O
,    O
which    O
invokes    O
physically    O
undetectable    O
or    O
unverifiable    O
energy    O
.    O

She    O
is    O
an    O
outspoken    O
critic    O
of    O
RAD    O
therapies    O
(    O
also    O
known    O
as    O
attachment    B-Therapy100661091
therapy    I-Therapy100661091
,    O
rebirthing    O
,    O
compression    O
or    O
coercive    O
restraint    O
therapy    O
)    O
which    O
,    O
she    O
says    O
,    O
are    O
"    O
completely    O
contrary    O
to    O
mainstream    O
medical    O
practice    O
"    O
and    O
are    O
used    O
without    O
empirical    O
support    O
for    O
their    O
efficacy    O
.    O

They    O
used    O
parenting    O
methods    O
similar    O
to    O
those    O
used    O
in    O
attachment    B-Therapy100661091
therapy    I-Therapy100661091
,    O
which    O
involves    O
very    O
strict    O
control    O
of    O
children    O
using    O
isolation    O
,    O
food    O
deprivation    O
,    O
and    O
other    O
disciplinary    O
measures    O
that    O
are    O
generally    O
considered    O
to    O
be    O
inhumane    O
.    O

Attachment    B-Therapy100661091
therapy    I-Therapy100661091
,    O
a    O
controversial    O
category    O
of    O
alternative    O
child    O
mental    O
health    O
interventions    O
intended    O
to    O
treat    O
attachment    O
disorders    O

The    O
notion    O
of    O
age    O
regression    O
is    O
central    O
to    O
attachment    B-Therapy100661091
therapy    I-Therapy100661091
whose    O
proponents    O
believe    O
that    O
a    O
child    O
who    O
has    O
missed    O
out    O
on    O
developmental    O
stages    O
can    O
be    O
made    O
to    O
redo    O
those    O
stages    O
at    O
a    O
later    O
age    O
by    O
a    O
variety    O
of    O
techniques    O
.    O

Occasionally    O
'    O
rebirthing    B-Therapy100661091
'    O
has    O
been    O
used    O
with    O
tragic    O
results    O
,    O
for    O
instance    O
for    O
Candace    O
Newmaker    O
.    O

These    O
beliefs    O
are    O
also    O
congruent    O
with    O
CAM    O
psychotherapies    O
such    O
as    O
attachment    B-Therapy100661091
therapy    I-Therapy100661091
(    O
not    O
based    O
on    O
attachment    O
theory    O
)    O
,    O
which    O
purport    O
to    O
bring    O
about    O
age    O
regression    O
and    O
to    O
recapitulate    O
early    O
development    O
to    O
produce    O
a    O
better    O
outcome    O
.    O

Both    O
Castles    O
and    O
Coltheart    O
have    O
also    O
criticised    O
the    O
Arrowsmith    O
Program    O
and    O
other    O
"    O
brain    O
training    O
"    O
programs    O
such    O
the    O
Dore    B-Therapy100661091
Programme    I-Therapy100661091
and    O
Brain    O
Gym    O
as    O
based    O
on    O
an    O
oversimplification    O
of    O
neuroplasticity    O
and    O
other    O
neuroscientific    O
concepts    O
.    O

He    O
was    O
the    O
father    O
of    O
Carl    O
Heinrich    O
Ebermaier    O
,    O
a    O
writer    O
on    O
medicinal    B-Therapy100661091
botany    I-Therapy100661091
.    O

The    O
flowers    O
were    O
used    O
medicinally    B-Therapy100661091
to    O
treat    O
pain    O
experienced    O
during    O
childbirth    O
.    O

The    O
products    O
were    O
made    O
using    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
plants    O
green    O
gentian    O
,    O
licorice    O
,    O
philodendron    O
bark    O
,    O
cinnamon    O
,    O
etc    O
.    O

Yaoxing    O
Lun    O
(    O
Yao    O
-    O
hsing    O
Lun    O
;    O
)    O
,    O
literally    O
"    O
Treatise    O
on    O
the    O
Nature    O
of    O
Medicinal    O
Herbs    O
"    O
,    O
is    O
a    O
7th    O
-    O
century    O
Tang    O
Dynasty    O
Chinese    O
treatise    O
on    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
.    O

Threats    O
to    O
the    O
species    O
include    O
over    O
-    O
collection    O
by    O
orchid    O
hunters    O
and    O
poaching    O
of    O
the    O
plant    O
for    O
use    O
as    O
an    O
herbal    B-Therapy100661091
remedy    I-Therapy100661091
.    O

His    O
father    O
was    O
a    O
herbalist    B-Therapy100661091
,    O
and    O
he    O
trained    O
under    O
him    O
and    O
joined    O
the    O
family    O
business    O
of    O
dispensing    O
herbal    O
medicines    O
.    O

Many    O
medicinal    B-Therapy100661091
plant    I-Therapy100661091
can    O
be    O
found    O
all    O
throughout    O
Kallara    O
.    O

This    O
was    O
a    O
time    O
when    O
plants    O
and    O
botany    O
was    O
linked    O
very    O
closely    O
with    O
medicine    O
and    O
herbal    B-Therapy100661091
remedies    I-Therapy100661091
.    O

Herbalism    B-Therapy100661091

Wood    O
betony    O
,    O
"    O
Stachys    O
officinalis    O
"    O
,    O
was    O
the    O
most    O
important    O
medicinal    B-Therapy100661091
herb    I-Therapy100661091
to    O
the    O
Anglo    O
-    O
Saxons    O
of    O
early    O
medieval    O
Great    O
Britain    O
.    O

The    O
name    O
woundwort    O
derives    O
from    O
the    O
past    O
use    O
of    O
certain    O
species    O
in    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
for    O
the    O
treatment    O
of    O
wounds    O
.    O

Several    O
species    O
are    O
grown    O
as    O
ornamental    O
plants    O
,    O
as    O
leaf    O
vegetables    O
,    O
as    O
root    O
vegetables    O
for    O
their    O
edible    O
tubers    O
,    O
or    O
as    O
medicine    B-Therapy100661091
.    O

Healing    O
practitioners    O
often    O
specialize    O
in    O
a    O
complementary    O
and    O
alternative    O
field    O
of    O
healthcare    O
that    O
could    O
be    O
anything    O
from    O
homeopathy    O
,    O
phytotherapy    B-Therapy100661091
,    O
Chinese    O
medicine    O
,    O
Ayurvedic    O
medicine    O
,    O
to    O
reflexology    O
or    O
acupuncture    O
.    O

Some    O
species    O
are    O
renowned    O
for    O
their    O
properties    O
in    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
and    O
herbalism    B-Therapy100661091
;    O
for    O
example    O
Vera    O
Cruz    O
jalap    O
(    O
"    O
I.    O
jalapa    O
"    O
)    O
and    O
Tampico    O
jalap    O
(    O
"    O
I.    O
simulans    O
"    O
)    O
are    O
used    O
to    O
produce    O
jalap    O
,    O
a    O
cathartic    O
preparation    O
accelerating    O
the    O
passage    O
of    O
stool    O
.    O

Herbology    B-Therapy100661091

Some    O
elderly    O
people    O
have    O
multiple    O
medical    O
disorders    O
;    O
some    O
have    O
self    O
-    O
prescribed    O
many    O
herbal    B-Therapy100661091
medication    I-Therapy100661091
and    O
over    O
-    O
the    O
-    O
counter    O
drugs    O
.    O

"    O
Ulmus    O
"    O
provides    O
important    O
timber    O
trees    O
mostly    O
for    O
furniture    O
,    O
and    O
"    O
U.    O
rubra    O
"    O
,    O
the    O
slippery    O
elm    O
,    O
is    O
a    O
medicinal    B-Therapy100661091
plant    I-Therapy100661091
known    O
for    O
the    O
demulcent    O
property    O
of    O
its    O
inner    O
bark    O
.    O

This    O
is    O
a    O
list    O
of    O
plants    O
used    O
or    O
formerly    O
used    O
as    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
.    O

Ayurvedic    O
medicine    O
,    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
and    O
traditional    O
Chinese    O
medicine    O
are    O
other    O
examples    O
of    O
medical    O
practices    O
that    O
incorporate    O
medical    O
uses    O
of    O
plants    O
.    O

Other    O
plant    O
species    O
reported    O
are    O
14    O
types    O
of    O
orchid    O
(    O
"    O
Orchidaceae    O
"    O
)    O
and    O
more    O
than    O
250    O
species    O
of    O
herbal    B-Therapy100661091
plants    I-Therapy100661091
.    O

This    O
deficiency    O
—    O
known    O
as    O
apparent    O
mineralocorticoid    O
excess    O
syndrome    O
—    O
can    O
either    O
be    O
congenital    O
or    O
caused    O
by    O
consumption    O
of    O
glycyrrhizin    O
,    O
which    O
is    O
contained    O
in    O
extract    O
of    O
licorice    O
,    O
sometimes    O
found    O
in    O
herbal    B-Therapy100661091
supplements    I-Therapy100661091
,    O
candies    O
,    O
and    O
chewing    O
tobacco    O
.    O

As    O
its    O
leaves    O
were    O
necessary    O
food    O
for    O
the    O
caterpillars    O
that    O
make    O
silk    O
,    O
much    O
of    O
the    O
plant    O
–    O
including    O
branches    O
,    O
fruits    O
,    O
leaves    O
,    O
and    O
root    O
bark    O
–    O
became    O
revered    O
in    O
ancient    O
China    O
as    O
source    O
of    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
.    O

Besides    O
being    O
respected    O
for    O
his    O
expertise    O
in    O
surgery    O
and    O
anaesthesia    O
,    O
Hua    O
Tuo    O
was    O
famous    O
for    O
his    O
abilities    O
in    O
acupuncture    O
,    O
moxibustion    O
,    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
and    O
medical    O
Daoyin    O
exercises    O
.    O

An    O
herbal    B-Therapy100661091
remedy    I-Therapy100661091
called    O
"    O
rhizoma    O
polygonati    O
"    O
is    O
a    O
mix    O
of    O
"    O
Polygonatum    O
"    O
species    O
used    O
in    O
traditional    O
Chinese    O
medicine    O
.    O

In    O
Mexico    O
the    O
plant    O
is    O
used    O
as    O
an    O
herbal    B-Therapy100661091
remedy    I-Therapy100661091
for    O
dysentery    O
and    O
fever    O
.    O

Buchu    O
formally    O
denotes    O
two    O
herbal    B-Therapy100661091
species    O
,    O
prized    O
for    O
their    O
fragrance    O
and    O
medicinal    O
use    O
.    O

The    O
leaves    O
of    O
"    O
Agathosma    O
betulina    O
"    O
have    O
traditionally    O
been    O
used    O
as    O
an    O
herbal    B-Therapy100661091
remedy    I-Therapy100661091
for    O
ailments    O
of    O
the    O
gastrointestinal    O
and    O
urinary    O
tracts    O
,    O
as    O
it    O
has    O
diuretic    O
and    O
antiseptic    O
properties    O
due    O
to    O
various    O
phenolic    O
compounds    O
.    O

Other    O
freight    O
traffic    O
included    O
goods    O
from    O
the    O
Ashton    O
Containers    O
factory    O
and    O
a    O
local    O
firm    O
dealing    O
in    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
.    O

The    O
bark    O
is    O
also    O
considered    O
to    O
have    O
traditional    O
medicinal    B-Therapy100661091
uses    I-Therapy100661091
.    O

A    O
major    O
component    O
of    O
traditional    O
medicine    O
is    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
,    O
which    O
is    O
the    O
use    O
of    O
natural    O
plant    O
substances    O
to    O
treat    O
or    O
prevent    O
illness    O
.    O

Michael    O
Moore    O
(    O
January    O
9    O
,    O
1941    O
–    O
February    O
20    O
,    O
2009    O
)    O
was    O
a    O
medicinal    O
herbalist    B-Therapy100661091
,    O
author    O
of    O
several    O
reference    O
works    O
on    O
botanical    O
medicine    O
,    O
and    O
founder    O
of    O
the    O
Southwest    O
School    O
of    O
Botanical    O
Medicine    O
(    O
SWSBM    O
)    O
.    O

Herbalism    B-Therapy100661091

Indian    O
banyan    O
(    O
"    O
F.    O
bengalensis    O
"    O
)    O
and    O
the    O
Indian    O
rubber    O
plant    O
,    O
as    O
well    O
as    O
other    O
species    O
,    O
have    O
use    O
in    O
herbalism    B-Therapy100661091
.    O

Gentian    O
is    O
used    O
in    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
to    O
treat    O
digestive    O
problems    O
,    O
fever    O
,    O
hypertension    O
,    O
muscle    O
spasms    O
,    O
parasitic    O
worms    O
,    O
wounds    O
,    O
cancer    O
,    O
sinusitis    O
,    O
and    O
malaria    O
,    O
although    O
studies    O
have    O
shown    O
no    O
efficacy    O
beyond    O
that    O
of    O
a    O
placebo    O
.    O

Its    O
spicy    O
fruits    O
are    O
used    O
for    O
preparing    O
vegetables    O
,    O
curry    O
and    O
fine    O
pickles    O
and    O
can    O
attract    O
helpful    O
insectivores    O
;    O
the    O
plant    O
also    O
is    O
used    O
in    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
and    O
herbalism    B-Therapy100661091
.    O

This    O
plant    O
has    O
a    O
number    O
of    O
traditional    O
medicinal    B-Therapy100661091
uses    I-Therapy100661091
,    O
including    O
treatment    O
of    O
snakebite    O
,    O
induction    O
of    O
abortion    O
,    O
and    O
for    O
chronic    O
renal    O
disease    O
.    O

Vaidyar    O
(    O
other    O
wise    O
known    O
as    O
Vaidyan    O
)    O
is    O
a    O
Malayalam    O
term    O
implies    O
physician    O
or    O
practitioner    O
of    O
any    O
Indian    O
systems    O
of    O
medicine    O
(    O
Ayurveda    O
,    O
Siddha    O
etc    O
)    O
,    O
particularly    O
referred    O
to    O
an    O
expert    O
who    O
practice    O
herbal    B-Therapy100661091
medicine    O
.    O

He    O
is    O
also    O
a    O
herbalist    B-Therapy100661091
,    O
or    O
a    O
“    O
herb    O
doctor    O
”    O
,    O
skilled    O
in    O
the    O
harvesting    O
and    O
collection    O
of    O
medicinal    O
plants    O
.    O

Herbalism    B-Therapy100661091

As    O
an    O
independent    O
body    O
,    O
ACAOM    O
accredits    O
first    O
professional    O
master    O
's    O
degree    O
and    O
professional    O
Master    O
's    O
level    O
certificate    O
and    O
diploma    O
programs    O
in    O
acupuncture    O
and    O
first    O
professional    O
master    O
's    O
degree    O
and    O
professional    O
Master    O
's    O
level    O
certificate    O
and    O
diploma    O
programs    O
in    O
Oriental    O
medicine    O
with    O
a    O
concentration    O
in    O
both    O
acupuncture    O
and    O
herbal    B-Therapy100661091
therapies    I-Therapy100661091
.    O

The    O
field    O
of    O
activity    O
and    O
the    O
subject    O
of    O
the    O
articles    O
are    O
biography    O
of    O
famous    O
Iranian    O
and    O
foreign    O
physicians    O
,    O
pharmacologists    O
,    O
pharmacists    O
and    O
herbalist    B-Therapy100661091
in    O
past    O
centuries    O
,    O
hospitals    O
,    O
medical    O
schools    O
and    O
centers    O
,    O
drugs    O
,    O
herbs    O
,    O
medical    O
instruments    O
and    O
Terms    O
in    O
the    O
history    O
of    O
medicine    O
.    O

The    O
root    O
was    O
formerly    O
employed    O
in    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
as    O
a    O
diuretic    O
and    O
cold    O
remedy    O
.    O

Many    O
hundreds    O
of    O
medicines    O
are    O
derived    O
from    O
plants    O
,    O
both    O
traditional    O
medicines    O
used    O
in    O
herbalism    B-Therapy100661091
and    O
chemical    O
substances    O
purified    O
from    O
plants    O
or    O
first    O
identified    O
in    O
them    O
,    O
sometimes    O
by    O
ethnobotanical    O
search    O
,    O
and    O
then    O
synthesised    O
for    O
use    O
in    O
modern    O
medicine    O
.    O

Herbal    B-Therapy100661091
Medicine    I-Therapy100661091

He    O
was    O
born    O
into    O
a    O
family    O
of    O
traditional    O
healers    O
;    O
he    O
states    O
that    O
he    O
established    O
Mayantuyacu    O
to    O
practice    O
plant    B-Therapy100661091
therapy    I-Therapy100661091
and    O
pass    O
on    O
the    O
traditional    O
knowledge    O
to    O
future    O
generations    O
.    O

She    O
learned    O
various    O
skills    O
from    O
her    O
mother    O
,    O
including    O
tanning    O
,    O
herbalism    B-Therapy100661091
,    O
sewing    O
,    O
and    O
Inupiat    O
culture    O
.    O

Neoplasene    O
is    O
an    O
herbal    B-Therapy100661091
veterinary    O
medicine    O
derived    O
from    O
certain    O
chemicals    O
,    O
such    O
as    O
sanguinarine    O
,    O
extracted    O
from    O
the    O
perennial    O
herb    O
"    O
Sanguinaria    O
canadensis    O
"    O
(    O
the    O
bloodroot    O
plant    O
)    O
.    O

The    O
plant    O
produces    O
cyclopeptide    O
alkaloids    O
known    O
as    O
ziziphines    O
and    O
has    O
a    O
long    O
history    O
of    O
use    O
as    O
an    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
.    O

John    O
Wilkinson    O
(    O
born    O
1961    O
)    O
is    O
an    O
English    O
,    O
independent    O
scientist    O
specialising    O
primarily    O
in    O
organic    O
chemistry    O
,    O
phytochemistry    O
,    O
pharmacognosy    O
,    O
and    O
synergism    O
in    O
botanical    O
medicines    O
,    O
botanical    O
foods    O
and    O
ecological    O
biochemistry    O
,    O
and    O
who    O
led    O
the    O
first    O
European    O
degree    O
course    O
(    O
Bachelor    O
of    O
Science    O
with    O
Honours    O
)    O
for    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
,    O
at    O
Middlesex    O
University    O
in    O
the    O
United    O
Kingdom    O
in    O
1994    O
.    O

Following    O
his    O
post    O
-    O
doctoral    O
work    O
in    O
the    O
United    O
States    O
,    O
Wilkinson    O
returned    O
to    O
the    O
UK    O
and    O
became    O
a    O
visiting    O
Research    O
Fellow    O
in    O
Phytochemistry    O
at    O
the    O
University    O
of    O
Exeter    O
in    O
1993    O
,    O
with    O
Professor    O
Stan    O
Roberts    O
,    O
and    O
was    O
also    O
a    O
visiting    O
lecturer    O
at    O
The    O
School    O
of    O
Phytotherapy    B-Therapy100661091
in    O
East    O
Sussex    O
with    O
the    O
eminent    O
medical    O
herbalist    B-Therapy100661091
and    O
scientist    O
,    O
Hein    O
Zeylstra    O
(    O
1928–2001    O
)    O
.    O

In    O
1994    O
,    O
Wilkinson    O
programme    O
led    O
the    O
first    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
degree    O
course    O
in    O
Europe    O
,    O
from    O
its    O
beginnings    O
in    O
1994    O
at    O
Middlesex    O
University    O
.    O

Dr    O
Wilkinson    O
continues    O
to    O
work    O
in    O
the    O
area    O
of    O
regulatory    O
approval    O
for    O
health    O
claims    O
on    O
food    O
labels    O
,    O
novel    O
foods    O
,    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
and    O
food    O
supplements    O
in    O
the    O
EU    O
,    O
the    O
US    O
and    O
elsewhere    O
.    O

Manuel    O
Córdova    O
-    O
Rios    O
(    O
November    O
22    O
,    O
1887    O
–    O
November    O
22    O
,    O
1978    O
)    O
was    O
a    O
vegetalista    O
(    O
herbalist    B-Therapy100661091
)    O
of    O
the    O
upper    O
Amazon    O
,    O
and    O
the    O
subject    O
of    O
several    O
popular    O
books    O
.    O

Córdova    O
told    O
also    O
about    O
the    O
time    O
he    O
journeyed    O
to    O
discuss    O
with    O
a    O
"    O
superstitious    O
and    O
clannish    O
people    O
"    O
their    O
on    O
-    O
site    O
employment    O
for    O
the    O
commercial    O
collection    O
of    O
medical    B-Therapy100661091
plant    I-Therapy100661091
.    O

Herbalist    B-Therapy100661091

The    O
leaves    O
are    O
used    O
in    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
for    O
the    O
treatment    O
of    O
some    O
diseases    O
such    O
as    O
of    O
liver    O
and    O
kidney    O
and    O
allergies    O
.    O

Herbalism    B-Therapy100661091

The    O
Kachin    O
people    O
are    O
traditionally    O
known    O
for    O
their    O
disciplined    O
fighting    O
skills    O
,    O
complex    O
clan    O
inter    O
-    O
relations    O
,    O
craftsmanship    O
,    O
herbal    B-Therapy100661091
healing    I-Therapy100661091
and    O
jungle    O
survival    O
skills    O
.    O

Herbalism    B-Therapy100661091

Medication    O
,    O
licensed    O
pharmaceutical    O
drugs    O
(    O
see    O
pharmacology    O
)    O
or    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091

Students    O
receive    O
training    O
in    O
herbalism    B-Therapy100661091
,    O
acupuncture    O
,    O
moxibustion    O
,    O
Asian    O
bodywork    O
,    O
qigong    B-Therapy100661091
and    O
nutrition    O
.    O

Myrtol    O
standardized    O
is    O
a    O
phytotherapeutic    B-Therapy100661091
extract    O
(    O
distillate    O
)    O
consisting    O
mainly    O
of    O
three    O
monoterpenes    O
:    O
(    O
+    O
)    O
-α-pinene    O
,    O
d    O
-    O
limonene    O
and    O
1,8-cineole    O
(    O
as    O
known    O
as    O
"    O
Eucalyptol    O
"    O
,    O
but    O
not    O
be    O
confused    O
with    O
Eucalyptus    O
oil    O
)    O
.    O

The    O
Syrian    O
rhubarb    O
a    O
partially    O
commercial    O
vegetable    O
collected    O
from    O
the    O
nature    O
in    O
Eastern    O
and    O
Southern    O
Anatolia    O
,    O
Northern    O
Iraq    O
and    O
partly    O
Northwestern    O
Iran    O
in    O
early    O
spring    O
.    O
"    O
Rheum    O
ribes    O
"    O
is    O
considered    O
as    O
a    O
valuable    O
medicinal    O
species    O
in    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
.    O

Traditional    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
stem    O
and    O
root    O
dry    O
plant    O
for    O
the    O
treatment    O
of    O
anemia    O
,    O
anorexia    O
,    O
weakness    O
,    O
anxiety    O
,    O
depression    O
and    O
diabetes    O
.    O

The    O
Jingpo    O
people    O
are    O
an    O
ethnic    O
affinity    O
of    O
several    O
tribal    O
groups    O
,    O
known    O
for    O
their    O
fierce    O
independence    O
,    O
disciplined    O
fighting    O
skills    O
,    O
complex    O
clan    O
inter    O
-    O
relations    O
,    O
embrace    O
of    O
Christianity    O
,    O
craftsmanship    O
,    O
herbal    B-Therapy100661091
healing    I-Therapy100661091
and    O
jungle    O
survival    O
skills    O
.    O

The    O
boys    O
and    O
girls    O
learn    O
the    O
plants    O
that    O
provide    O
the    O
Pojulu    O
with    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
,    O
such    O
as    O
"    O
Dikori    O
Ti    O
–    O
Melo    O
"    O
,    O
in    O
the    O
community    O
medicine    O
tradition    O
.    O

They    O
plant    O
rice    O
,    O
mustard    O
,    O
corn    O
and    O
lentils    O
,    O
but    O
also    O
collect    O
forest    O
products    O
such    O
as    O
wild    O
fruits    O
,    O
vegetables    O
,    O
medicinal    B-Therapy100661091
plant    I-Therapy100661091
and    O
materials    O
to    O
build    O
their    O
houses    O
;    O
hunt    O
deer    O
,    O
rabbit    O
and    O
wild    O
boar    O
,    O
and    O
go    O
fishing    O
in    O
the    O
rivers    O
and    O
oxbow    O
lakes    O
.    O

Ashoka    O
also    O
claims    O
that    O
he    O
encouraged    O
the    O
development    O
of    O
herbalism    B-Therapy100661091
,    O
for    O
men    O
and    O
animals    O
,    O
in    O
the    O
territories    O
of    O
the    O
Hellenistic    O
Kings    O
.    O

Several    O
species    O
,    O
most    O
notably    O
"    O
S.    O
album    O
"    O
,    O
produce    O
highly    O
aromatic    O
wood    O
,    O
used    O
for    O
scents    O
and    O
perfumes    O
and    O
for    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
.    O

Studies    O
have    O
shown    O
no    O
benefit    O
for    O
the    O
use    O
of    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
on    O
all    O
cause    O
mortality    O
in    O
viral    O
myocarditis    O
.    O

"    O
Eupatorium    O
perfoliatum    O
"    O
was    O
used    O
in    O
the    O
traditional    O
medicine    O
of    O
Native    O
Americans    O
and    O
extracts    O
are    O
now    O
used    O
in    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
for    O
fever    O
and    O
colds    O
.    O

However    O
,    O
the    O
institutionalization    O
of    O
mental    O
health    O
was    O
viewed    O
with    O
suspicion    O
by    O
many    O
Nigerians    O
and    O
many    O
still    O
depended    O
on    O
native    O
medicines    O
and    O
herbalists    B-Therapy100661091
for    O
care    O
.    O

Besides    O
fruit    O
,    O
the    O
tree    O
yields    O
valuable    O
wood    O
and    O
hard    O
seeds    O
which    O
are    O
burned    O
for    O
fuel    O
,    O
and    O
has    O
parts    O
used    O
medicinally    B-Therapy100661091
in    O
Vietnam    O
.    O

The    O
Chilean    O
myrtle    O
has    O
medicinal    B-Therapy100661091
uses    I-Therapy100661091
for    O
the    O
Mapuche    O
people    O
.    O

In    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
,    O
an    O
herbal    O
tonic    O
is    O
used    O
to    O
help    O
restore    O
,    O
tone    O
and    O
invigorate    O
systems    O
in    O
the    O
body    O
or    O
to    O
promote    O
general    O
health    O
and    O
well    O
-    O
being    O
.    O

Ephedra    O
was    O
used    O
5000    O
years    O
ago    O
in    O
China    O
as    O
a    O
medicinal    B-Therapy100661091
plant    I-Therapy100661091
;    O
its    O
active    O
ingredients    O
are    O
alkaloids    O
ephedrine    O
,    O
pseudoephedrine    O
,    O
norephedrine    O
(    O
phenylpropanolamine    O
)    O
and    O
norpseudoephedrine    O
(    O
cathine    O
)    O
.    O

They    O
are    O
also    O
used    O
in    O
some    O
herbal    B-Therapy100661091
remedies    I-Therapy100661091
;    O
the    O
plant    O
's    O
rhizomes    O
are    O
collected    O
in    O
the    O
autumn    O
and    O
winter    O
and    O
dried    O
in    O
the    O
sun    O
before    O
use    O
.    O

Certificates    O
were    O
offered    O
in    O
iridology    O
,    O
Herbalism    B-Therapy100661091
,    O
Companion    O
Animal    O
Studies    O
,    O
Practitioner    O
Education    O
Studies    O
,    O
and    O
Natural    O
Wellness    O
Studies    O
.    O

Important    O
Indian    O
trees    O
include    O
the    O
medicinal    O
neem    O
,    O
widely    O
used    O
in    O
rural    O
Indian    O
herbal    B-Therapy100661091
remedies    O
.    O

;    O
Yvette    O
Valence    O
:    O
A    O
local    O
herbalist    B-Therapy100661091
who    O
is    O
from    O
the    O
Basque    O
country    O
.    O

It    O
is    O
used    O
as    O
a    O
medicinal    B-Therapy100661091
plant    I-Therapy100661091
and    O
has    O
a    O
bitter    O
taste    O
.    O

Herbalist    B-Therapy100661091
have    O
used    O
the    O
rhizome    O
of    O
"    O
Iris    O
setosa    O
"    O
for    O
centuries    O
as    O
an    O
ingredient    O
in    O
various    O
medicines    O
,    O
(    O
similar    O
to    O
the    O
usage    O
of    O
Orris    O
roots    O
)    O
.    O

There    O
is    O
an    O
important    O
research    O
facility    O
that    O
started    O
life    O
as    O
a    O
base    O
to    O
develop    O
herbal    B-Therapy100661091
remedies    I-Therapy100661091
and    O
to    O
house    O
the    O
species    O
collected    O
from    O
the    O
new    O
-    O
world    O
trips    O
,    O
today    O
it    O
is    O
dedicated    O
to    O
maintaining    O
Europe    O
's    O
ecosystem    O
.    O

This    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
is    O
composed    O
of    O
Korean    O
ginseng    O
,    O
Rehmannia    O
root    O
,    O
Poria    O
Cocos    O
and    O
Honey    O
based    O
on    O
the    O
prescription    O
on    O
the    O
Korean    O
traditional    O
medical    O
book    O
Dongeui    O
Bogam    O
,    O
which    O
is    O
recognized    O
as    O
a    O
restorative    O
enforcing    O
the    O
vitality    O
of    O
whole    O
organs    O
,    O
elimination    O
fatigues    O
,    O
anti    O
-    O
exhaustion    O
followed    O
by    O
weariness    O
.    O

Big    O
sagebrush    O
is    O
used    O
as    O
a    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
by    O
Native    O
Americans    O
throughout    O
the    O
Intermountain    O
West    O
of    O
North    O
America    O
,    O
most    O
notably    O
as    O
a    O
smudging    O
herb    O
.    O

Some    O
definitions    O
restrict    O
the    O
term    O
to    O
topical    O
medications    O
,    O
including    O
herbal    B-Therapy100661091
simples    I-Therapy100661091
such    O
as    O
onion    O
,    O
lily    O
,    O
root    O
of    O
mallows    O
,    O
leaves    O
of    O
violet    O
,    O
and    O
elderberry    O
.    O

The    O
teaching    O
clinic    O
at    O
ICAOM    O
provides    O
instruction    O
to    O
students    O
and    O
medical    O
care    O
to    O
the    O
local    O
population    O
using    O
the    O
modalities    O
of    O
acupuncture    O
,    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
,    O
tui    O
na    O
,    O
cupping    O
,    O
moxibustion    O
and    O
lifestyle    O
counseling    O
.    O

.    O
D.D.DCM    O
.    O
pharmacist    O
by    O
profession    O
,    O
specializing    O
in    O
herbalism    B-Therapy100661091
.    O

Thomas    O
Corbett    O
(    O
1780–1857    O
)    O
,    O
a    O
Shaker    O
doctor    O
that    O
was    O
well    O
known    O
nationally    O
for    O
his    O
botanical    B-Therapy100661091
medicine    I-Therapy100661091

There    O
,    O
he    O
continued    O
his    O
business    O
of    O
manufacturing    O
woodworking    O
machinery    O
,    O
while    O
she    O
practiced    O
medicine    O
and    O
made    O
and    O
sold    O
herbal    B-Therapy100661091
remedies    I-Therapy100661091
.    O

The    O
dried    O
root    O
of    O
"    O
Lithospermum    O
erythrorhizon    O
"    O
is    O
a    O
Chinese    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
with    O
various    O
antiviral    O
and    O
biological    O
activities    O
,    O
including    O
inhibition    O
of    O
human    O
immunodeficiency    O
virus    O
type    O
1    O
(    O
HIV-1    O
)    O
.    O

Herbal    B-Therapy100661091
medicine    I-Therapy100661091

KMA    O
is    O
liable    O
to    O
protect    O
the    O
health    O
,    O
provide    O
quality    O
and    O
guaranteed    O
medical    O
products    O
,    O
equipment    O
,    O
and    O
services    O
through    O
the    O
licensing    O
of    O
professional    O
companies    O
and    O
individuals    O
and    O
yet    O
,    O
"    O
regulates    O
the    O
production    O
,    O
import    O
and    O
distribution    O
of    O
medicinal    O
products    O
,    O
active    O
substances    O
,    O
herbal    B-Therapy100661091
products    I-Therapy100661091
,    O
dietary    O
supplements    O
,    O
excipients    O
,    O
therapeutic    O
dosage    O
vitamins    O
,    O
medical    O
equipment    O
(    O
medical    O
imaging    O
machines    O
,    O
medical    O
lasers    O
,    O
life    O
support    O
equipment    O
,    O
in    O
vitro    O
diagnostic    O
,    O
etc    O
)    O
.    O
"    O

This    O
plant    O
has    O
historically    O
been    O
used    O
as    O
a    O
natural    O
sweetener    O
and    O
medicinal    B-Therapy100661091
herb    I-Therapy100661091
in    O
its    O
native    O
Mexico    O
and    O
parts    O
of    O
Central    O
America    O
.    O

Of    O
the    O
500    O
+    O
species    O
,    O
only    O
a    O
few    O
were    O
used    O
traditionally    O
as    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
,    O
"    O
Aloe    O
vera    O
"    O
again    O
being    O
the    O
most    O
commonly    O
used    O
species    O
.    O

Herbal    B-Therapy100661091
medicine    I-Therapy100661091
,    O
or    O
phytotherapy    B-Therapy100661091
,    O
includes    O
not    O
just    O
the    O
use    O
of    O
plant    O
products    O
,    O
but    O
may    O
also    O
include    O
the    O
use    O
of    O
animal    O
and    O
mineral    O
products    O
.    O

The    O
most    O
common    O
CAM    O
therapies    O
used    O
in    O
the    O
US    O
in    O
2002    O
were    O
prayer    O
(    O
45%    O
)    O
,    O
herbalism    B-Therapy100661091
(    O
19%    O
)    O
,    O
breathing    O
meditation    O
(    O
12%    O
)    O
,    O
meditation    O
(    O
8%    O
)    O
,    O
chiropractic    O
medicine    O
(    O
8%    O
)    O
,    O
yoga    O
(    O
5–6%    O
)    O
,    O
body    O
work    O
(    O
5%    O
)    O
,    O
diet    O
-    O
based    O
therapy    O
(    O
4%    O
)    O
,    O
progressive    O
relaxation    O
(    O
3%    O
)    O
,    O
mega    O
-    O
vitamin    O
therapy    O
(    O
3%    O
)    O
and    O
Visualization    O
(    O
2%    O
)    O

File    O
:    O
American    O
medical    O
botany    O
,    O
being    O
a    O
collection    O
of    O
the    O
native    O
medicinal    O
plants    O
of    O
the    O
United    O
States    O
,    O
containing    O
their    O
botanical    O
history    O
and    O
chemical    O
analysis    O
,    O
and    O
properties    O
and    O
uses    O
in    O
medicine    O
,    O
diet    O
and    O
(    O
Phytotherapy    B-Therapy100661091
(    O
herbal    O
medicine    O
)    O
:    O
an    O
engraving    O
of    O
"    O
magnolia    O
glauca    O
"    O
in    O
Jacob    O
Bigelow    O
's    O
"    O
American    O
Medical    O
Botany    O
"    O

The    O
plants    O
are    O
used    O
in    O
herbalism    B-Therapy100661091
against    O
a    O
range    O
of    O
conditions    O
,    O
such    O
as    O
urinary    O
tract    O
,    O
neurological    O
and    O
menstruation    O
disorders    O
,    O
constipation    O
,    O
edema    O
,    O
fevers    O
,    O
tuberculosis    O
,    O
ulcers    O
,    O
Parkinson    O
's    O
disease    O
,    O
and    O
helminthiases    O
like    O
elephantiasis    O
.    O

The    O
Eora    O
people    O
did    O
not    O
grow    O
or    O
plant    O
crops    O
;    O
although    O
the    O
women    O
picked    O
herbs    O
which    O
were    O
used    O
in    O
herbal    B-Therapy100661091
remedies    I-Therapy100661091
.    O

The    O
feverfew    O
plant    O
is    O
used    O
in    O
herbalism    B-Therapy100661091
for    O
a    O
variety    O
of    O
aliments    O
.    O

Brown    O
married    O
a    O
local    O
woman    O
and    O
remained    O
in    O
London    O
until    O
his    O
death    O
,    O
earning    O
a    O
living    O
as    O
a    O
herbalist    B-Therapy100661091
.    O

No    O
uses    O
in    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
are    O
commonly    O
known    O
.    O

They    O
worked    O
as    O
herbalists    B-Therapy100661091
,    O
midwives    O
,    O
surgeons    O
,    O
barber    O
-    O
surgeons    O
,    O
nurses    O
,    O
and    O
traditional    O
empirics    O
.    O

Herbalism    B-Therapy100661091

Another    O
ancient    O
analgesic    O
method    O
,    O
aging    O
back    O
to    O
5000    O
BCE    O
in    O
Sumer    O
,    O
is    O
to    O
use    O
natural    O
minerals    O
,    O
vitamins    O
,    O
and    O
herbs    B-Therapy100661091
,    O
usually    O
in    O
a    O
mixture    O
with    O
other    O
natural    O
products    O
.    O

Keewaydinoquay    O
Pakawakuk    O
Peschel    O
was    O
a    O
scholar    O
,    O
ethnobotanist    O
,    O
herbalist    B-Therapy100661091
,    O
medicine    O
woman    O
,    O
teacher    O
and    O
author    O
.    O

Herbalism    B-Therapy100661091

The    O
National    O
Institute    O
of    O
Medical    O
Herbalists    O
(    O
NIMH    O
)    O
is    O
a    O
professional    O
body    O
regulating    O
medical    O
herbalists    B-Therapy100661091
in    O
the    O
United    O
Kingdom    O
.    O

NIMH    O
-    O
registered    O
medical    O
herbalists    B-Therapy100661091
are    O
trained    O
in    O
the    O
same    O
diagnostic    O
skills    O
as    O
mainstream    O
doctors    O
and    O
take    O
a    O
holistic    O
approach    O
to    O
health    O
.    O

He    O
continues    O
to    O
attend    O
conferences    O
on    O
herbology    B-Therapy100661091
as    O
a    O
keynote    O
speaker    O
or    O
contributor    O
.    O

In    O
the    O
Córdoba    O
hills    O
are    O
stands    O
of    O
olives    O
,    O
peach    O
,    O
pear    O
,    O
apricot    O
,    O
fig    O
trees    O
,    O
quince    O
,    O
lemon    O
trees    O
,    O
cypress    O
,    O
cedar    O
,    O
ponderosa    O
pine    O
,    O
eucalyptus    O
,    O
poplar    O
,    O
oak    O
and    O
willow    O
Especially    O
in    O
the    O
Córdoba    O
and    O
San    O
Luis    O
areas    O
are    O
found    O
shrubs    O
and    O
medicinal    B-Therapy100661091
herbs    I-Therapy100661091
peperina    O
,    O
pennyroyal    O
,    O
dandelion    O
,    O
plantain    O
,    O
canchalagua    O
,    O
wild    O
grapes    O
,    O
chamomile    O
,    O
malva    O
,    O
lime    O
and    O
passion    O
fruit    O
.    O

As    O
the    O
population    O
of    O
Chinatown    O
increased    O
,    O
small    O
shops    O
appeared    O
,    O
wells    O
were    O
sunk    O
to    O
supply    O
water    O
,    O
there    O
were    O
cooks    O
,    O
herbalist    B-Therapy100661091
,    O
doctors    O
and    O
merchants    O
etc    O
.    O

The    O
Durnos    O
began    O
manufacturing    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
and    O
Durno    O
Catarrh    O
Snuff    O
.    O

As    O
Mulder    O
and    O
Scully    O
investigate    O
,    O
they    O
discover    O
a    O
Malaysian    O
orderly    O
is    O
illicitly    O
giving    O
the    O
patients    O
an    O
herbal    B-Therapy100661091
drug    O
made    O
of    O
mushrooms    O
he    O
cultures    O
in    O
the    O
building    O
's    O
basement    O
.    O

For    O
his    O
research    O
on    O
new    O
medicinal    B-Therapy100661091
plants    I-Therapy100661091
,    O
he    O
was    O
named    O
one    O
of    O
eleven    O
"    O
Heroes    O
of    O
Medicine    O
"    O
by    O
"    O
"    O
Time    O
"    O
"    O
magazine    O
.    O

Lapacho    O
is    O
used    O
in    O
the    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
of    O
several    O
South    O
and    O
Central    O
American    O
indigenous    O
peoples    O
to    O
treat    O
a    O
number    O
of    O
ailments    O
including    O
infection    O
,    O
fever    O
and    O
stomach    O
complaints    O
.    O

Their    O
medicine    O
is    O
heavily    O
characterized    O
by    O
Islamic    O
influence    O
from    O
the    O
East    O
as    O
well    O
as    O
traditional    O
African    O
style    O
herbology    B-Therapy100661091
and    O
religious    O
practices    O
which    O
are    O
still    O
prevalent    O
today    O
.    O

First    O
Databank    O
's    O
MedKnowledge    O
provides    O
prices    O
,    O
descriptions    O
,    O
and    O
collateral    O
clinical    O
information    O
on    O
drugs    O
approved    O
by    O
the    O
US    O
Food    O
and    O
Drug    O
Administration    O
(    O
FDA    O
)    O
,    O
plus    O
commonly    O
used    O
over    O
-    O
the    O
-    O
counter    O
drugs    O
,    O
herbal    B-Therapy100661091
remedies    I-Therapy100661091
,    O
nutraceuticals    O
and    O
dietary    O
supplements    O
.    O

It    O
is    O
used    O
for    O
food    O
and    O
medicine    B-Therapy100661091
,    O
and    O
as    O
an    O
insecticide    O
and    O
an    O
ornamental    O
plant    O
.    O

As    O
Michael    O
Weiner    O
,    O
he    O
has    O
written    O
books    O
on    O
nutrition    O
,    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
,    O
and    O
homeopathy    O
;    O
as    O
Michael    O
Savage    O
,    O
he    O
has    O
written    O
four    O
political    O
books    O
that    O
have    O
reached    O
"    O
The    O
New    O
York    O
Times    O
Best    O
Seller    O
List    O
"    O
.    O

In    O
them    O
,    O
he    O
advocates    O
nutritional    O
,    O
herbal    B-Therapy100661091
,    O
and    O
homeopathic    O
options    O
to    O
approach    O
the    O
prevention    O
and    O
treatment    O
of    O
diseases    O
such    O
as    O
poor    O
diet    O
,    O
aging    O
,    O
arthritis    O
,    O
Alzheimer    O
's    O
disease    O
,    O
cancer    O
,    O
allergies    O
,    O
cocaine    O
addiction    O
,    O
the    O
common    O
cold    O
,    O
and    O
AIDS    O
.    O

Gemmotherapy    B-Therapy100661091
[    O
from    O
Lat    O
.    O
"    O
gemma    O
"    O
,    O
bud    O
,    O
and    O
New    O
Lat    O
.    O
"    O
therapīa    O
"    O
,    O
Grk    O
.    O

Insulin    B-Therapy100661091
analog    I-Therapy100661091

Long    O
-    O
acting    O
insulin    B-Therapy100661091
analog    I-Therapy100661091
such    O
as    O
insulin    B-Therapy100661091
glargine    I-Therapy100661091
(    O
brand    O
name    O
"    O
Lantus    O
"    O
,    O
made    O
by    O
Sanofi    O
-    O
Aventis    O
)    O
and    O
insulin    B-Therapy100661091
detemir    I-Therapy100661091
(    O
brand    O
name    O
"    O
Levemir    O
"    O
,    O
made    O
by    O
Novo    O
Nordisk    O
)    O
are    O
also    O
used    O
,    O
with    O
insulin    O
glargine    O
used    O
more    O
than    O
insulin    O
detemir    O
.    O

Insulin    B-Therapy100661091
degludec    I-Therapy100661091
(    O
INN    O
/    O
USAN    O
)    O
is    O
an    O
ultralong    O
-    O
acting    O
basal    O
insulin    B-Therapy100661091
analogue    I-Therapy100661091
that    O
was    O
developed    O
by    O
Novo    O
Nordisk    O
under    O
the    O
brand    O
name    O
Tresiba    B-Therapy100661091
.    O

It    O
has    O
an    O
intermediate    O
duration    O
of    O
action    O
,    O
meaning    O
longer    O
than    O
that    O
of    O
regular    O
and    O
rapid    O
-    O
acting    O
insulin    O
,    O
and    O
shorter    O
than    O
long    O
acting    O
insulins    O
(    O
ultralente    B-Therapy100661091
,    O
glargine    B-Therapy100661091
or    O
detemir    B-Therapy100661091
)    O
.    O

In    O
relation    O
to    O
phytoncide    B-Therapy100661091
,    O
it    O
is    O
speculated    O
that    O
smells    O
associated    O
with    O
trees    O
/    O
forests    O
would    O
stimulate    O
the    O
most    O
physiological    O
change    O
.    O

Professor    O
Zhilin    O
stated    O
'    O
The    O
idol    O
was    O
made    O
from    O
the    O
phytoncidic    B-Therapy100661091
larch    O
,    O
then    O
'    O
canned    O
'    O
in    O
turf    O
which    O
is    O
an    O
acid    O
anaerobic    O
environment    O
that    O
kills    O
microorganisms    O
and    O
also    O
has    O
a    O
tanning    O
effect    O
.    O
'    O

---    O
color    B-Therapy100661091
therapy    I-Therapy100661091

=    O
=    O
=    O
=    O
---    O
color    B-Therapy100661091
therapy    I-Therapy100661091

Chromotherapy    B-Therapy100661091
,    O
sometimes    O
called    O
color    B-Therapy100661091
therapy    I-Therapy100661091
,    O
colorology    B-Therapy100661091
or    O
cromatherapy    B-Therapy100661091
,    O
is    O
an    O
alternative    O
medicine    O
method    O
,    O
which    O
is    O
considered    O
pseudoscience    O
.    O

In    O
1933    O
,    O
Indian    O
-    O
born    O
American    O
-    O
citizen    O
scientist    O
Dinshah    B-Therapy100661091
P.    I-Therapy100661091
Ghadiali    I-Therapy100661091
(    O
1873–1966    O
)    O
,    O
published    O
"    O
The    O
Spectro    O
Chromemetry    O
Encyclopaedia    O
"    O
,    O
a    O
work    O
on    O
color    O
therapy    O
.    O

The    O
Medtronic    O
Diabetes    O
Minimed    B-Therapy100661091
Paradigm    I-Therapy100661091
series    O
of    O
insulin    O
pumps    O
allow    O
for    O
radio    O
frequency    O
(    O
RF    O
)    O
communication    O
.    O

A    O
hologram    B-Therapy100661091
bracelet    I-Therapy100661091
or    O
power    O
bracelet    O
is    O
a    O
small    O
rubber    O
wristband    O
fitted    O
with    O
a    O
hologram    O
.    O

Fluorescent    B-Therapy100661091
glucose    I-Therapy100661091
biosensors    I-Therapy100661091

An    O
insulin    B-Therapy100661091
port    I-Therapy100661091
functions    O
as    O
a    O
medication    O
delivery    O
channel    O
directly    O
into    O
the    O
subcutaneous    O
tissue    O
(    O
the    O
tissue    O
layer    O
located    O
just    O
beneath    O
the    O
skin    O
)    O
.    O

by    O
fish    O
:    O
ichthyotherapy    B-Therapy100661091
(    O
wading    O
with    O
fish    O
)    O
,    O
aquarium    O
therapy    O
(    O
watching    O
fish    O
)    O

Nambudripad's    B-Therapy100661091
Allergy    I-Therapy100661091
Elimination    I-Therapy100661091
Techniques    I-Therapy100661091
are    O
a    O
form    O
of    O
alternative    O
medicine    O
which    O
proponents    O
claim    O
can    O
treat    O
allergies    O
and    O
related    O
disorders    O
.    O

This    O
effect    O
was    O
associated    O
with    O
miR-223    O
role    O
in    O
Glut4    O
regulation    O
and    O
glucose    B-Therapy100661091
metabolism    I-Therapy100661091
.    O

Insulin    O
from    O
animal    O
sources    O
differs    O
somewhat    O
in    O
effectiveness    O
(    O
in    O
carbohydrate    B-Therapy100661091
metabolism    I-Therapy100661091
effects    O
)    O
from    O
human    O
insulin    O
because    O
of    O
these    O
variations    O
.    O

He    O
also    O
performed    O
significant    O
research    O
of    O
carbohydrate    B-Therapy100661091
metabolism    I-Therapy100661091
.    O

Glucose    B-Therapy100661091
metabolism    I-Therapy100661091

As    O
a    O
crossroad    O
between    O
carbohydrate    B-Therapy100661091
and    O
lipid    O
metabolism    O
,    O
pyruvate    O
carboxylase    O
expression    O
in    O
gluconeogenic    O
tissues    O
,    O
adipose    O
tissues    O
and    O
pancreatic    O
islets    O
must    O
be    O
coordinated    O
.    O

Carbohydrate    B-Therapy100661091
metabolism    I-Therapy100661091

The    O
name    O
"    O
glucocorticoid    O
"    O
derives    O
from    O
early    O
observations    O
that    O
these    O
hormones    O
were    O
involved    O
in    O
glucose    B-Therapy100661091
metabolism    I-Therapy100661091
.    O

In    O
a    O
review    O
of    O
these    O
trials    O
it    O
was    O
again    O
concluded    O
that    O
chromium    O
supplements    O
had    O
no    O
effect    O
on    O
healthy    O
people    O
,    O
but    O
that    O
there    O
might    O
be    O
an    O
improvement    O
in    O
glucose    B-Therapy100661091
metabolism    I-Therapy100661091
in    O
diabetics    O
,    O
although    O
the    O
authors    O
stated    O
that    O
the    O
evidence    O
for    O
this    O
effect    O
remains    O
weak    O
.    O

The    O
"    O
B.    O
trematum    O
"    O
genome    O
was    O
sequenced    O
in    O
2013    O
,    O
and    O
is    O
currently    O
undergoing    O
annotation    O
.    O
The    O
genome    O
is    O
estimated    O
to    O
possess    O
4,145    O
coding    O
sequences    O
with    O
the    O
majority    O
of    O
sequences    O
coding    O
for    O
amino    O
acids    O
,    O
amino    O
acid    O
derivatives    O
,    O
and    O
carbohydrate    B-Therapy100661091
pathways    I-Therapy100661091
.    O

The    O
SIAE    O
protein    O
functions    O
in    O
carbohydrate    B-Therapy100661091
metabolism    I-Therapy100661091
and    O
catalyzes    O
the    O
removal    O
of    O
O    O
-    O
acetyl    O
ester    O
groups    O
from    O
position    O
9    O
of    O
the    O
parent    O
sialic    O
acid    O
.    O

It    O
was    O
characterized    O
as    O
an    O
inborn    O
error    O
of    O
carbohydrate    B-Therapy100661091
metabolism    I-Therapy100661091
in    O
1908    O
.    O

Glycerol-3-phosphate    O
dehydrogenase    O
serves    O
as    O
a    O
major    O
link    O
between    O
carbohydrate    B-Therapy100661091
metabolism    I-Therapy100661091
and    O
lipid    O
metabolism    O
.    O

The    O
show    O
has    O
featured    O
stunts    O
including    O
Grylls    O
climbing    O
cliffs    O
,    O
parachuting    O
from    O
helicopters    O
,    O
balloons    O
,    O
and    O
planes    O
,    O
paragliding    O
,    O
ice    O
climbing    O
,    O
running    O
through    O
a    O
forest    O
fire    O
,    O
wading    O
rapids    O
,    O
eating    O
snakes    O
,    O
wrapping    O
his    O
urine    O
-    O
soaked    O
T    O
-    O
shirt    O
around    O
his    O
head    O
to    O
help    O
stave    O
off    O
the    O
desert    O
heat    O
,    O
drinking    B-Therapy100661091
urine    I-Therapy100661091
saved    O
in    O
a    O
rattlesnake    O
skin    O
,    O
drinking    O
fecal    O
liquid    O
from    O
elephant    O
dung    O
,    O
eating    O
deer    O
droppings    O
,    O
wrestling    O
alligators    O
,    O
field    O
dressing    O
a    O
camel    O
carcass    O
and    O
drinking    O
water    O
from    O
it    O
,    O
eating    O
various    O
"    O
creepy    O
crawlies    O
"    O
[    O
insects    O
]    O
,    O
using    O
the    O
corpse    O
of    O
a    O
sheep    O
as    O
a    O
sleeping    O
bag    O
and    O
flotation    O
device    O
,    O
free    O
climbing    O
waterfalls    O
and    O
using    O
a    O
bird    O
guano    O
/    O
water    O
enema    O
for    O
hydration    O
.    O

Though    O
there    O
is    O
a    O
small    O
community    O
devoted    O
to    O
such    O
fetishism    O
outside    O
Japan    O
,    O
it    O
is    O
usually    O
overshadowed    O
by    O
the    O
more    O
hardcore    O
fetishes    O
,    O
urolagnia    O
and    O
urophagia    B-Therapy100661091
.    O

His    O
writings    O
are    O
intertwined    O
with    O
recurring    O
humorous    O
themes    O
,    O
notably    O
,    O
in    O
the    O
chapter    O
Crossing    O
Australia    O
he    O
makes    O
constant    O
reference    O
to    O
drinking    B-Therapy100661091
of    I-Therapy100661091
urine    I-Therapy100661091
to    O
survive    O
,    O
as    O
was    O
done    O
by    O
many    O
19th    O
century    O
explorers    O
.    O

With    O
no    O
water    O
,    O
he    O
is    O
forced    O
to    O
drink    B-Therapy100661091
his    I-Therapy100661091
urine    I-Therapy100661091
.    O

A    O
student    O
of    O
Wilhelm    O
Reich    O
,    O
he    O
developed    O
bioenergetic    B-Therapy100661091
analysis    I-Therapy100661091
,    O
a    O
form    O
of    O
mind    O
-    O
body    O
psychotherapy    O
,    O
with    O
his    O
then    O
-    O
colleague    O
Alexander    O
Lowen    O
(    O
December    O
23    O
,    O
1910    O
–    O
October    O
28    O
,    O
2008    O
)    O
.    O

Reich    O
's    O
work    O
on    O
character    O
contributed    O
to    O
the    O
development    O
of    O
Anna    O
Freud    O
's    O
"    O
The    O
Ego    O
and    O
the    O
Mechanisms    O
of    O
Defence    O
"    O
(    O
1936    O
)    O
,    O
and    O
his    O
idea    O
of    O
muscular    O
armour    O
–    O
the    O
expression    O
of    O
the    O
personality    O
in    O
the    O
way    O
the    O
body    O
moves    O
–    O
shaped    O
innovations    O
such    O
as    O
body    O
psychotherapy    O
,    O
Gestalt    O
therapy    O
,    O
bioenergetic    B-Therapy100661091
analysis    I-Therapy100661091
and    O
primal    O
therapy    O
.    O

Despite    O
Reich    O
's    O
precarious    O
mental    O
health    O
,    O
his    O
work    O
on    O
character    O
and    O
the    O
idea    O
of    O
muscular    O
armouring    O
contributed    O
to    O
the    O
development    O
of    O
what    O
is    O
now    O
known    O
as    O
ego    O
psychology    O
,    O
gave    O
rise    O
to    O
body    O
psychotherapy    O
,    O
and    O
helped    O
shape    O
the    O
Gestalt    O
therapy    O
of    O
Fritz    O
Perls    O
,    O
the    O
bioenergetic    B-Therapy100661091
analysis    I-Therapy100661091
of    O
Reich    O
's    O
student    O
Alexander    O
Lowen    O
,    O
and    O
the    O
primal    O
therapy    O
of    O
Arthur    O
Janov    O
.    O

Thought    B-Therapy100661091
Field    I-Therapy100661091
Therapy    I-Therapy100661091
,    O
a    O
type    O
of    O
Energy    O
psychology    O
therapy    O

Emotional    B-Therapy100661091
Freedom    I-Therapy100661091
Techniques    I-Therapy100661091
(    O
EFT    B-Therapy100661091
)    O
is    O
a    O
form    O
of    O
counseling    O
intervention    O
that    O
draws    O
on    O
various    O
theories    O
of    O
alternative    O
medicine    O
including    O
acupuncture    O
,    O
neuro    O
-    O
linguistic    O
programming    O
,    O
energy    B-Therapy100661091
medicine    I-Therapy100661091
,    O
and    O
Thought    B-Therapy100661091
Field    I-Therapy100661091
Therapy    I-Therapy100661091
(    O
TFT    O
)    O
.    O

Bioresonance    B-Therapy100661091
therapy    I-Therapy100661091
–    O
diagnosis    O
and    O
therapy    O
delivered    O
by    O
attaching    O
an    O
electrical    O
device    O
to    O
the    O
patient    O
,    O
on    O
the    O
basis    O
that    O
cancer    O
cells    O
emit    O
certain    O
electromagnetic    O
oscillations    O
.    O

Provoked    B-Therapy100661091
urine    I-Therapy100661091
testing    I-Therapy100661091
for    O
heavy    O
metal    O
toxicity    O

Adams    O
has    O
hypothesized    O
that    O
heavy    O
metals    O
,    O
particularly    O
cadmium    O
and    O
mercury    O
,    O
may    O
play    O
a    O
role    O
in    O
the    O
pathogenesis    O
of    O
autism    O
,    O
and    O
has    O
advocated    O
treatment    O
with    O
chelation    B-Therapy100661091
therapy    I-Therapy100661091
and    O
pioglitazone    O
,    O
though    O
evidence    O
supporting    O
both    O
the    O
association    O
and    O
the    O
treatment    O
is    O
anecdotal    O
at    O
best    O
.    O

The    O
ASAT    O
has    O
condemned    O
chelation    B-Therapy100661091
therapy    I-Therapy100661091
as    O
an    O
autism    O
treatment    O
,    O
noting    O
that    O
two    O
children    O
have    O
been    O
reported    O
to    O
have    O
died    O
as    O
a    O
result    O
of    O
this    O
therapy    O
,    O
and    O
concluding    O
that    O
"    O
there    O
is    O
not    O
enough    O
scientific    O
evidence    O
available    O
at    O
this    O
time    O
to    O
advocate    O
a    O
role    O
for    O
chelation    O
of    O
heavy    O
metals    O
in    O
the    O
treatment    O
of    O
autism    O
,    O
and    O
there    O
is    O
potential    O
for    O
adverse    O
side    O
effects    O
.    O

For    O
biological    O
effects    O
of    O
substances    O
such    O
as    O
radioactive    O
iodine    O
the    O
ingestion    O
of    O
non    O
-    O
radioactive    O
isotopes    O
may    O
substantially    O
reduce    O
the    O
biological    O
uptake    O
of    O
the    O
radioactive    O
form    O
,    O
and    O
chelation    B-Therapy100661091
therapy    I-Therapy100661091
may    O
be    O
applied    O
to    O
accelerate    O
the    O
removal    O
of    O
radioactive    O
materials    O
formed    O
from    O
heavy    O
metals    O
from    O
the    O
body    O
by    O
natural    O
processes    O
.    O

Chelation    B-Therapy100661091
therapy    I-Therapy100661091

Paul    O
Offit    O
's    O
2008    O
book    O
'    O
'    O
Autism    O
's    O
False    O
Prophets    O
''    O
applied    O
the    O
phrase    O
to    O
promoters    O
of    O
unproven    O
theories    O
and    O
therapies    O
such    O
as    O
the    O
thiomersal    O
controversy    O
and    O
chelation    B-Therapy100661091
therapy    I-Therapy100661091
.    O

Her    O
research    O
,    O
conducted    O
with    O
James    O
B.    O
Adams    O
and    O
Jeff    O
Bradstreet    O
as    O
coauthors    O
,    O
has    O
concluded    O
that    O
chelation    B-Therapy100661091
therapy    I-Therapy100661091
is    O
a    O
safe    O
and    O
effective    O
treatment    O
for    O
autism    O
.    O

Shaw    O
has    O
also    O
contended    O
that    O
yeast    O
infections    O
may    O
also    O
cause    O
autism    O
,    O
and    O
has    O
also    O
endorsed    O
chelation    B-Therapy100661091
therapy    I-Therapy100661091
as    O
an    O
autism    O
treatment    O
.    O

These    O
practitioners    O
may    O
use    O
unproven    O
,    O
disproven    O
,    O
or    O
questionable    O
methods    O
,    O
devices    O
,    O
and    O
products    O
such    O
as    O
adjusting    O
machines    O
,    O
applied    O
kinesiology    O
,    O
chelation    B-Therapy100661091
therapy    I-Therapy100661091
,    O
colonic    O
irrigation    O
,    O
computerized    O
nutrition    O
deficiency    O
tests    O
,    O
cranial    O
osteopathy    O
,    O
cytotoxic    O
food    O
allergy    O
testing    O
,    O
DMSO    O
,    O
Gerovital    O
,    O
glandular    O
therapy    O
,    O
hair    O
analysis    O
,    O
herbal    O
crystallization    O
analyses    O
,    O
homeopathy    O
,    O
internal    O
managements    O
,    O
iridology    O
,    O
laser    O
beam    O
acupuncture    O
,    O
laetrile    O
,    O
magnetic    B-Therapy100661091
therapy    I-Therapy100661091
,    O
and    O
so    O
forth    O
.    O

Since    O
then    O
,    O
Laidler    O
has    O
become    O
an    O
outspoken    O
opponent    O
of    O
alternative    O
treatments    O
for    O
autism    O
,    O
particularly    O
chelation    B-Therapy100661091
therapy    I-Therapy100661091
;    O
for    O
example    O
when    O
a    O
child    O
died    O
after    O
receiving    O
it    O
in    O
2005    O
,    O
Laidler    O
said    O
he    O
was    O
confident    O
that    O
the    O
therapy    O
was    O
responsible    O
for    O
the    O
child    O
's    O
death    O
,    O
saying    O
,    O
"    O
This    O
is    O
what    O
I    O
've    O
been    O
holding    O
my    O
breath    O
hoping    O
would    O
n't    O
happen    O
.    O
"    O

Their    O
tests    O
have    O
proven    O
controversial    O
because    O
of    O
the    O
four    O
lawsuits    O
that    O
have    O
been    O
filed    O
by    O
people    O
who    O
say    O
that    O
Doctor    O
's    O
Data    O
victimized    O
them    O
by    O
diagnosing    O
them    O
as    O
having    O
toxic    O
metal    O
poisoning    O
based    O
on    O
their    O
urinalysis    O
tests    O
,    O
and    O
then    O
prescribing    O
them    O
chelation    B-Therapy100661091
therapy    I-Therapy100661091
.    O

In    O
2008    O
,    O
Atwood    O
told    O
the    O
Associated    O
Press    O
that    O
the    O
Trial    O
to    O
Assess    O
Chelation    O
Therapy    O
,    O
which    O
had    O
been    O
approved    O
in    O
2002    O
,    O
"    O
should    O
never    O
have    O
been    O
approved    O
.    O
"    O
In    O
2009    O
,    O
Atwood    O
was    O
one    O
of    O
the    O
authors    O
of    O
a    O
journal    O
article    O
that    O
called    O
for    O
the    O
termination    O
of    O
an    O
ongoing    O
clinical    O
trial    O
of    O
chelation    B-Therapy100661091
therapy    I-Therapy100661091
,    O
on    O
the    O
grounds    O
that    O
it    O
was    O
"    O
unethical    O
,    O
dangerous    O
,    O
pointless    O
,    O
and    O
wasteful    O
"    O
.    O

Chelation    B-Therapy100661091
therapy    I-Therapy100661091

These    O
treatments    O
include    O
prism    O
lenses    O
,    O
physical    O
exercise    O
,    O
auditory    B-Therapy100661091
integration    I-Therapy100661091
training    I-Therapy100661091
,    O
and    O
sensory    O
stimulation    O
or    O
inhibition    O
techniques    O
such    O
as    O
"    O
deep    O
pressure    O
"—    O
firm    O
touch    O
pressure    O
applied    O
either    O
manually    O
or    O
via    O
an    O
apparatus    O
such    O
as    O
a    O
hug    O
machine    O
or    O
a    O
pressure    O
garment    O
.    O

Since    O
the    O
insulin    O
pump    O
needs    O
to    O
be    O
worn    O
most    O
of    O
the    O
time    O
,    O
pump    O
users    O
need    O
strategies    B-Therapy100661091
to    O
participate    O
in    O
activities    O
that    O
may    O
damage    O
the    O
pump    O
,    O
such    O
as    O
rough    O
sports    O
and    O
activities    O
in    O
the    O
water    O
.    O

Haflingers    O
have    O
many    O
uses    O
including    O
light    O
draft    O
,    O
harness    O
work    O
and    O
various    O
under    O
-    O
saddle    O
disciplines    O
such    O
as    O
endurance    O
riding    O
,    O
dressage    O
,    O
equestrian    O
vaulting    O
and    O
therapeutic    B-Therapy100661091
riding    I-Therapy100661091
.    O

Today    O
the    O
breed    O
is    O
used    O
in    O
many    O
activities    O
that    O
include    O
draft    O
and    O
pack    O
work    O
,    O
light    O
harness    O
and    O
combined    O
driving    O
,    O
and    O
many    O
under    O
-    O
saddle    O
events    O
,    O
including    O
western    O
-    O
style    O
horse    O
-    O
show    O
classes    O
,    O
trail    O
and    O
endurance    O
riding    O
,    O
dressage    O
,    O
show    O
jumping    O
,    O
vaulting    O
,    O
and    O
therapeutic    B-Therapy100661091
riding    I-Therapy100661091
programs    O
.    O

by    O
horses    O
:    O
equine    B-Therapy100661091
therapy    I-Therapy100661091
,    O
hippotherapy    B-Therapy100661091

Horses    O
are    O
also    O
used    O
for    O
therapeutic    B-Therapy100661091
purposes    O
,    O
both    O
in    O
specialized    O
paraequestrian    O
competition    O
as    O
well    O
as    O
non    O
-    O
competitive    O
riding    O
to    O
improve    O
human    O
health    O
and    O
emotional    O
development    O
.    O

The    O
publicity    O
from    O
the    O
book    O
and    O
movie    O
,    O
along    O
with    O
Brannaman    O
's    O
approach    O
to    O
treating    O
troubled    O
horses    O
and    O
troubled    O
humans    O
with    O
equal    O
doses    O
of    O
compassion    O
,    O
has    O
helped    O
promote    O
other    O
fields    O
such    O
as    O
therapeutic    B-Therapy100661091
horseback    I-Therapy100661091
riding    I-Therapy100661091
.    O

Professional    O
Association    O
of    O
Therapeutic    O
Horsemanship    O
International    O
(    O
PATH    O
Intl    O
.    O
)    O
,    O
formerly    O
the    O
North    O
American    O
Riding    O
for    O
the    O
Handicapped    O
Association    O
(    O
NARHA    O
)    O
is    O
a    O
non    O
-    O
profit    O
organization    O
based    O
in    O
Denver    O
,    O
Colorado    O
that    O
promotes    O
the    O
benefits    O
of    O
therapeutic    B-Therapy100661091
horseback    I-Therapy100661091
riding    I-Therapy100661091
and    O
other    O
equine    O
-    O
assisted    O
activities    O
and    O
therapies    O
for    O
people    O
with    O
physical    O
,    O
emotional    O
and    O
learning    O
disabilities    O
.    O

Today    O
,    O
the    O
Fjord    O
horse    O
is    O
a    O
favourite    O
at    O
Norwegian    O
riding    O
and    O
therapeutic    B-Therapy100661091
schools    I-Therapy100661091
,    O
as    O
its    O
generally    O
mild    O
temperament    O
and    O
small    O
size    O
make    O
it    O
suitable    O
for    O
children    O
and    O
disabled    O
individuals    O
.    O

Today    O
,    O
the    O
NSCD    O
facilitates    O
a    O
variety    O
of    O
both    O
winter    O
and    O
summer    O
programs    O
,    O
including    O
alpine    O
skiing    O
,    O
snowboarding    O
,    O
Nordic    O
skiing    O
,    O
snowshoeing    O
,    O
rock    O
climbing    O
,    O
kayaking    O
,    O
Sports    O
Ability    O
Clinics    O
and    O
therapeutic    B-Therapy100661091
horseback    I-Therapy100661091
riding    I-Therapy100661091
.    O

Pulsatile    O
insulin    O
delivery    O
to    O
the    O
portal    O
vein    O
or    O
islet    B-Therapy100661091
cell    I-Therapy100661091
transplantation    I-Therapy100661091
to    O
the    O
liver    O
of    O
diabetic    O
patients    O
are    O
therefore    O
attractive    O
therapeutic    O
alternatives    O
.    O

It    O
is    O
also    O
used    O
in    O
some    O
conditioning    O
regimens    O
for    O
bone    O
marrow    O
transplantation    O
,    O
kidney    O
transplantation    O
and    O
islet    B-Therapy100661091
cell    I-Therapy100661091
transplantation    I-Therapy100661091
.    O

Climatotherapy    B-Therapy100661091
,    O
relocation    O
to    O
another    O
climate    O

The    O
beneficial    O
effects    O
of    O
the    O
local    O
climate    O
and    O
seawater    O
on    O
certain    O
medical    O
conditions    O
inspired    O
the    O
physician    O
Carl    O
Haeberlin    O
(    O
1870–1954    O
)    O
from    O
Wyk    O
to    O
develop    O
treatments    O
for    O
climatotherapy    B-Therapy100661091
and    O
thalassotherapy    B-Therapy100661091
at    O
the    O
beginning    O
of    O
the    O
20th    O
century    O
.    O

Rapid    O
-    O
acting    O
insulin    O
analogs    O
such    O
as    O
lispro    B-Therapy100661091
(    O
brand    O
name    O
"    O
Humalog    O
"    O
,    O
made    O
by    O
Eli    O
Lilly    O
and    O
Company    O
)    O
and    O
aspart    B-Therapy100661091
(    O
brand    O
name    O
"    O
Novolog"/"Novorapid    O
"    O
,    O
made    O
by    O
Novo    O
Nordisk    O
and    O
"    O
Apidra    O
"    O
made    O
by    O
Sanofi    O
Aventis    O
)    O
are    O
preferred    O
by    O
many    O
clinicians    O
over    O
older    O
regular    O
insulin    O
for    O
meal    O
coverage    O
and    O
high    O
correction    O
.    O

This    O
allows    O
the    O
creation    O
of    O
a    O
novel    O
formulation    O
that    O
retains    O
the    O
smooth    O
control    O
of    O
a    O
long    O
-    O
acting    O
basal    O
with    O
rapid    O
-    O
acting    O
mealtime    O
control    O
from    O
insulin    B-Therapy100661091
aspart    I-Therapy100661091
.    O

Likewise    O
,    O
another    O
protracted    O
insulin    O
analogue    O
(    O
Levemir    B-Therapy100661091
)    O
is    O
based    O
on    O
a    O
fatty    O
acid    O
acylation    O
approach    O
.    O

Long    O
-    O
acting    O
insulin    B-Therapy100661091
analog    I-Therapy100661091
such    O
as    O
insulin    B-Therapy100661091
glargine    I-Therapy100661091
(    O
brand    O
name    O
"    O
Lantus    O
"    O
,    O
made    O
by    O
Sanofi    O
-    O
Aventis    O
)    O
and    O
insulin    B-Therapy100661091
detemir    I-Therapy100661091
(    O
brand    O
name    O
"    O
Levemir    O
"    O
,    O
made    O
by    O
Novo    O
Nordisk    O
)    O
are    O
also    O
used    O
,    O
with    O
insulin    O
glargine    O
used    O
more    O
than    O
insulin    O
detemir    O
.    O

It    O
has    O
a    O
duration    O
of    O
action    O
that    O
lasts    O
up    O
to    O
42    O
hours    O
(    O
compared    O
to    O
18    O
to    O
26    O
hours    O
provided    O
by    O
other    O
marketed    O
long    O
-    O
acting    O
insulins    O
such    O
as    O
insulin    B-Therapy100661091
glargine    I-Therapy100661091
and    O
insulin    B-Therapy100661091
detemir    I-Therapy100661091
)    O
,    O
making    O
it    O
a    O
once    O
-    O
daily    O
basal    O
insulin    O
,    O
that    O
is    O
one    O
that    O
provides    O
a    O
base    O
insulin    O
level    O
,    O
as    O
opposed    O
to    O
the    O
fast    O
and    O
short    O
acting    O
bolus    O
insulins    O
.    O

Ray    O
suspects    O
his    O
beloved    O
wife    O
Iris    O
of    O
an    O
affair    O
with    O
Davis    O
Morel    O
,    O
a    O
Harvard    O
-    O
educated    O
eclectic    B-Therapy100661091
medicine    I-Therapy100661091
practitioner    O
and    O
anti    O
-    O
theist    O
with    O
a    O
mission    O
to    O
rid    O
Africa    O
of    O
religion    O
,    O
Christianity    O
in    O
particular    O
.    O

The    O
Eclectic    B-Therapy100661091
School    I-Therapy100661091
of    I-Therapy100661091
medicine    I-Therapy100661091
,    O
which    O
grew    O
out    O
of    O
the    O
sectarian    O
medical    O
reform    O
movements    O
of    O
the    O
1830s    O
,    O
was    O
an    O
active    O
and    O
publicly    O
accepted    O
school    O
of    O
medicine    O
in    O
the    O
mid    O
19th    O
century    O
in    O
the    O
Midwest    O
that    O
competed    O
with    O
homeopathy    O
and    O
allopathic    O
(    O
or    O
regular    O
,    O
scientific    O
)    O
medical    O
approaches    O
.    O

Life    O
root    O
,    O
as    O
it    O
was    O
called    O
by    O
the    O
Eclectics    B-Therapy100661091
,    O
was    O
used    O
as    O
a    O
uterine    O
tonic    O
.    O

The    O
new    O
father    O
enrolled    O
at    O
Bennett    O
Medical    O
College    O
,    O
an    O
unaccredited    O
school    O
with    O
questionable    O
curricula    O
focused    O
on    O
Eclectic    B-Therapy100661091
medicine    I-Therapy100661091
.    O

Instead    O
,    O
Brinkley    O
bought    O
a    O
certificate    O
from    O
a    O
shady    O
diploma    O
mill    O
known    O
as    O
the    O
Kansas    O
City    O
Eclectic    B-Therapy100661091
Medical    I-Therapy100661091
University    I-Therapy100661091
and    O
returned    O
home    O
.    O

Eclectic    B-Therapy100661091
medicine    I-Therapy100661091

In    O
1862    O
,    O
he    O
graduated    O
from    O
Eclectic    B-Therapy100661091
Medical    I-Therapy100661091
College    I-Therapy100661091
in    O
Cincinnati    O
,    O
Ohio    O
.    O

Altovis    B-Therapy100661091

Chronic    B-Therapy100661091
Somogyi    I-Therapy100661091
rebound    I-Therapy100661091
,    O
the    O
Somogyi    B-Therapy100661091
effect    I-Therapy100661091
of    O
insulin    O
overdosage    O

Somogyi    O
showed    O
that    O
excessive    O
insulin    O
makes    O
diabetes    O
unstable    O
in    O
the    O
Chronic    B-Therapy100661091
Somogyi    I-Therapy100661091
rebound    I-Therapy100661091
of    O
which    O
he    O
gave    O
his    O
name    O
,    O
and    O
first    O
published    O
his    O
findings    O
in    O
1938    O
.    O

Reiki    B-Therapy100661091
.    O

Her    O
areas    O
of    O
expertise    O
include    O
Reiki    B-Therapy100661091
and    O
hypnotherapy    O
.    O

He    O
was    O
a    O
business    O
analyst    O
and    O
reiki    B-Therapy100661091
healer    O
,    O
and    O
operated    O
a    O
new    O
age    O
website    O
.    O

2009    O
—    O
Mehmet    O
Oz    O
,    O
for    O
his    O
promotion    O
of    O
energy    O
therapies    O
such    O
as    O
Reiki    B-Therapy100661091
.    O

Reiki    O
share    O
,    O
also    O
known    O
as    O
Reiki    O
circle    O
or    O
exchange    O
,    O
is    O
a    O
gathering    O
of    O
like    O
-    O
minded    O
Reiki    B-Therapy100661091
believers    O
who    O
participate    O
in    O
group    O
healing    O
treatments    O
on    O
each    O
other    O
.    O

The    O
medical    O
-    O
education    O
centers    O
all    O
aim    O
at    O
integrating    O
alternative    O
approaches    O
to    O
medicine    O
such    O
as    O
reiki    B-Therapy100661091
and    O
touch    O
healing    O
into    O
science    O
-    O
based    O
medicine    O
.    O

World    O
Healing    O
Day    O
events    O
have    O
included    O
Yoga    O
,    O
Prayer    O
,    O
Tai    O
Chi    O
,    O
Qigong    B-Therapy100661091
,    O
Reiki    B-Therapy100661091
,    O
Healing    O
Prayer    O
,    O
Meditation    O
Day    O
,    O
Native    O
Aboriginal    O
Sacred    O
Dance    O
Day    O
,    O
Sufi    O
Dance    O
,    O
Art    O
and    O
Music    O
Healing    O
.    O

He    O
’s    O
part    O
Tony    O
Robbins    O
,    O
part    O
Reiki    B-Therapy100661091
Master    I-Therapy100661091
,    O
part    O
shrink    O
.    O

When    O
not    O
performing    O
,    O
Billard    O
practices    O
reiki    B-Therapy100661091
on    O
animals    O
.    O

Ney    O
Yépez    O
Cortés    O
(    O
Quito    O
,    O
1968    O
)    O
is    O
an    O
Ecuadorian    O
writer    O
,    O
journalist    O
,    O
poet    O
,    O
songwriter    O
,    O
screen    O
writer    O
,    O
lecturer    O
,    O
and    O
teacher    O
of    O
Tai    O
Chi    O
,    O
Reiki    B-Therapy100661091
and    O
Qi    B-Therapy100661091
Gong    I-Therapy100661091
.    O

Reiki    B-Therapy100661091

Spirituality    O
places    O
an    O
emphasis    O
upon    O
the    O
well    O
-    O
being    O
of    O
the    O
"    O
mind    O
-    O
body    O
-    O
spirit    O
"    O
,    O
so    O
"    O
holistic    O
"    O
activities    O
such    O
as    O
tai    O
chi    O
,    O
reiki    B-Therapy100661091
,    O
and    O
yoga    O
are    O
common    O
within    O
the    O
SBNR    O
movement    O
.    O

"    O
For    O
the    O
alternative    O
therapy    O
sometimes    O
referred    O
to    O
as    O
Sekhem    O
,    O
see    O
Seichim    B-Therapy100661091
.    O
"    O

1865    O
–    O
Mikao    O
Usui    O
,    O
Japanese    O
spiritual    O
leader    O
,    O
founded    O
Reiki    B-Therapy100661091
(    O
d.    O
1926    O
)    O

The    O
dantian    O
are    O
important    O
points    O
of    O
reference    O
in    O
neidan    O
,    O
qigong    B-Therapy100661091
,    O
neigong    O
,    O
tao    O
yin    O
,    O
Taoist    O
sexual    O
practices    O
,    O
Reiki    B-Therapy100661091
and    O
other    O
self    O
-    O
cultivation    O
practices    O
of    O
exercise    O
,    O
breathing    O
,    O
and    O
meditation    O
,    O
as    O
well    O
as    O
in    O
martial    O
arts    O
and    O
in    O
traditional    O
Chinese    O
medicine    O
.    O

Karl    O
Theodor    O
Menke    O
(    O
September    O
13    O
,    O
1791    O
–    O
1861    O
)    O
was    O
a    O
German    O
malacologist    O
and    O
balneologist    B-Therapy100661091
who    O
was    O
a    O
native    O
of    O
Bremen    O
.    O

Another    O
topical    O
therapy    O
used    O
to    O
treat    O
psoriasis    O
is    O
a    O
form    O
of    O
balneotherapy    B-Therapy100661091
,    O
which    O
involves    O
daily    O
baths    O
in    O
the    O
Dead    O
Sea    O
.    O

In    O
1888    O
he    O
obtained    O
his    O
habilitation    O
,    O
and    O
ten    O
years    O
later    O
became    O
an    O
associate    O
professor    O
of    O
balneology    B-Therapy100661091
,    O
hydrotherapy    O
and    O
massage    O
at    O
Würzburg    O
.    O

Among    O
the    O
academic    O
staff    O
were    O
Friedrich    O
Menius    O
,    O
Professor    O
of    O
History    O
(    O
the    O
history    O
of    O
Livonia    O
,    O
the    O
first    O
scientific    O
approach    O
to    O
Estonian    O
folklore    O
)    O
;    O
Sven    O
Dimberg    O
,    O
Professor    O
of    O
Mathematics    O
(    O
the    O
first    O
in    O
the    O
world    O
to    O
deliver    O
lectures    O
based    O
on    O
Newton    O
's    O
theory    O
)    O
;    O
Olaus    O
Hermelin    O
,    O
Professor    O
of    O
Rhetoric    O
and    O
Poetry    O
;    O
Lars    O
Micrander    O
,    O
Professor    O
of    O
Medicine    O
(    O
founder    O
of    O
balneology    B-Therapy100661091
,    O
and    O
discoverer    O
of    O
natural    O
mineral    O
water    O
springs    O
)    O
;    O
Georg    O
Mancelius    O
,    O
Professor    O
of    O
Theology    O
(    O
author    O
of    O
the    O
first    O
Latvian    O
-    O
German    O
dictionary    O
in    O
1638    O
)    O
.    O

Foundational    O
work    O
of    O
Polish    O
balneology    B-Therapy100661091
.    O
Classifies    O
mineral    O
waters    O
and    O
springs    O
in    O
Poland    O
,    O
and    O
describing    O
how    O
they    O
might    O
be    O
used    O
in    O
curing    O
patients    O
.    O

Balneotherapy    B-Therapy100661091
,    O
the    O
medical    O
use    O
of    O
bathing    O

The    O
town    O
is    O
home    O
to    O
a    O
number    O
of    O
balneological    B-Therapy100661091
resorts    O
,    O
where    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
and    O
silt    O
mud    O
from    O
the    O
Lake    O
Solyanoye    O
are    O
used    O
.    O

Kashin    O
itself    O
is    O
known    O
as    O
a    O
balneological    B-Therapy100661091
resort    O
.    O

In    O
addition    O
to    O
his    O
written    O
works    O
on    O
syphilis    O
and    O
its    O
treatment    O
,    O
he    O
published    O
a    O
number    O
of    O
works    O
in    O
the    O
field    O
of    O
balneology    B-Therapy100661091
.    O

For    O
massage    O
,    O
nerve    O
problems    O
and    O
detoxification    O
etc    O
.    O
-    O
in    O
balneology    B-Therapy100661091
and    O
sanatoria    O
in    O
many    O
countries    O
around    O
the    O
Baltic    O
Sea    O
and    O
Russia    O
.    O

He    O
later    O
opened    O
a    O
research    O
institute    O
of    O
balneology    B-Therapy100661091
in    O
Breslau    O
,    O
but    O
when    O
the    O
city    O
became    O
part    O
of    O
Poland    O
,    O
he    O
returned    O
to    O
Bad    O
Pyrmont    O
.    O

Heine    O
had    O
recognized    O
the    O
healing    O
effects    O
medical    O
baths    O
–    O
he    O
tried    O
to    O
match    O
orthopedics    O
and    O
balneotherapy    B-Therapy100661091
.    O

Balneotherapy    B-Therapy100661091

Balneotherapy    B-Therapy100661091
(    O
"    O
bath    O
"    O
)    O
is    O
the    O
treatment    O
of    O
disease    O
by    O
bathing    O
,    O
usually    O
practiced    O
at    O
spas    O
.    O

It    O
was    O
approved    O
by    O
the    O
US    O
FDA    O
in    O
September    O
2016    O
and    O
was    O
the    O
first    O
approved    O
hybrid    O
closed    O
loop    O
system    O
which    O
senses    O
a    O
diabetic    O
person    O
's    O
basal    B-Therapy100661091
insulin    O
requirement    O
and    O
automatically    O
adjusts    O
its    O
delivery    O
to    O
the    O
body    O
.    O

a    O
basal    B-Therapy100661091
dose    O
that    O
is    O
pumped    O
continuously    O
at    O
an    O
adjustable    O
basal    B-Therapy100661091
rate    I-Therapy100661091
to    O
deliver    O
insulin    O
needed    O
between    O
meals    O
and    O
at    O
night    O
.    O

Sensory    B-Therapy100661091
integration    I-Therapy100661091
therapy    I-Therapy100661091

As    O
an    O
intervention    O
approach    O
,    O
Sensory    B-Therapy100661091
integration    I-Therapy100661091
therapy    I-Therapy100661091
is    O
used    O
as    O
“    O
a    O
clinical    O
frame    O
of    O
reference    O
for    O
the    O
assessment    O
and    O
treatment    O
of    O
people    O
who    O
have    O
functional    O
disorders    O
in    O
sensory    O
processing    O
”    O

Electroacupuncture    B-Therapy100661091

Electroacupuncture    B-Therapy100661091
is    O
a    O
form    O
of    O
acupuncture    O
in    O
which    O
acupuncture    O
needles    O
are    O
attached    O
to    O
a    O
device    O
that    O
generates    O
continuous    O
electric    O
pulses    O
(    O
this    O
has    O
been    O
described    O
as    O
"    O
essentially    O
transdermal    O
electrical    O
nerve    O
stimulation    O
TENS    O
masquerading    O
as    O
acupuncture    O
"    O
)    O
.    O

PENS    O
is    O
related    O
to    O
both    O
electroacupuncture    B-Therapy100661091
and    O
transcutaneous    O
electrical    O
nerve    O
stimulation    O
.    O

Attunement    B-Therapy100661091

Carroll    O
studied    O
Voice    O
Dialogue    O
with    O
Drs    O
.    O
Hal    O
and    O
Sidra    O
Stone    O
,    O
Holotropic    B-Therapy100661091
Breathwork    I-Therapy100661091
with    O
Dr.    O
Stanislav    O
Grof    O
,    O
the    O
Four    O
-    O
Fold    O
with    O
Angeles    O
Arrien    O
,    O
the    O
Diamond    O
Heart    O
Work    O
of    O
A.H.    O
Almaas    O
,    O
and    O
trained    O
with    O
The    O
Couples    O
Institute    O
of    O
Drs    O
.    O
Ellyn    O
Bader    O
and    O
Peter    O
Pearson    O
.    O

At    O
Esalen    O
,    O
Price    O
encouraged    O
Grof    O
to    O
develop    O
the    O
therapeutic    O
technique    O
of    O
Holotropic    B-Therapy100661091
Breathwork    I-Therapy100661091
,    O
which    O
functioned    O
as    O
a    O
substitute    O
for    O
psychedelic    O
drugs    O
.    O

Rebirthing    O
-    O
breathwork    O
is    O
a    O
type    O
of    O
breathwork    B-Therapy100661091
invented    O
by    O
Leonard    O
Orr    O
.    O

An    O
insulin    O
pump    O
is    O
an    O
alternative    O
to    O
multiple    O
daily    O
injections    O
of    O
insulin    O
by    O
insulin    O
syringes    O
or    O
an    O
insulin    B-Therapy100661091
pen    I-Therapy100661091
and    O
allows    O
for    O
intensive    B-Therapy100661091
insulin    I-Therapy100661091
therapy    I-Therapy100661091
when    O
used    O
in    O
conjunction    O
with    O
blood    B-Therapy100661091
glucose    I-Therapy100661091
monitoring    I-Therapy100661091
and    O
carb    O
counting    O
.    O

Many    O
people    O
on    O
MDI    O
regimens    O
carry    O
insulin    B-Therapy100661091
pen    I-Therapy100661091
to    O
inject    O
their    O
rapid    O
-    O
acting    O
insulins    O
instead    O
of    O
traditional    O
syringes    O
.    O

Zheng    O
Gu    O
Shui    O
is    O
a    O
variety    O
of    O
pain    O
relief    O
liniment    O
called    O
Dit    B-Therapy100661091
da    I-Therapy100661091
jow    I-Therapy100661091
or    O
die    O
da    O
jiu    O
.    O

Applied    O
kinesiology    O
,    O
including    O
the    O
Bi-Digital    B-Therapy100661091
O    I-Therapy100661091
Ring    I-Therapy100661091
Test    I-Therapy100661091

The    O
"    O
Improver    O
"    O
decision    O
was    O
cited    O
with    O
approval    O
by    O
the    O
Supreme    O
Court    O
of    O
Canada    O
in    O
its    O
landmark    O
2000    O
"    O
Free    B-Therapy100661091
World    I-Therapy100661091
Trust    I-Therapy100661091
v    I-Therapy100661091
Électro    I-Therapy100661091
Santé    I-Therapy100661091
Inc    I-Therapy100661091
"    O
decision    O
.    O

The    O
first    O
biosynthetic    O
insulin    O
analog    O
was    O
developed    O
for    O
clinical    O
use    O
at    O
mealtime    O
(    O
prandial    O
insulin    O
)    O
,    O
Humalog    B-Therapy100661091
(    O
insulin    O
lispro    O
)    O
,    O
it    O
is    O
more    O
rapidly    O
absorbed    O
after    O
subcutaneous    O
injection    O
than    O
regular    O
insulin    O
,    O
with    O
an    O
effect    O
15    O
minutes    O
after    O
injection    O
.    O

Rapid    O
-    O
acting    O
insulin    O
analogs    O
such    O
as    O
lispro    B-Therapy100661091
(    O
brand    O
name    O
"    O
Humalog    O
"    O
,    O
made    O
by    O
Eli    O
Lilly    O
and    O
Company    O
)    O
and    O
aspart    B-Therapy100661091
(    O
brand    O
name    O
"    O
Novolog"/"Novorapid    O
"    O
,    O
made    O
by    O
Novo    O
Nordisk    O
and    O
"    O
Apidra    O
"    O
made    O
by    O
Sanofi    O
Aventis    O
)    O
are    O
preferred    O
by    O
many    O
clinicians    O
over    O
older    O
regular    O
insulin    O
for    O
meal    O
coverage    O
and    O
high    O
correction    O
.    O

Another    O
device    O
used    O
in    O
intensive    O
insulinotherapy    O
is    O
the    O
injection    B-Therapy100661091
port    I-Therapy100661091
.    O

The    O
charm    O
in    O
question    O
is    O
known    O
as    O
the    O
"    O
Nine    B-Therapy100661091
Herbs    I-Therapy100661091
Charm    I-Therapy100661091
"    O
,    O
and    O
involves    O
a    O
discussion    O
of    O
nine    O
different    O
herbs    O
used    O
medicinally    O
.    O

As    O
Old    O
English    O
"    O
stune    O
"    O
,    O
the    O
plant    O
is    O
cited    O
as    O
one    O
of    O
the    O
herbs    O
invoked    O
in    O
the    O
pagan    O
Anglo    O
-    O
Saxon    O
"    O
Nine    B-Therapy100661091
Herbs    I-Therapy100661091
Charm    I-Therapy100661091
"    O
,    O
recorded    O
in    O
the    O
10th    O
century    O
.    O

Some    O
contemporary    O
"    O
galdr    O
"    O
chants    O
and    O
songs    O
are    O
influenced    O
by    O
Anglo    O
-    O
Saxon    O
folk    O
magical    O
charms    O
,    O
such    O
as    O
"    O
Æcerbot    O
"    O
and    O
the    O
"    O
Nine    B-Therapy100661091
Herbs    I-Therapy100661091
Charm    I-Therapy100661091
"    O
.    O

by    O
urine    O
:    O
urine    B-Therapy100661091
therapy    I-Therapy100661091
(    O
some    O
scientific    O
forms    O
;    O
many    O
prescientific    O
or    O
pseudoscientific    O
forms    O
)    O

"    O
Continuum    O
"    O
claimed    O
to    O
be    O
a    O
scientific    O
journal    O
for    O
those    O
who    O
had    O
alternative    O
theories    O
about    O
HIV    O
/    O
AIDS    O
,    O
even    O
though    O
it    O
had    O
no    O
peer    O
review    O
and    O
promoted    O
and    O
advertised    O
alternative    O
therapies    O
such    O
as    O
urinotherapy    B-Therapy100661091
.    O

Jubb    O
practices    O
urine    B-Therapy100661091
therapy    I-Therapy100661091
,    O
drinking    O
his    O
own    O
urine    O
a    O
few    O
times    O
a    O
day    O
.    O

A    O
non    O
-    O
canonical    O
branch    O
of    O
the    O
Notch    O
signaling    O
pathway    O
that    O
involves    O
the    O
phosphorylation    O
of    O
STAT3    O
on    O
the    O
serine    O
residue    O
at    O
amino    O
acid    O
position    O
727    O
and    O
subsequent    O
Hes3    O
expression    O
increase    O
(    O
STAT3-Ser/Hes3    B-Therapy100661091
Signaling    I-Therapy100661091
Axis    I-Therapy100661091
)    O
has    O
been    O
shown    O
to    O
regulate    O
the    O
number    O
of    O
NPCs    O
in    O
culture    O
and    O
in    O
the    O
adult    O
rodent    O
brain    O
.    O

By    O
massacring    O
Warriors    O
,    O
she    O
gained    O
enhanced    O
strength    O
,    O
Healers    O
for    O
healing    B-Therapy100661091
abilities    I-Therapy100661091
so    O
great    O
she    O
healed    O
Deucalion    O
's    O
eyesight    O
,    O
Philosophers    O
for    O
intelligence    O
and    O
strategy    O
,    O
and    O
Virgins    O
,    O
to    O
seduce    O
people    O
easily    O
for    O
her    O
agenda    O
as    O
with    O
Derek    O
.    O

These    O
therapies    O
included    O
spiritual    B-Therapy100661091
healing    I-Therapy100661091
,    O
massage    O
,    O
chiropractic    O
,    O
herbs    O
and    O
special    O
diets    O
,    O
homeopathy    O
,    O
self    O
hypnosis    O
and    O
other    O
methods    O
of    O
complementary    O
and    O
alternative    O
medicine    O
.    O

The    O
college    O
teaches    O
classes    O
on    O
Traditional    O
Chinese    O
Medicine    O
(    O
TCM    O
)    O
,    O
tui    O
na    O
,    O
naturopathy    O
,    O
"    O
natural    O
nutrition    O
"    O
,    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
(    O
phytotherapy    B-Therapy100661091
)    O
,    O
holistic    O
psychotherapy    O
,    O
body    O
-    O
oriented    O
psychotherapy    O
,    O
transpersonal    O
psychotherapy    O
,    O
energy    B-Therapy100661091
healing    I-Therapy100661091
,    O
touch    O
therapies    O
such    O
as    O
reflexology    O
,    O
acupressure    O
and    O
"    O
integrative    O
"    O
massage    O
therapy    O
,    O
zen    O
-    O
shiatsu    O
,    O
ayurvedic    O
medicine    O
,    O
yoga    O
and    O
holistic    O
coaching    O
.    O

If    O
homeopathy    O
is    O
correct    O
,    O
much    O
of    O
physics    O
,    O
chemistry    O
,    O
and    O
pharmacology    O
must    O
be    O
incorrect    O
....    O
To    O
have    O
an    O
open    O
mind    O
about    O
homeopathy    O
or    O
similarly    O
implausible    O
forms    O
of    O
alternative    O
medicine    O
(    O
e.g.    O
,    O
Bach    B-Therapy100661091
flower    I-Therapy100661091
remedies    I-Therapy100661091
,    O
spiritual    B-Therapy100661091
healing    I-Therapy100661091
,    O
crystal    B-Therapy100661091
therapy    I-Therapy100661091
)    O
is    O
therefore    O
not    O
an    O
option    O
.    O

Electrical    B-Therapy100661091
quackery    I-Therapy100661091

As    O
a    O
spiritual    O
teacher    O
,    O
George    O
King    O
taught    O
certain    O
yoga    O
practices    O
,    O
spiritual    B-Therapy100661091
healing    I-Therapy100661091
,    O
Eastern    O
mantra    O
and    O
“    O
dynamic    O
prayer”—tools    O
for    O
spiritual    O
self    O
-    O
advancement    O
and    O
service    O
to    O
the    O
world    O
—    O
which    O
the    O
Aetherius    O
Society    O
is    O
principally    O
based    O
upon    O
.    O

Polarity    B-Therapy100661091
therapy    I-Therapy100661091

Energy    B-Therapy100661091
medicine    I-Therapy100661091

Energy    B-Therapy100661091
medicine    I-Therapy100661091

It    O
is    O
interesting    O
to    O
note    O
that    O
a    O
colleague    O
of    O
Neil    O
-    O
Smith    O
,    O
Jack    O
Dover    O
Wellman    O
,    O
vicar    O
of    O
Emmanuel    O
Church    O
,    O
Hampstead    O
was    O
also    O
an    O
authority    O
on    O
the    O
paranormal    O
and    O
upon    O
exorcism    O
,    O
although    O
with    O
a    O
greater    O
emphasis    O
upon    O
Christian    O
spiritual    B-Therapy100661091
healing    I-Therapy100661091
.    O

Another    O
case    O
involving    O
the    O
defense    O
of    O
factual    O
impossibility    O
is    O
"    O
Commonwealth    O
v.    O
Johnson    O
"    O
,    O
in    O
which    O
a    O
psychic    B-Therapy100661091
healer    I-Therapy100661091
was    O
charged    O
and    O
convicted    O
of    O
fraud    O
,    O
despite    O
the    O
fact    O
that    O
a    O
fictitious    O
name    O
was    O
used    O
to    O
catch    O
him    O
.    O

Therapeutic    B-Therapy100661091
touch    I-Therapy100661091
(    O
commonly    O
shortened    O
to    O
"    O
TT    B-Therapy100661091
"    O
)    O
,    O
known    O
by    O
some    O
as    O
"    O
non-contact    B-Therapy100661091
therapeutic    I-Therapy100661091
touch    I-Therapy100661091
"    O
(    O
NCTT    O
)    O
,    O
is    O
a    O
pseudoscientific    O
energy    B-Therapy100661091
therapy    I-Therapy100661091
which    O
practitioners    O
claim    O
promotes    O
healing    O
and    O
reduces    O
pain    O
and    O
anxiety    O
.    O

The    O
practitioners    O
then    O
were    O
to    O
indicate    O
if    O
they    O
could    O
sense    O
her    O
biofield    B-Therapy100661091
,    O
and    O
where    O
her    O
hand    O
was    O
.    O

Sas    O
Carey    O
(    O
born    O
1945    O
)    O
is    O
an    O
American    O
film    O
director    O
,    O
author    O
,    O
teacher    O
,    O
holistic    O
nurse    O
and    O
spiritual    B-Therapy100661091
healer    I-Therapy100661091
.    O

Use    O
of    O
magnets    O
was    O
the    O
most    O
common    O
tool    O
in    O
energy    B-Therapy100661091
medicine    I-Therapy100661091
in    O
America    O
,    O
and    O
among    O
users    O
of    O
it    O
,    O
58    O
percent    O
described    O
it    O
as    O
at    O
least    O
"    O
sort    O
of    O
scientific    O
"    O
,    O
when    O
it    O
is    O
not    O
at    O
all    O
scientific    O
.    O

Emotional    B-Therapy100661091
Freedom    I-Therapy100661091
Techniques    I-Therapy100661091
(    O
EFT    B-Therapy100661091
)    O
is    O
a    O
form    O
of    O
counseling    O
intervention    O
that    O
draws    O
on    O
various    O
theories    O
of    O
alternative    O
medicine    O
including    O
acupuncture    O
,    O
neuro    O
-    O
linguistic    O
programming    O
,    O
energy    B-Therapy100661091
medicine    I-Therapy100661091
,    O
and    O
Thought    B-Therapy100661091
Field    I-Therapy100661091
Therapy    I-Therapy100661091
(    O
TFT    O
)    O
.    O

Bôtchô    B-Therapy100661091
is    O
a    O
cream    O
sold    O
in    O
Côte    O
d'Ivoire    O
allegedly    O
to    O
increase    O
breast    O
and    O
buttock    O
size    O
,    O
which    O
has    O
become    O
increasingly    O
popular    O
due    O
to    O
the    O
Bobaraba    O
(    O
big    O
bottom    O
)    O
dance    O
.    O

In    O
1927    O
,    O
Katsuzo    O
Nishi    O
created    O
'    O
The    O
Nishi    B-Therapy100661091
Health    I-Therapy100661091
System    I-Therapy100661091
'    O
,    O
a    O
series    O
of    O
six    O
exercises    O
,    O
one    O
of    O
which    O
(    O
kingyō    O
undō    O
)    O
was    O
the    O
basis    O
for    O
the    O
motion    O
of    O
the    O
modern    O
day    O
Chi    O
Machine    O
.    O

The    O
Kundalini    O
yoga    O
that    O
he    O
practiced    O
for    O
several    O
years    O
and    O
the    O
Chi    B-Therapy100661091
kung    I-Therapy100661091
.    O

Daoyin    O
is    O
a    O
similar    O
Daoist    O
practice    O
in    O
China    O
,    O
part    O
of    O
a    O
broader    O
meditation    O
system    O
which    O
includes    O
Qigong    B-Therapy100661091
and    O
Taijiquan    O

Traditionally    O
some    O
Chinese    O
dances    O
may    O
also    O
have    O
connection    O
with    O
the    O
martial    O
arts    O
that    O
were    O
used    O
to    O
train    O
fighting    O
skills    O
as    O
well    O
as    O
for    O
fitness    O
,    O
and    O
some    O
martial    O
art    O
exercises    O
such    O
as    O
Tai    O
chi    O
or    O
Qigong    B-Therapy100661091
are    O
similar    O
to    O
a    O
choreographed    O
dance    O
.    O

Qigong    B-Therapy100661091

Qigong    B-Therapy100661091

Qigong    B-Therapy100661091

During    O
his    O
training    O
Huang    O
learned    O
both    O
northern    O
and    O
southern    O
style    O
martial    O
arts    O
as    O
well    O
as    O
TaiJiQuan    O
and    O
Qi    B-Therapy100661091
Gong    I-Therapy100661091
.    O

She    O
taught    O
at    O
Columbia    O
College    O
Chicago    O
in    O
the    O
Interdisciplinary    O
Arts    O
Graduate    O
Program    O
and    O
the    O
Theater    O
Department    O
She    O
also    O
taught    O
modern    O
dance    O
,    O
Qi    B-Therapy100661091
Gong    I-Therapy100661091
,    O
and    O
Psychocalesthenics    O
through    O
the    O
Chicago    O
Moving    O
Company    O
.    O

A    O
former    O
aerospace    O
engineer    O
,    O
he    O
is    O
also    O
noted    O
for    O
his    O
expertise    O
in    O
tai    O
chi    O
and    O
qigong    B-Therapy100661091
,    O
as    O
well    O
as    O
feng    O
shui    O
.    O

He    O
is    O
so    O
well    O
-    O
renowned    O
for    O
his    O
work    O
in    O
the    O
martial    O
arts    O
that    O
he    O
was    O
elected    O
International    O
President    O
of    O
the    O
official    O
Praying    O
Mantis    O
Kung    O
Fu    O
school    O
from    O
China    O
,    O
plus    O
four    O
related    O
Qigong    B-Therapy100661091
medicine    O
schools    O
.    O

His    O
abilities    O
include    O
Healing    O
and    O
Qigong    B-Therapy100661091
.    O

He    O
learned    O
qigong    B-Therapy100661091
during    O
that    O
time    O
and    O
could    O
sit    O
on    O
a    O
bed    O
of    O
nails    O
.    O

An    O
expert    O
of    O
qigong    B-Therapy100661091
said    O
that    O
it    O
was    O
a    O
way    O
of    O
hypnosis    O
using    O
qigong    O
.    O

Vickie    O
Wong    O
(    O
or    O
Vicki    O
Wong    O
)    O
is    O
an    O
American    O
actress    O
,    O
licensed    O
chiropractor    O
and    O
practitioner    O
/    O
proponent    O
of    O
self    O
healing    O
techniques    O
,    O
such    O
as    O
Taoist    O
Chi    B-Therapy100661091
Kung    I-Therapy100661091
.    O

Some    O
examples    O
are    O
Daoyin    O
"    O
guide    O
and    O
pull    O
"    O
breathing    O
exercises    O
,    O
Neidan    O
"    O
internal    O
alchemy    O
"    O
techniques    O
,    O
Neigong    O
"    O
internal    O
skill    O
"    O
practices    O
,    O
Qigong    B-Therapy100661091
breathing    O
exercises    O
,    O
Zhan    O
zhuang    O
"    O
standing    O
like    O
a    O
post    O
"    O
,    O
and    O
Taijiquan    O
"    O
great    O
ultimate    O
fist    O
"    O
techniques    O
.    O

In    O
the    O
20th    O
century    O
,    O
the    O
"    O
Qigong    B-Therapy100661091
"    O
movement    O
has    O
incorporated    O
and    O
popularized    O
Daoist    O
meditation    O
,    O
and    O
"    O
mainly    O
employs    O
concentrative    O
exercises    O
but    O
also    O
favors    O
the    O
circulation    O
of    O
energy    O
in    O
an    O
inner    O
-    O
alchemical    O
mode    O
"    O
(    O
Kohn    O
2008a:120    O
)    O
.    O

Students    O
receive    O
training    O
in    O
herbalism    B-Therapy100661091
,    O
acupuncture    O
,    O
moxibustion    O
,    O
Asian    O
bodywork    O
,    O
qigong    B-Therapy100661091
and    O
nutrition    O
.    O

One    O
example    O
is    O
"    O
navel    O
-    O
gazing    O
,    O
"    O
which    O
is    O
apparently    O
attested    O
to    O
within    O
Eastern    O
Orthodoxy    O
as    O
well    O
as    O
Chinese    O
qigong    B-Therapy100661091
practice    O
.    O

Federatsiya    O
Tam    O
Kui    O
Khi    O
-    O
Kong    O
(    O
Russian    O
)    O
is    O
a    O
Moscow    O
-    O
based    O
martial    O
arts    O
organization    O
founded    O
in    O
2006    O
,    O
promoting    O
a    O
Vietnamese    O
martial    O
art    O
with    O
the    O
name    O
,    O
which    O
translates    O
to    O
"    O
Three    O
Refuges    O
Qigong    B-Therapy100661091
"    O
(    O
Qigong    O
being    O
the    O
Chinese    O
term    O
for    O
"    O
cultivation    O
of    O
life    O
-    O
energy    O
"    O
.    O

T'ai    O
chi    O
ch'uan    O
master    O
Da    O
Liu    O
stated    O
that    O
Li    O
learned    O
qigong    B-Therapy100661091
from    O
a    O
hermit    O
over    O
age    O
500    O
.    O

World    O
Healing    O
Day    O
events    O
have    O
included    O
Yoga    O
,    O
Prayer    O
,    O
Tai    O
Chi    O
,    O
Qigong    B-Therapy100661091
,    O
Reiki    B-Therapy100661091
,    O
Healing    O
Prayer    O
,    O
Meditation    O
Day    O
,    O
Native    O
Aboriginal    O
Sacred    O
Dance    O
Day    O
,    O
Sufi    O
Dance    O
,    O
Art    O
and    O
Music    O
Healing    O
.    O

There    O
is    O
no    O
evidence    O
to    O
substantiate    O
that    O
acupuncture    O
and    O
practice    O
of    O
Qigong    B-Therapy100661091
,    O
or    O
T'ai    O
chi    O
,    O
have    O
any    O
effect    O
on    O
the    O
course    O
of    O
the    O
disease    O
or    O
symptoms    O
.    O

The    O
'    O
"    O
Microcosmic    O
Orbit    O
"    O
(    O
小周天    O
)    O
,    O
also    O
known    O
as    O
the    O
'    O
Self    O
Winding    O
Wheel    O
of    O
the    O
Law    O
'    O
and    O
the    O
circulation    O
of    O
light    O
is    O
a    O
Taoist    O
Qigong    B-Therapy100661091
or    O
Taoist    O
yoga    O
Qi    O
energy    O
cultivation    O
technique    O
.    O

It    O
involves    O
deep    O
breathing    O
exercises    O
in    O
conjunction    O
with    O
meditation    O
and    O
concentration    O
techniques    O
which    O
develop    O
the    O
flow    O
of    O
qi    O
along    O
certain    O
pathways    O
of    O
energy    O
in    O
the    O
human    O
body    O
which    O
may    O
be    O
familiar    O
to    O
those    O
who    O
are    O
studying    O
Traditional    O
Chinese    O
Medicine    O
,    O
Qigong    B-Therapy100661091
,    O
T'ai    O
chi    O
ch'uan    O
,    O
Neidan    O
and    O
Taoist    O
alchemy    O
.    O

Davies    O
is    O
also    O
a    O
keen    O
practitioner    O
of    O
Tai    O
Chi    O
and    O
Qigong    B-Therapy100661091
,    O
and    O
is    O
a    O
registered    O
instructor    O
with    O
the    O
Tai    O
Chi    O
Union    O
for    O
Great    O
Britain    O
.    O

It    O
is    O
commonly    O
called    O
a    O
form    O
of    O
Qigong    B-Therapy100661091
,    O
despite    O
the    O
differences    O
from    O
other    O
Qigong    O
methods    O
in    O
Zhan    O
zhuang    O
's    O
orientation    O
.    O

Qigong    B-Therapy100661091

Dietfurt    O
is    O
known    O
as    O
the    O
"    O
Bavarian    O
China    O
"    O
(    O
,    O
)    O
,    O
Chinese    O
culture    O
is    O
the    O
theme    O
adopted    O
for    O
Carnival    O
in    O
Dietfurt    O
,    O
and    O
the    O
city    O
promotes    O
other    O
Chinese    O
cultural    O
activities    O
such    O
as    O
courses    O
in    O
Qigong    B-Therapy100661091
.    O

He    O
was    O
named    O
one    O
of    O
the    O
"    O
top    O
5    O
fitness    O
instructors    O
in    O
the    O
world    O
"    O
by    O
IDEA    O
and    O
the    O
Association    O
of    O
Fitness    O
Professionals    O
&    O
Associates    O
(    O
AFPA    O
)    O
and    O
was    O
featured    O
in    O
"    O
The    O
Wall    O
Street    O
Journal    O
"    O
as    O
one    O
of    O
the    O
US    O
'    O
leading    O
fitness    O
experts    O
in    O
T'ai    O
chi    O
and    O
qigong    B-Therapy100661091
.    O

Falun    O
Gong    O
is    O
a    O
qigong    B-Therapy100661091
-    O
based    O
practise    O
of    O
meditation    O
with    O
a    O
moral    O
philosophy    O
based    O
on    O
Buddhist    O
traditions    O
.    O

Ney    O
Yépez    O
Cortés    O
(    O
Quito    O
,    O
1968    O
)    O
is    O
an    O
Ecuadorian    O
writer    O
,    O
journalist    O
,    O
poet    O
,    O
songwriter    O
,    O
screen    O
writer    O
,    O
lecturer    O
,    O
and    O
teacher    O
of    O
Tai    O
Chi    O
,    O
Reiki    B-Therapy100661091
and    O
Qi    B-Therapy100661091
Gong    I-Therapy100661091
.    O

The    O
curriculum    O
for    O
the    O
Master    O
of    O
Oriental    O
Medicine    O
program    O
provides    O
about    O
3,000    O
hours    O
of    O
didactic    O
and    O
clinical    O
instruction    O
in    O
acupuncture    O
,    O
Chinese    O
herbology    O
,    O
and    O
related    O
studies    O
such    O
as    O
Tui    O
Na    O
,    O
Qigong    B-Therapy100661091
,    O
introductory    O
Chinese    O
language    O
skills    O
and    O
practice    O
management    O
.    O

Dantian    O
are    O
the    O
Qi    O
Focus    O
Flow    O
Centers    O
,    O
important    O
focal    O
points    O
for    O
meditative    O
and    O
exercise    O
techniques    O
such    O
as    O
qigong    B-Therapy100661091
,    O
martial    O
arts    O
such    O
as    O
t'ai    O
chi    O
ch'uan    O
,    O
and    O
in    O
traditional    O
Chinese    O
medicine    O
.    O

The    O
dantian    O
are    O
important    O
points    O
of    O
reference    O
in    O
neidan    O
,    O
qigong    B-Therapy100661091
,    O
neigong    O
,    O
tao    O
yin    O
,    O
Taoist    O
sexual    O
practices    O
,    O
Reiki    B-Therapy100661091
and    O
other    O
self    O
-    O
cultivation    O
practices    O
of    O
exercise    O
,    O
breathing    O
,    O
and    O
meditation    O
,    O
as    O
well    O
as    O
in    O
martial    O
arts    O
and    O
in    O
traditional    O
Chinese    O
medicine    O
.    O

The    O
term    O
dantian    O
used    O
by    O
itself    O
usually    O
refers    O
to    O
the    O
lower    O
dantian    O
,    O
which    O
is    O
considered    O
to    O
be    O
the    O
foundation    O
of    O
rooted    O
standing    O
,    O
breathing    O
,    O
and    O
body    O
awareness    O
in    O
qigong    B-Therapy100661091
,    O
Chinese    O
martial    O
arts    O
,    O
and    O
other    O
martial    O
arts    O
.    O

Qigong    B-Therapy100661091

Ch'i    B-Therapy100661091
Kung    I-Therapy100661091

He    O
has    O
taught    O
Shaolin    O
Cosmos    O
Qigong    B-Therapy100661091
,    O
Shaolin    O
Kung    O
Fu    O
,    O
Tai    O
Chi    O
Chuan    O
,    O
Zen    O
and    O
also    O
Lion    O
dance    O
worldwide    O
for    O
more    O
than    O
25    O
years    O
.    O

Ionized    B-Therapy100661091
bracelet    I-Therapy100661091

The    O
beneficial    O
effects    O
of    O
the    O
local    O
climate    O
and    O
seawater    O
on    O
certain    O
medical    O
conditions    O
inspired    O
the    O
physician    O
Carl    O
Haeberlin    O
(    O
1870–1954    O
)    O
from    O
Wyk    O
to    O
develop    O
treatments    O
for    O
climatotherapy    B-Therapy100661091
and    O
thalassotherapy    B-Therapy100661091
at    O
the    O
beginning    O
of    O
the    O
20th    O
century    O
.    O

The    O
onboard    O
Samsara    O
spa    O
,    O
a    O
two    O
-    O
level    O
,    O
wellness    O
facility    O
with    O
gym    O
,    O
a    O
thalassotherapy    B-Therapy100661091
pool    O
,    O
treatment    O
rooms    O
,    O
sauna    O
,    O
Turkish    O
bath    O
and    O
a    O
solarium    O
.    O

Thalassotherapy    B-Therapy100661091
,    O
the    O
medical    O
use    O
of    O
seawater    O

Today    O
the    O
beach    O
is    O
the    O
principal    O
tourist    O
seaside    O
location    O
in    O
the    O
municipality    O
of    O
Sassari    O
,    O
there    O
are    O
present    O
some    O
hotels    O
,    O
restaurants    O
,    O
campings    O
,    O
bed    O
&    O
breakfasts    O
,    O
supermarkets    O
and    O
resorts    O
,    O
and    O
also    O
one    O
air    O
field    O
,    O
with    O
a    O
flying    O
school    O
,    O
an    O
Emergency    O
Medical    O
Service    O
ambulatory    O
,    O
a    O
thalassotherapy    B-Therapy100661091
treatment    O
centre    O
and    O
a    O
waterpark    O
(    O
located    O
in    O
Marina    O
di    O
Sorso    O
)    O
.    O

In    O
the    O
year    O
2000    O
plans    O
were    O
drawn    O
up    O
to    O
complete    O
the    O
complex    O
in    O
the    O
style    O
intended    O
by    O
"    O
Sert    O
"    O
,    O
for    O
use    O
as    O
an    O
exclusive    O
tourist    O
attraction    O
and    O
Thalassotherapy    B-Therapy100661091
centre    O
.    O

Thalassotherapy    B-Therapy100661091

Other    O
rapid    O
-    O
acting    O
analogues    O
are    O
NovoRapid    B-Therapy100661091
and    O
Apidra    B-Therapy100661091
,    O
with    O
similar    O
profiles    O
.    O

Infused    O
insulin    O
analogs    O
such    O
as    O
NovoLog    B-Therapy100661091
and    O
Apidra    B-Therapy100661091
typically    O
begin    O
to    O
reduce    O
blood    O
sugar    O
levels    O
15    O
or    O
20    O
minutes    O
after    O
infusion    O
.    O

Genentech    O
,    O
founded    O
by    O
Swanson    O
,    O
Boyer    O
and    O
Eli    O
Lilly    O
and    O
Company    O
,    O
went    O
on    O
in    O
1982    O
to    O
sell    O
the    O
first    O
commercially    O
available    O
biosynthetic    O
human    O
insulin    O
under    O
the    O
brand    O
name    O
Humulin    B-Therapy100661091
.    O

Insulin    B-Therapy100661091
therapy    I-Therapy100661091

Innovation    O
continued    O
at    O
the    O
company    O
after    O
it    O
was    O
made    O
a    O
publicly    O
traded    O
corporation    O
in    O
1952    O
;    O
it    O
developed    O
Humulin    B-Therapy100661091
,    O
Merthiolate    O
,    O
Prozac    O
,    O
and    O
many    O
other    O
medicines    O
.    O

Insulin    B-Therapy100661091

This    O
destruction    O
of    O
beta    O
cells    O
causes    O
patients    O
to    O
develop    O
a    O
lifelong    O
dependence    O
on    O
insulin    B-Therapy100661091
replacement    I-Therapy100661091
therapy    I-Therapy100661091
.    O

Charles    O
Best    O
,    O
a    O
co    O
-    O
inventor    O
of    O
medical    B-Therapy100661091
insulin    I-Therapy100661091
founded    O
the    O
Diabetic    O
Association    O
of    O
Ontario    O
in    O
the    O
late    O
1940s    O
.    O

When    O
managing    O
the    O
blood    O
glucose    O
level    O
with    O
insulin    B-Therapy100661091
injections    O
,    O
this    O
effect    O
is    O
counter    O
-    O
intuitive    O
to    O
insulin    O
users    O
who    O
experience    O
high    O
blood    O
sugar    O
in    O
the    O
morning    O
as    O
a    O
result    O
of    O
an    O
overabundance    O
of    O
insulin    O
at    O
night    O
.    O

1982    O
–    O
Humulin    B-Therapy100661091
,    O
Genentech    O
's    O
human    O
insulin    O
drug    O
produced    O
by    O
genetically    O
engineered    O
bacteria    O
for    O
the    O
treatment    O
of    O
diabetes    O
,    O
is    O
the    O
first    O
biotech    O
drug    O
to    O
be    O
approved    O
by    O
the    O
Food    O
and    O
Drug    O
Administration    O
.    O

Irlen    B-Therapy100661091
syndrome    I-Therapy100661091

The    O
school    O
also    O
caters    O
for    O
a    O
small    O
number    O
of    O
pupils    O
with    O
Irlen    B-Therapy100661091
scotopic    I-Therapy100661091
sensitivity    I-Therapy100661091
syndrome    I-Therapy100661091
,    O
a    O
visual    O
perceptual    O
disorder    O
affecting    O
primarily    O
reading    O
and    O
writing    O
.    O

Thus    O
,    O
the    O
overhead    O
press    O
is    O
a    O
good    O
exercise    O
for    O
strengthening    B-Therapy100661091
the    O
shoulders    O
and    O
arms    O
,    O
but    O
,    O
even    O
though    O
it    O
uses    O
some    O
of    O
the    O
same    O
muscles    O
that    O
are    O
involved    O
in    O
running    O
,    O
it    O
is    O
not    O
directly    O
related    O
to    O
running    O
.    O

Chinese    B-Therapy100661091
food    I-Therapy100661091
therapy    I-Therapy100661091
(    O
or    O
shíliáo    O
)    O
,    O
practice    O
in    O
the    O
belief    O
of    O
healing    O
through    O
the    O
use    O
of    O
natural    O
foods    O
instead    O
of    O
,    O
or    O
in    O
addition    O
to    O
medications    O

Food    B-Therapy100661091
therapy    I-Therapy100661091

For    O
a    O
number    O
of    O
years    O
the    O
senior    O
tutor    O
and    O
principal    O
psychologist    O
for    O
these    O
courses    O
was    O
Irene    O
Caspari    O
who    O
did    O
much    O
to    O
promote    O
the    O
concept    O
and    O
practice    O
of    O
Educational    B-Therapy100661091
therapy    I-Therapy100661091
.    O

Types    O
of    O
"    O
putative    O
energy    O
medicine    O
"    O
include    O
biofield    O
energy    O
healing    O
therapies    O
where    O
the    O
hands    O
are    O
claimed    O
to    O
direct    O
or    O
modulate    O
"    O
energies    O
"    O
which    O
are    O
believed    O
to    O
effect    O
healing    O
in    O
the    O
patient    O
;    O
this    O
includes    O
spiritual    O
healing    O
and    O
psychic    O
healing    O
,    O
Therapeutic    B-Therapy100661091
touch    I-Therapy100661091
,    O
Healing    B-Therapy100661091
Touch    I-Therapy100661091
,    O
Hands    O
of    O
light    O
,    O
Esoteric    O
healing    O
,    O
Magnetic    O
healing    O
(    O
now    O
a    O
historical    O
term    O
not    O
to    O
be    O
confused    O
with    O
magnet    B-Therapy100661091
therapy    I-Therapy100661091
)    O
,    O
Qigong    B-Therapy100661091
healing    O
,    O
Reiki    B-Therapy100661091
,    O
Pranic    B-Therapy100661091
healing    I-Therapy100661091
,    O
Crystal    B-Therapy100661091
healing    I-Therapy100661091
,    O
distant    O
healing    O
,    O
intercessory    O
prayer    O
,    O
and    O
similar    O
modalities    O
.    O

Within    O
the    O
TNZ    O
the    O
basal    B-Therapy100661091
rate    I-Therapy100661091
of    O
heat    O
production    O
is    O
in    O
equilibrium    O
with    O
the    O
rate    O
of    O
heat    O
loss    O
to    O
the    O
external    O
environment    O
.    O

This    O
newer    O
approach    O
contrasts    O
with    O
conventional    B-Therapy100661091
insulinotherapy    I-Therapy100661091
.    O

The    O
law    O
has    O
brought    O
difficulties    O
to    O
diabetes    O
patients    O
,    O
as    O
the    O
test    O
strip    O
papers    O
required    O
by    O
glucose    B-Therapy100661091
meter    I-Therapy100661091
used    O
for    O
home    O
blood    B-Therapy100661091
glucose    I-Therapy100661091
monitoring    I-Therapy100661091
were    O
considered    O
pharmacological    O
supplies    O
under    O
the    O
law    O
,    O
and    O
thus    O
legally    O
could    O
only    O
be    O
sold    O
by    O
pharmacies    O
.    O

Capillary    O
blood    O
glucose    O
is    O
measured    O
every    O
4    O
hours    O
using    O
a    O
reflectance    B-Therapy100661091
meter    I-Therapy100661091
,    O
until    O
values    O

Examples    O
of    O
peripheral    O
devices    O
are    O
:    O
blood    O
pressure    O
cuff    O
,    O
pulse    O
oximeter    O
,    O
and    O
glucometer    B-Therapy100661091
.    O

The    O
Omnipod    O
PDM    O
is    O
essentially    O
a    O
Blood    B-Therapy100661091
Glucose    I-Therapy100661091
(BG)    I-Therapy100661091
meter    I-Therapy100661091
that    O
also    O
acts    O
in    O
compatibility    O
with    O
the    O
pod    O
as    O
a    O
wireless    O
remote    O
.    O

The    O
Omnipod    O
System    O
’s    O
Personal    O
Diabetes    O
Manager    O
is    O
a    O
technologically    O
advanced    O
blood    B-Therapy100661091
glucose    I-Therapy100661091
mete    I-Therapy100661091
.    O

Entra    O
Health    O
Systems    O
makes    O
integrated    O
bluetooth    O
-    O
enabled    O
,    O
WiFi    O
,    O
and    O
Cellular    O
blood    B-Therapy100661091
glucose    I-Therapy100661091
meter    I-Therapy100661091
that    O
work    O
with    O
an    O
online    O
data    O
collection    O
network    O
to    O
upload    O
and    O
report    O
patient    O
blood    O
glucose    O
readings    O
.    O

Alternatively    O
,    O
testing    O
blood    O
sugar    O
more    O
often    O
,    O
8    O
to    O
10    O
times    O
daily    O
with    O
a    O
traditional    O
blood    B-Therapy100661091
glucose    I-Therapy100661091
meter    I-Therapy100661091
,    O
facilitates    O
detecting    O
the    O
low    O
blood    O
sugar    O
level    O
before    O
such    O
a    O
rebound    O
occurs    O
.    O

Frequency    B-Therapy100661091
specific    I-Therapy100661091
microcurrent    I-Therapy100661091

Applicant    O
Fei    O
Wang    O
appeared    O
before    O
the    O
skeptic    O
audience    O
July    O
2014    O
with    O
the    O
claim    O
that    O
he    O
could    O
send    O
energy    O
through    O
his    O
hand    O
using    O
a    O
type    O
of    O
therapeutic    B-Therapy100661091
touch    I-Therapy100661091
.    O

Therapeutic    B-Therapy100661091
touch    I-Therapy100661091

Ironically    O
,    O
the    O
only    O
thing    O
that    O
distinguishes    O
Reiki    O
from    O
Therapeutic    B-Therapy100661091
Touch    I-Therapy100661091
is    O
that    O
it    O
[    O
Reiki    O
]    O
involves    O
actual    O
touch    O
.    O

Therapeutic    B-Therapy100661091
touch    I-Therapy100661091
practitioner    O

Raskin    O
published    O
a    O
paper    O
highly    O
critical    O
of    O
pseudoscience    O
in    O
nursing    O
,    O
such    O
as    O
therapeutic    B-Therapy100661091
touch    I-Therapy100661091
and    O
rogerian    O
science    O
,    O
wherein    O
he    O
said    O
:    O
"    O
Unlike    O
science    O
,    O
nursing    O
theory    O
has    O
no    O
built    O
-    O
in    O
mechanisms    O
for    O
rejecting    O
falsehoods    O
,    O
tautologies    O
,    O
and    O
irrelevancies    O
.    O
"    O

Therapeutic    B-Therapy100661091
touch    I-Therapy100661091
(    O
commonly    O
shortened    O
to    O
"    O
TT    B-Therapy100661091
"    O
)    O
,    O
known    O
by    O
some    O
as    O
"    O
non-contact    B-Therapy100661091
therapeutic    I-Therapy100661091
touch    I-Therapy100661091
"    O
(    O
NCTT    O
)    O
,    O
is    O
a    O
pseudoscientific    O
energy    B-Therapy100661091
therapy    I-Therapy100661091
which    O
practitioners    O
claim    O
promotes    O
healing    O
and    O
reduces    O
pain    O
and    O
anxiety    O
.    O

TNF    O
or    O
its    O
effects    O
are    O
inhibited    O
by    O
several    O
natural    O
compounds    O
,    O
including    O
curcumin    B-Therapy100661091
(    O
a    O
compound    O
present    O
in    O
turmeric    O
)    O
,    O
and    O
catechins    O
(    O
in    O
green    O
tea    O
)    O
.    O

Some    O
other    O
natural    O
and    O
synthetic    O
molecules    O
,    O
such    O
as    O
celasterols    O
from    O
medicinal    O
herbs    O
and    O
curcumin    B-Therapy100661091
from    O
the    O
spice    O
turmeric    O
have    O
also    O
been    O
found    O
to    O
have    O
hormetic    O
beneficial    O
effects    O
.    O

The    O
implementation    O
of    O
Turmeric    O
in    O
medical    O
administration    O
can    O
typically    O
be    O
explained    O
by    O
the    O
factor    O
that    O
Curcumin    B-Therapy100661091
is    O
a    O
component    O
that    O
is    O
contained    O
within    O
Turmeric    O
.    O

His    O
team    O
was    O
successful    O
in    O
showing    O
the    O
antimalarial    O
property    O
of    O
Curcumin    B-Therapy100661091
and    O
its    O
efficacy    O
in    O
combination    O
therapy    O
in    O
2004    O
.    O

A    O
2014    O
review    O
of    O
research    O
concluded    O
that    O
there    O
was    O
evidence    O
that    O
consumption    O
of    O
citrus    O
fruits    O
and    O
curcumin    B-Therapy100661091
reduced    O
risk    O
of    O
pancreatic    O
cancer    O
,    O
while    O
there    O
was    O
possibly    O
a    O
beneficial    O
effect    O
from    O
whole    O
grains    O
,    O
folate    O
,    O
selenium    O
,    O
and    O
non    O
-    O
fried    O
fish    O
.    O

Curcumin    B-Therapy100661091
as    O
of    O
2010    O
has    O
not    O
shown    O
benefit    O
in    O
people    O
even    O
though    O
there    O
is    O
tentative    O
evidence    O
in    O
animals    O
.    O

Aspirin    O
and    O
Curcumin    B-Therapy100661091
(    O
diferuloylmethane    O
)    O
too    O
activate    O
caspase-8    O
to    O
cleave    O
and    O
translocated    O
Bid    O
,    O
induced    O
a    O
conformational    O
change    O
in    O
and    O
translocation    O
of    O
Bax    O
and    O
cytochrome    O
-    O
c    O
release    O
.    O

Some    O
chemicals    O
found    O
in    O
trace    O
amounts    O
in    O
food    O
,    O
and    O
some    O
dietary    O
supplements    O
,    O
also    O
have    O
been    O
shown    O
in    O
inhibit    O
5-LOX    O
,    O
such    O
as    O
baicalein    O
,    O
caffeic    O
acid    O
,    O
curcumin    B-Therapy100661091
,    O
hyperforin    O
and    O
St    O
John    O
's    O
wort    O
.    O

Azerizin    O
is    O
claimed    O
to    O
be    O
a    O
proprietary    O
blend    O
of    O
the    O
natural    O
ingredients    O
nicotinamide    O
,    O
azelaic    O
acid    O
,    O
quercetin    O
and    O
curcumin    B-Therapy100661091
that    O
purportedly    O
combine    O
the    O
anti    O
-    O
inflammatory    O
and    O
antimicrobial    O
properties    O
,    O
along    O
with    O
inhibiting    O
effects    O
on    O
sebum    O
production    O
.    O

Curcumin    B-Therapy100661091

Other    O
topics    O
of    O
research    O
have    O
included    O
investigations    O
into    O
mannitol    O
,    O
dexamethasone    O
,    O
progesterone    O
,    O
xenon    O
,    O
barbiturates    O
,    O
magnesium    O
,    O
calcium    O
channel    O
blockers    O
,    O
PPAR-γ    O
agonists    O
,    O
curcumin    B-Therapy100661091
,    O
ethanol    O
,    O
NMDA    O
antagonists    O
,    O
caffeine    O
.    O

This    O
may    O
be    O
achieved    O
by    O
delivering    B-Therapy100661091
insulin    I-Therapy100661091
rhythmically    I-Therapy100661091
to    O
the    O
portal    O
vein    O
or    O
by    O
islet    B-Therapy100661091
cell    I-Therapy100661091
transplantation    I-Therapy100661091
to    O
the    O
liver    O
.    O

The    O
ASAT    O
responded    O
by    O
saying    O
that    O
,    O
in    O
recent    O
years    O
,    O
the    O
Autism    O
Research    O
Review    O
International    O
,    O
where    O
Rimland    O
had    O
published    O
his    O
article    O
,    O
had    O
displayed    O
"    O
a    O
consistent    O
pattern    O
of    O
premature    O
and    O
uncritical    O
promotion    O
of    O
treatment    O
“    O
breakthroughs    O
”    O
in    O
the    O
absence    O
of    O
credible    O
research    O
support    O
,    O
"    O
including    O
facilitated    B-Therapy100661091
communication    I-Therapy100661091
.    O

He    O
was    O
initially    O
reported    O
as    O
communicating    O
by    O
typing    O
into    O
a    O
keyboard    O
with    O
his    O
right    O
hand    O
,    O
though    O
the    O
presence    O
of    O
a    O
facilitator    B-Therapy100661091
to    O
move    O
his    O
hand    O
attracted    O
sharp    O
criticism    O
and    O
strong    O
doubts    O
that    O
Houben    O
's    O
communications    O
were    O
authentic    O
.    O

Some    O
reviewers    O
,    O
including    O
Temple    O
Grandin    O
were    O
initially    O
concerned    O
that    O
"    O
The    O
Reason    O
I    O
Jump    O
"    O
might    O
be    O
written    O
using    O
the    O
controversial    O
method    O
of    O
facilitated    B-Therapy100661091
communication    I-Therapy100661091
since    O
there    O
was    O
little    O
accompanying    O
information    O
about    O
teaching    O
and    O
communication    O
methods    O
used    O
,    O
but    O
later    O
satisfied    O
themselves    O
that    O
the    O
books    O
were    O
all    O
Higashida    O
's    O
own    O
work    O
.    O

With    O
help    O
from    O
his    O
mother    O
,    O
he    O
is    O
purported    O
to    O
have    O
written    O
the    O
book    O
using    O
a    O
method    O
he    O
calls    O
"    O
facilitated    O
finger    O
writing    O
"    O
,    O
also    O
known    O
as    O
facilitated    B-Therapy100661091
communication    I-Therapy100661091
(    O
FC    O
)    O
,    O
a    O
method    O
which    O
has    O
been    O
repeatedly    O
discredited    O
as    O
pseudoscience    O
and    O
deemed    O
invalid    O
by    O
numerous    O
organizations    O
since    O
the    O
1980s    O
,    O
such    O
as    O
the    O
American    O
Academy    O
of    O
Pediatrics    O
and    O
the    O
American    O
Psychological    O
Association    O
(    O
APA    O
)    O
,    O
among    O
others    O
.    O

He    O
said    O
the    O
book    O
also    O
contains    O
many    O
familiar    O
tropes    O
that    O
have    O
been    O
propagated    O
by    O
advocates    O
of    O
facilitated    B-Therapy100661091
communication    I-Therapy100661091
,    O
such    O
as    O
"    O
Higashida    O
's    O
claim    O
that    O
people    O
with    O
autism    O
are    O
like    O
'    O
travellers    O
from    O
a    O
distant    O
,    O
distant    O
past    O
'    O
who    O
have    O
come    O
...    O
'to    O
help    O
the    O
people    O
of    O
the    O
world    O
remember    O
what    O
truly    O
matters    O
for    O
the    O
Earth    O
,    O
'    O
"    O
which    O
Fitzpatrick    O
compared    O
to    O
the    O
notion    O
promoted    O
by    O
anti    O
-    O
immunisation    O
advocates    O
that    O
autistic    O
children    O
are    O
"    O
heralds    O
of    O
environmental    O
catastrophe    O
"    O
.    O

Facilitated    B-Therapy100661091
Communication    I-Therapy100661091
(    O
FC    O
)    O
,    O
popularized    O
in    O
the    O
early    O
1990s    O
in    O
the    O
United    O
States    O
by    O
Douglas    O
Biklen    O
,    O
is    O
an    O
alleged    O
communication    O
technique    O
in    O
which    O
the    O
facilitator    O
(    O
usually    O
a    O
parent    O
,    O
educator    O
,    O
or    O
caregiver    O
)    O
holds    O
the    O
hand    O
,    O
shoulder    O
or    O
arm    O
of    O
a    O
person    O
with    O
disabilities    O
in    O
order    O
to    O
type    O
on    O
a    O
paper    O
letter    O
board    O
or    O
mechanical    O
keyboard    O
.    O

Jay    O
Cataldo    O
's    O
techniques    O
include    O
NLP    O
,    O
EFT    B-Therapy100661091
,    O
Focusing    O
and    O
Hypnosis    O
.    O

Emotional    B-Therapy100661091
Freedom    I-Therapy100661091
Techniques    I-Therapy100661091
(    O
EFT    B-Therapy100661091
)    O
is    O
a    O
form    O
of    O
counseling    O
intervention    O
that    O
draws    O
on    O
various    O
theories    O
of    O
alternative    O
medicine    O
including    O
acupuncture    O
,    O
neuro    O
-    O
linguistic    O
programming    O
,    O
energy    B-Therapy100661091
medicine    I-Therapy100661091
,    O
and    O
Thought    B-Therapy100661091
Field    I-Therapy100661091
Therapy    I-Therapy100661091
(    O
TFT    O
)    O
.    O

Energy    B-Therapy100661091
field    I-Therapy100661091
disturbance    I-Therapy100661091

Qigong    O
is    O
now    O
practiced    O
by    O
millions    O
worldwide    O
,    O
primarily    O
for    O
its    O
health    O
benefits    O
,    O
though    O
many    O
practitioners    O
have    O
also    O
adopted    O
traditional    O
philosophical    O
,    O
medical    O
,    O
or    O
martial    O
arts    O
perspectives    O
,    O
and    O
even    O
use    O
the    O
long    O
history    B-Therapy100661091
of    I-Therapy100661091
qigong    I-Therapy100661091
as    O
evidence    O
of    O
its    O
effectiveness    O
.    O

Hyperinsulinemic    B-Therapy100661091
hypoglycemia    I-Therapy100661091
describes    O
the    O
condition    O
and    O
effects    O
of    O
low    O
blood    O
glucose    O
caused    O
by    O
excessive    O
insulin    O
.    O

Mutations    O
in    O
this    O
gene    O
cause    O
one    O
form    O
of    O
familial    O
hyperinsulinemic    B-Therapy100661091
hypoglycemia    I-Therapy100661091
.    O

Hyperinsulinemic    B-Therapy100661091
hypoglycemia    I-Therapy100661091

Medicinal    B-Therapy100661091
clay    I-Therapy100661091

Medicinal    B-Therapy100661091
clay    I-Therapy100661091
are    O
also    O
widely    O
used    O
,    O
which    O
practice    O
is    O
known    O
as    O
'    O
fangotherapy    O
'    O
.    O

Other    O
minority    O
practices    O
include    O
paper    O
preparations    O
,    O
where    O
the    O
substance    O
and    O
dilution    O
are    O
written    O
on    O
pieces    O
of    O
paper    O
and    O
either    O
pinned    O
to    O
the    O
patients    O
'    O
clothing    O
,    O
put    O
in    O
their    O
pockets    O
,    O
or    O
placed    O
under    O
glasses    O
of    O
water    O
that    O
are    O
then    O
given    O
to    O
the    O
patients    O
,    O
and    O
the    O
use    O
of    O
radionics    B-Therapy100661091
to    O
manufacture    O
preparations    O
.    O

In    O
1953    O
he    O
resigned    O
from    O
this    O
post    O
to    O
work    O
on    O
the    O
controversial    O
field    O
of    O
radionics    B-Therapy100661091
,    O
in    O
which    O
he    O
was    O
a    O
pioneer    O
.    O

---    O
radiesthesia    B-Therapy100661091

Betz    O
also    O
investigates    O
Radiesthesia    B-Therapy100661091
and    O
Dowsing    O
,    O
ten    O
years    O
in    O
Order    O
by    O
the    O
German    O
Government    O
.    O
for    O
example    O
the    O
extensive    O
Munich    O
"    O
Scheunenexperimenten    O
"    O
.    O

Radionics    B-Therapy100661091

Bioinstrumentation    O
/    O
Bioelectrical    O
Systems    O
:    O
Focus    O
includes    O
medical    O
devices    O
,    O
modeling    O
of    O
biological    O
systems    O
,    O
in    O
particular    O
circuit    O
analogies    O
to    O
the    O
nervous    O
system    O
,    O
bioelectric    B-Therapy100661091
phenomena    O
and    O
signal    O
processing    O
.    O

Bioelectric    B-Therapy100661091
dressings    O
can    O
be    O
effective    O
in    O
attacking    O
certain    O
antibiotic    O
-    O
resistant    O
bacteria    O
and    O
speeding    O
up    O
the    O
healing    O
process    O
.    O

This    O
was    O
one    O
of    O
the    O
first    O
forays    O
into    O
the    O
study    O
of    O
bioelectricity    B-Therapy100661091
,    O
a    O
field    O
that    O
still    O
studies    O
the    O
electrical    O
patterns    O
and    O
signals    O
in    O
tissues    O
such    O
as    O
nerves    O
and    O
muscles    O
.    O

In    O
1832    O
,    O
he    O
completed    O
a    O
series    O
of    O
experiments    O
aimed    O
at    O
investigating    O
the    O
fundamental    O
nature    O
of    O
electricity    O
;    O
Faraday    O
used    O
"    O
static    O
"    O
,    O
batteries    O
,    O
and    O
"    O
animal    B-Therapy100661091
electricity    I-Therapy100661091
"    O
to    O
produce    O
the    O
phenomena    O
of    O
electrostatic    O
attraction    O
,    O
electrolysis    O
,    O
magnetism    O
,    O
etc    O
.    O

The    O
goal    O
of    O
implantable    O
microelectrodes    O
is    O
to    O
interface    O
with    O
the    O
body    O
’s    O
nervous    O
system    O
for    O
recording    O
and    O
sending    O
bioelectrical    B-Therapy100661091
signals    O
to    O
study    O
disease    O
,    O
improve    O
prostheses    O
,    O
and    O
monitor    O
clinical    O
parameters    O
.    O

Integrating    O
microelectronics    O
onto    O
thin    O
,    O
flexible    O
substrates    O
has    O
led    O
to    O
the    O
development    O
of    O
a    O
cardiac    O
patch    O
that    O
adheres    O
to    O
the    O
curvilinear    O
surface    O
of    O
the    O
heart    O
by    O
surface    O
tension    O
alone    O
for    O
measuring    O
cardiac    O
electrophysiology    O
,    O
and    O
electronic    O
tattoos    O
for    O
measuring    O
skin    O
temperature    O
and    O
bioelectricity    B-Therapy100661091
.    O

The    O
Cylons    O
believe    O
that    O
a    O
critical    O
symptom    O
of    O
this    O
virus    O
,    O
a    O
harmful    O
bioelectric    B-Therapy100661091
feedback    O
,    O
can    O
be    O
transmitted    O
during    O
a    O
download    O
and    O
attempt    O
to    O
prevent    O
infected    O
Cylons    O
from    O
downloading    O
.    O

Reich    O
wrote    O
in    O
an    O
essay    O
,    O
"    O
"    O
Der    O
Orgasmus    O
als    O
Elektro    O
-    O
physiologische    O
Entladung    O
"    O
"    O
(    O
"    O
The    O
Orgasm    O
as    O
an    O
Electrophysiological    O
Discharge    O
"    O
,    O
1934    O
)    O
,    O
that    O
the    O
orgasm    O
is    O
just    O
such    O
a    O
bioelectrical    B-Therapy100661091
discharge    O
and    O
proposed    O
his    O
"    O
orgasm    O
formula    O
"    O
:    O
mechanical    O
tension    O
(    O
filling    O
of    O
the    O
organs    O
with    O
fluid    O
;    O
tumescence    O
)    O
→    O
bioelectrical    O
charge    O
→    O
bioelectrical    O
discharge    O
→    O
mechanical    O
relaxation    O
(    O
detumescence    O
)    O
.    O

Several    O
species    O
of    O
this    O
family    O
have    O
the    O
ability    O
to    O
produce    O
an    O
electric    B-Therapy100661091
shock    I-Therapy100661091
of    O
up    O
to    O
350    O
volts    O
using    O
electroplaques    O
of    O
an    O
electric    O
organ    O
.    O

#    O
Bioelectromagnetic    B-Therapy100661091
-    O
based    O
therapies    O
use    O
verifiable    O
electromagnetic    O
fields    O
,    O
such    O
as    O
pulsed    O
fields    O
,    O
alternating    O
-    O
current    O
,    O
or    O
direct    O
-    O
current    O
fields    O
in    O
an    O
unconventional    O
manner    O
.    O

Medical    O
researchers    O
develop    O
a    O
new    O
method    O
of    O
efficiently    O
detecting    O
cancer    O
using    O
bioelectric    B-Therapy100661091
signals    O
.    O

His    O
sword    O
's    O
hilt    O
is    O
wrapped    O
with    O
Andrea    O
's    O
skin    O
to    O
release    O
powerful    O
bioelectric    B-Therapy100661091
blasts    O
of    O
concussive    O
force    O
.    O

Bush    B-Therapy100661091
medicine    I-Therapy100661091
,    O
also    O
called    O
traditional    O
medicine    O
,    O
is    O
the    O
sum    O
of    O
the    O
total    O
knowledge    O
,    O
skills    O
and    O
practices    O
based    O
on    O
the    O
theories    O
,    O
beliefs    O
and    O
experiences    O
indigenous    O
to    O
different    O
cultures    O
,    O
whether    O
explicable    O
or    O
not    O
,    O
used    O
in    O
the    O
maintenance    O
of    O
health    O
as    O
well    O
as    O
in    O
the    O
prevention    O
,    O
diagnosis    O
,    O
improvement    O
or    O
treatment    O
of    O
physical    O
and    O
mental    O
illness    O
.    O

The    O
people    O
harvest    O
and    O
consume    O
traditional    O
foods    O
–    O
and    O
to    O
some    O
extent    O
medicines    B-Therapy100661091
–    O
especially    O
the    O
elders    O
.    O

A    O
very    O
wide    O
array    O
of    O
methods    O
are    O
utilised    O
within    O
the    O
holistic    O
health    O
movement    O
,    O
with    O
some    O
of    O
the    O
most    O
common    O
including    O
acupuncture    O
,    O
reiki    O
,    O
biofeedback    O
,    O
chiropractic    O
,    O
yoga    O
,    O
kinesiology    O
,    O
homeopathy    O
,    O
aromatherapy    O
iridology    O
,    O
massage    O
and    O
other    O
forms    O
of    O
bodywork    O
,    O
meditation    O
and    O
visualisation    O
,    O
nutritional    O
therapy    O
,    O
psychic    B-Therapy100661091
healing    I-Therapy100661091
,    O
herbal    B-Therapy100661091
medicine    I-Therapy100661091
,    O
healing    B-Therapy100661091
using    I-Therapy100661091
crystals    I-Therapy100661091
,    O
metals    O
,    O
music    O
,    O
chromotherapy    B-Therapy100661091
,    O
and    O
reincarnation    O
therapy    O
.    O

The    O
friends    O
then    O
lay    O
down    O
in    O
a    O
circle    O
,    O
while    O
one    O
of    O
them    O
proceeds    O
into    O
acts    O
of    O
shamanism    O
,    O
which    O
includes    O
placing    O
healing    B-Therapy100661091
crystal    I-Therapy100661091
on    O
top    O
of    O
each    O
person    O
.    O

If    O
homeopathy    O
is    O
correct    O
,    O
much    O
of    O
physics    O
,    O
chemistry    O
,    O
and    O
pharmacology    O
must    O
be    O
incorrect    O
....    O
To    O
have    O
an    O
open    O
mind    O
about    O
homeopathy    O
or    O
similarly    O
implausible    O
forms    O
of    O
alternative    O
medicine    O
(    O
e.g.    O
,    O
Bach    B-Therapy100661091
flower    I-Therapy100661091
remedies    I-Therapy100661091
,    O
spiritual    B-Therapy100661091
healing    I-Therapy100661091
,    O
crystal    B-Therapy100661091
therapy    I-Therapy100661091
)    O
is    O
therefore    O
not    O
an    O
option    O
.    O

quackery    O
type    O
:    O
electromagnetic    B-Therapy100661091
therapy    I-Therapy100661091
(alternative    I-Therapy100661091
medicine)    I-Therapy100661091

As    O
a    O
result    O
,    O
it    O
can    O
be    O
used    O
for    O
people    O
with    O
either    O
type-1    O
or    O
type-2    O
diabetes    O
mellitus    O
to    O
identify    O
glycemic    O
variability    O
or    O
a    O
history    O
of    O
high    O
blood    O
glucose    O
even    O
if    O
current    O
glycemic    O
measurements    O
such    O
as    O
hemoglobin    O
A1c    O
(    O
HbA1c    O
)    O
and    O
blood    B-Therapy100661091
glucose    I-Therapy100661091
monitoring    I-Therapy100661091
have    O
near    O
normal    O
values    O
.    O

In    O
2006    O
,    O
1,5-AG    O
showed    O
its    O
most    O
compelling    O
clinical    O
use    O
when    O
it    O
was    O
demonstrated    O
that    O
an    O
assay    O
(    O
GlycoMark    O
,    O
developed    O
by    O
Nippon    O
Kayaku    O
,    O
Inc.    O
)    O
for    O
postprandial    O
hyperglycemia    O
was    O
able    O
to    O
differentiate    O
two    O
patients    O
who    O
had    O
similar    O
,    O
near    O
goal    O
,    O
hemoglobin    O
A1c    O
values    O
,    O
yet    O
very    O
different    O
glucose    O
profiles    O
as    O
shown    O
by    O
continuous    O
blood    B-Therapy100661091
glucose    I-Therapy100661091
monitoring    I-Therapy100661091
-    O
one    O
of    O
the    O
patients    O
having    O
excessive    O
glycemic    O
variability    O
.    O

Measures    O
will    O
include    O
fasting    O
insulin    O
,    O
HOMA2-IR    O
,    O
indices    O
from    O
continuous    B-Therapy100661091
glucose    I-Therapy100661091
monitoring    I-Therapy100661091
and    O
the    O
behaviour    O
of    O
glucose    O
,    O
insulin    O
,    O
C    O
-    O
peptide    O
and    O
the    O
insulinogenic    O
index    O
during    O
the    O
course    O
of    O
a    O
mixed    O
meal    O
tolerance    O
test(duration    O
four    O
months    O
)    O
.    O

An    O
insulin    O
pump    O
is    O
an    O
alternative    O
to    O
multiple    O
daily    O
injections    O
of    O
insulin    O
by    O
insulin    O
syringes    O
or    O
an    O
insulin    B-Therapy100661091
pen    I-Therapy100661091
and    O
allows    O
for    O
intensive    B-Therapy100661091
insulin    I-Therapy100661091
therapy    I-Therapy100661091
when    O
used    O
in    O
conjunction    O
with    O
blood    B-Therapy100661091
glucose    I-Therapy100661091
monitoring    I-Therapy100661091
and    O
carb    O
counting    O
.    O

Improvements    O
in    O
blood    B-Therapy100661091
glucose    I-Therapy100661091
monitoring    I-Therapy100661091
.    O

To    O
achieve    O
the    O
best    O
balance    O
of    O
blood    O
sugar    O
with    O
either    O
intensive    O
/    O
flexible    O
method    O
,    O
a    O
patient    O
must    O
check    O
his    O
or    O
her    O
glucose    O
level    O
with    O
a    O
meter    O
monitoring    B-Therapy100661091
of    I-Therapy100661091
blood    I-Therapy100661091
glucose    I-Therapy100661091
several    O
times    O
a    O
day    O
.    O

In    O
2006    O
the    O
U.S.    O
Food    O
and    O
Drug    O
Administration    O
approved    O
the    O
use    O
of    O
Exubera    B-Therapy100661091
,    O
the    O
first    O
inhalable    O
insulin    O
.    O

Inhaled    B-Therapy100661091
insulin    I-Therapy100661091
is    O
also    O
available    O
in    O
the    O
U.S.    O
market    O
now    O
.    O

Insulin    B-Therapy100661091
degludec    I-Therapy100661091
(    O
INN    O
/    O
USAN    O
)    O
is    O
an    O
ultralong    O
-    O
acting    O
basal    O
insulin    B-Therapy100661091
analogue    I-Therapy100661091
that    O
was    O
developed    O
by    O
Novo    O
Nordisk    O
under    O
the    O
brand    O
name    O
Tresiba    B-Therapy100661091
.    O

Compare    O
with    O
the    O
dawn    B-Therapy100661091
phenomenon    I-Therapy100661091
,    O
which    O
is    O
a    O
morning    O
rise    O
in    O
blood    O
sugar    O
in    O
response    O
to    O
waning    O
insulin    O
and    O
a    O
growth    O
hormone    O
surge    O
(    O
that    O
further    O
antagonizes    O
insulin    O
)    O
.    O

Album    B-Therapy100661091
graecum    I-Therapy100661091

#    O
"    O
Four    B-Therapy100661091
Thieves    I-Therapy100661091
Vinegar    I-Therapy100661091
"    O
–    O
3:34    O

Extracts    O
of    O
the    O
bark    O
,    O
leaves    O
,    O
stems    O
,    O
and    O
unripe    O
fruits    O
have    O
demonstrated    O
antibiotic    O
properties    O
in    O
vitro    O
,    O
and    O
are    O
used    O
in    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
.    O

They    O
claimed    O
that    O
a    O
traditional    B-Therapy100661091
healer    I-Therapy100661091
told    O
them    O
they    O
would    O
get    O
rich    O
if    O
they    O
mixed    O
Mpunzi    O
's    O
blood    O
and    O
parts    O
with    O
'    O
muthi    O
'    O
.    O

Some    O
species    O
are    O
renowned    O
for    O
their    O
properties    O
in    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
and    O
herbalism    B-Therapy100661091
;    O
for    O
example    O
Vera    O
Cruz    O
jalap    O
(    O
"    O
I.    O
jalapa    O
"    O
)    O
and    O
Tampico    O
jalap    O
(    O
"    O
I.    O
simulans    O
"    O
)    O
are    O
used    O
to    O
produce    O
jalap    O
,    O
a    O
cathartic    O
preparation    O
accelerating    O
the    O
passage    O
of    O
stool    O
.    O

Jamaica    O
Plain    O
has    O
several    O
botánicas    O
,    O
such    O
as    O
this    O
one    O
on    O
Centre    O
Street    O
,    O
that    O
cater    O
to    O
the    O
Latino    O
community    O
and    O
typically    O
sell    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
alongside    O
statues    O
of    O
saints    O
,    O
candles    O
decorated    O
with    O
prayers    O
,    O
lucky    O
bamboo    O
,    O
and    O
other    O
items    O
.    O

According    O
to    O
another    O
practitioner    O
of    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
:    O

It    O
is    O
used    O
in    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
and    O
ritual    O
in    O
its    O
native    O
range    O
.    O

While    O
the    O
efficacy    O
of    O
these    O
remedies    O
has    O
not    O
been    O
proven    O
,    O
this    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
is    O
so    O
renowned    O
that    O
even    O
non    O
-    O
Baka    O
seek    O
out    O
their    O
healers    O
for    O
treatment    O
.    O

Vestiges    O
of    O
their    O
native    O
animism    O
still    O
persist    O
,    O
however    O
,    O
especially    O
in    O
the    O
realm    O
of    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
.    O

Vestiges    O
of    O
their    O
native    O
animism    O
still    O
persist    O
,    O
however    O
,    O
especially    O
in    O
the    O
realm    O
of    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
.    O

Also    O
,    O
many    O
families    O
had    O
a    O
choice    O
of    O
whether    O
or    O
not    O
they    O
wanted    O
to    O
employ    O
a    O
midwife    O
who    O
practiced    O
the    O
traditional    B-Therapy100661091
folk    I-Therapy100661091
medicine    I-Therapy100661091
or    O
the    O
newer    O
methods    O
of    O
professional    O
parturition    O
.    O

From    O
the    O
18th    O
century    O
,    O
a    O
conflict    O
between    O
surgeons    O
and    O
midwives    O
arose    O
,    O
as    O
medical    O
men    O
began    O
to    O
assert    O
that    O
their    O
modern    O
scientific    O
techniques    O
were    O
better    O
for    O
mothers    O
and    O
infants    O
than    O
the    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
practiced    O
by    O
midwives    O
.    O

The    O
plant    O
is    O
both    O
poisonous    O
and    O
used    O
in    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
.    O

The    O
use    O
of    O
the    O
plant    O
in    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
has    O
been    O
limited    O
by    O
the    O
bitter    O
taste    O
of    O
the    O
bark    O
and    O
root    O
.    O

In    O
Malaysia    O
there    O
is    O
a    O
substantial    O
domestic    O
market    O
in    O
recent    O
years    O
for    O
tiger    O
meat    O
and    O
manufactured    O
tiger    B-Therapy100661091
bone    I-Therapy100661091
medicines    I-Therapy100661091
.    O

The    O
delicate    O
,    O
feathery    O
foliage    O
has    O
been    O
used    O
as    O
a    O
condiment    O
and    O
in    O
the    O
preparation    O
of    O
a    O
wide    O
variety    O
of    O
home    B-Therapy100661091
remedies    I-Therapy100661091
as    O
a    O
diuretic    O
,    O
to    O
control    O
menstruation    O
and    O
uterine    O
complaints    O
and    O
to    O
treat    O
catarrh    O
,    O
hysteria    O
and    O
stomach    O
ailments    O
.    O

In    O
Australia    O
,    O
Aborigines    O
have    O
used    O
"    O
Phellinus    O
"    O
fruit    O
bodies    O
medicinally    B-Therapy100661091
.    O

Tan    O
has    O
authored    O
numerous    O
books    O
and    O
articles    O
,    O
often    O
focusing    O
on    O
:    O
indigenous    B-Therapy100661091
medical    I-Therapy100661091
beliefs    I-Therapy100661091
,    O
sex    O
and    O
sexuality    O
,    O
reproductive    O
and    O
sexual    O
health    O
(    O
particularly    O
HIV    O
/    O
AIDS    O
)    O
,    O
pharmaceuticals    O
,    O
and    O
health    O
policy    O
issues    O
.    O

"    O
Rheum    O
officinale    O
"    O
is    O
used    O
in    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
,    O
in    O
Chinese    O
is    O
called    O
"    O
yào    O
yòng    O
dà    O
huáng    O
"    O
.    O

It    O
is    O
sometimes    O
planted    O
as    O
an    O
ornamental    O
;    O
and    O
has    O
virtue    O
in    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
.    O

Rambutan    O
roots    O
,    O
bark    O
,    O
and    O
leaves    O
have    O
various    O
uses    O
in    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
and    O
in    O
the    O
production    O
of    O
dyes    O
.    O

The    O
fig    O
fruits    O
,    O
important    O
as    O
both    O
food    O
and    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
,    O
contain    O
laxative    O
substances    O
,    O
flavonoids    O
,    O
sugars    O
,    O
vitamins    O
A    O
and    O
C    O
,    O
acids    O
and    O
enzymes    O
.    O

Datura    O
has    O
been    O
used    O
in    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
to    O
relieve    O
asthma    O
symptoms    O
and    O
as    O
an    O
analgesic    O
during    O
surgery    O
or    O
bonesetting    O
.    O

Traditional    O
burial    O
rituals    O
,    O
especially    O
those    O
requiring    O
embalming    O
of    O
bodies    O
,    O
ought    O
to    O
be    O
discouraged    O
or    O
modified    O
,    O
ideally    O
with    O
the    O
help    O
of    O
local    O
traditional    B-Therapy100661091
healer    I-Therapy100661091
.    O

With    O
a    O
little    O
turmeric    O
powder    O
mixed    O
in    O
,    O
it    O
is    O
also    O
used    O
as    O
a    O
folk    B-Therapy100661091
remedy    I-Therapy100661091
for    O
gastroenteritis    O
.    O

Its    O
spicy    O
fruits    O
are    O
used    O
for    O
preparing    O
vegetables    O
,    O
curry    O
and    O
fine    O
pickles    O
and    O
can    O
attract    O
helpful    O
insectivores    O
;    O
the    O
plant    O
also    O
is    O
used    O
in    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
and    O
herbalism    B-Therapy100661091
.    O

Khellin    O
has    O
been    O
used    O
as    O
an    O
herbal    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
,    O
with    O
use    O
in    O
the    O
Mediterranean    O
dating    O
back    O
to    O
Ancient    O
Egypt    O
,    O
to    O
treat    O
a    O
variety    O
of    O
maladies    O
including    O
:    O
renal    O
colic    O
,    O
kidney    O
stones    O
,    O
coronary    O
disease    O
,    O
bronchial    O
asthma    O
,    O
vitiligo    O
,    O
and    O
psoriasis    O
.    O

Essential    O
oils    O
extracted    O
from    O
the    O
root    O
have    O
been    O
used    O
in    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
and    O
in    O
perfumes    O
since    O
ancient    O
times    O
.    O

"    O
Die    O
volksmedizin    O
,    O
ihre    O
geschichtliche    O
entwickelung    O
und    O
ihre    O
beziehungen    O
zur    O
kultur    O
"    O
,    O
1905    O
–    O
Folk    B-Therapy100661091
medicine    I-Therapy100661091
,    O
its    O
historical    O
development    O
and    O
its    O
relationship    O
to    O
culture    O
.    O

Iranian    O
Traditional    O
Medicine    O
,    O
also    O
called    O
Persian    O
Traditional    O
Medicine    O
(    O
Persian    O
:    O
طب    O
سنتی‌    O
ایرانی    O
"    O
tebbe    O
sonnati    O
irāni    O
"    O
)    O
is    O
one    O
of    O
famous    O
forms    O
of    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
which    O
is    O
grounded    O
in    O
the    O
four    O
humours    O
concept    O
:    O
Phlegm    O
(    O
Balgham    O
)    O
,    O
Blood    O
(    O
Dam    O
)    O
,    O
Yellow    O
bile    O
(    O
Ṣafrā    O
'    O
)    O
and    O
Black    O
bile    O
(    O
Saudā    O
'    O
)    O
.    O

Some    O
suggest    O
that    O
the    O
only    O
answer    O
to    O
a    O
personality    O
clash    O
is    O
the    O
folk    B-Therapy100661091
remedy    I-Therapy100661091
of    O
distancing    O
-    O
reducing    O
contact    O
with    O
the    O
clashing    O
personality    O
involved    O
.    O

In    O
Taïwan    O
,    O
it    O
is    O
used    O
in    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
as    O
an    O
analgesic    O
,    O
antiphlogistic    O
and    O
spasmolytic    O
agent    O
.    O

Propolis    O
has    O
been    O
used    O
in    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
for    O
thousands    O
of    O
years    O
.    O

F.    O
aurea    O
"    O
is    O
used    O
in    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
,    O
for    O
live    O
fencing    O
,    O
as    O
an    O
ornamental    O
and    O
as    O
a    O
bonsai    O

F.    O
aurea    O
"    O
was    O
also    O
used    O
in    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
in    O
The    O
Bahamas    O
and    O
Florida    O
.    O

In    O
low    O
income    O
countries    O
,    O
burns    O
are    O
treated    O
up    O
to    O
one    O
-    O
third    O
of    O
the    O
time    O
with    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
,    O
which    O
may    O
include    O
applications    O
of    O
eggs    O
,    O
mud    O
,    O
leaves    O
or    O
cow    O
dung    O
.    O

Although    O
eaten    O
or    O
used    O
in    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
in    O
some    O
areas    O
,    O
it    O
is    O
typically    O
considered    O
inedible    O
.    O

C.    O
cinnabarinum    O
"    O
has    O
also    O
been    O
used    O
in    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
.    O

In    O
Australia    O
it    O
was    O
used    O
as    O
a    O
folk    B-Therapy100661091
remedy    I-Therapy100661091
to    O
relieve    O
the    O
itching    O
of    O
mosquito    O
and    O
sand    O
fly    O
bites    O
.    O

Air    O
potato    O
has    O
been    O
used    O
as    O
a    O
folk    B-Therapy100661091
remedy    I-Therapy100661091
to    O
treat    O
conjunctivitis    O
,    O
diarrhea    O
,    O
and    O
dysentery    O
,    O
among    O
other    O
ailments    O
.    O

"    O
Stichopus    O
"    O
species    O
are    O
important    O
in    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
practices    O
in    O
Malaysia    O
.    O

"    O
Cyclemys    O
"    O
species    O
are    O
often    O
caught    O
and    O
sold    O
for    O
the    O
pet    O
trade    O
,    O
food    O
,    O
or    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
.    O

As    O
is    O
the    O
case    O
in    O
the    O
rest    O
of    O
the    O
African    O
continent    O
,    O
the    O
Senegalese    O
have    O
long    O
used    O
traditional    B-Therapy100661091
medicines    I-Therapy100661091
and    O
rely    O
on    O
traditional    O
healers    O
for    O
their    O
ailments    O
.    O

More    O
adventurous    O
entrants    O
made    O
use    O
of    O
some    O
of    O
Nicaragua    O
's    O
most    O
obscure    O
flora    O
such    O
as    O
the    O
mamoncillo    O
,    O
the    O
extract    O
of    O
which    O
is    O
used    O
as    O
a    O
local    B-Therapy100661091
cure    O
for    O
stomachache    O
.    O

Millipedes    O
appear    O
in    O
folklore    O
and    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
around    O
the    O
world    O
.    O

Pennyroyal    O
is    O
a    O
traditional    O
folk    B-Therapy100661091
remedy    I-Therapy100661091
,    O
emmenagogue    O
,    O
abortifacient    O
,    O
and    O
culinary    O
herb    O
.    O

It    O
was    O
often    O
used    O
as    O
a    O
home    B-Therapy100661091
remedy    I-Therapy100661091
in    O
the    O
treatment    O
of    O
contact    O
dermatitis    O
caused    O
by    O
exposure    O
to    O
poison    O
ivy    O
,    O
poison    O
oak    O
,    O
and    O
other    O
oil    O
-    O
based    O
organic    O
skin    O
-    O
irritants    O
where    O
they    O
have    O
touched    O
the    O
skin    O
but    O
not    O
yet    O
inflamed    O
the    O
area    O
.    O

The    O
latter    O
custom    O
was    O
very    O
popular    O
among    O
Romanians    O
,    O
who    O
viewed    O
it    O
as    O
a    O
folk    B-Therapy100661091
remedy    I-Therapy100661091
for    O
back    O
pain    O
;    O
welcoming    O
Ursari    O
into    O
one    O
's    O
household    O
to    O
perform    O
the    O
task    O
formed    O
part    O
of    O
a    O
string    O
of    O
events    O
leading    O
to    O
the    O
celebration    O
of    O
Easter    O
,    O
or    O
part    O
of    O
customs    O
ushering    O
in    O
Christmas    O
and    O
the    O
New    O
Years    O
'    O
Eve    O
.    O

In    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
,    O
"    O
C.    O
asiatica    O
"    O
has    O
been    O
used    O
in    O
an    O
attempt    O
to    O
treat    O
varicose    O
veins    O
,    O
chronic    O
venous    O
insufficiency    O
,    O
psoriasis    O
,    O
minor    O
wounds    O
,    O
strangury    O
,    O
and    O
to    O
encourage    O
lactation    O
.    O

It    O
is    O
a    O
digestive    O
spirit    O
,    O
high    O
in    O
powerful    O
antioxidants    O
such    O
as    O
flavonoids    O
and    O
is    O
traditionally    O
used    O
by    O
many    O
Greeks    O
as    O
a    O
home    B-Therapy100661091
remedy    I-Therapy100661091
for    O
a    O
sore    O
throat    O
or    O
cough    O
.    O

The    O
seeds    O
have    O
been    O
used    O
in    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
as    O
a    O
stimulant    O
and    O
diuretic    O
.    O

The    O
resin    O
is    O
used    O
in    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
by    O
the    O
people    O
of    O
Central    O
America    O
and    O
South    O
America    O
.    O

It    O
is    O
also    O
part    O
of    O
tonic    O
drinks    O
and    O
infusions    O
to    O
expel    O
intestinal    O
parasites    O
and    O
treat    O
asthma    O
,    O
arthritis    O
,    O
dysentery    O
,    O
stomach    O
ache    O
,    O
malaria    O
,    O
and    O
nervous    O
diseases    O
in    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
practiced    O
in    O
North    O
and    O
South    O
America    O
,    O
China    O
,    O
and    O
Turkey    O
.    O

Its    O
leaves    O
,    O
seeds    O
,    O
and    O
root    O
are    O
also    O
used    O
in    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
,    O
primarily    O
in    O
Asia    O
.    O

Preliminary    O
studies    O
have    O
investigated    O
claims    O
from    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
that    O
"    O
N.    O
sativa    O
"    O
has    O
efficacy    O
as    O
a    O
therapy    O
,    O
mainly    O
using    O
the    O
seed    O
oil    O
extract    O
,    O
volatile    O
oil    O
,    O
and    O
isolated    O
constituent    O
thymoquinone    O
.    O

Boneset    O
,    O
although    O
poisonous    O
to    O
humans    O
and    O
grazing    O
livestock    O
,    O
has    O
been    O
used    O
in    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
,    O
for    O
instance    O
to    O
excrete    O
excess    O
uric    O
acid    O
which    O
causes    O
gout    O
.    O

Both    O
varieties    O
of    O
"    O
S.    O
ramalana    O
"    O
have    O
been    O
used    O
locally    O
in    O
traditional    B-Therapy100661091
folk    I-Therapy100661091
medicine    I-Therapy100661091
.    O

Traditional    B-Therapy100661091
medicine    I-Therapy100661091

Ya    O
-    O
mong    O
is    O
a    O
household    B-Therapy100661091
remedy    I-Therapy100661091
that    O
is    O
widely    O
used    O
in    O
Thailand    O
.    O

It    O
is    O
named    O
after    O
the    O
fennel    O
(    O
Marathos    O
)    O
an    O
aromatic    O
and    O
flavourful    O
herb    O
used    O
in    O
cooking    O
and    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
.    O

Suburban    O
Shaman    O
"    O
,    O
his    O
2006    O
memoir    O
of    O
medical    O
school    O
in    O
apartheid    O
South    O
Africa    O
,    O
ship    O
’s    O
doctoring    O
in    O
the    O
Mediterranean    O
,    O
family    O
practice    O
in    O
London    O
,    O
and    O
visits    O
to    O
traditional    B-Therapy100661091
healer    I-Therapy100661091
in    O
different    O
countries    O
,    O
was    O
serialized    O
by    O
BBC    O
Radio    O
4    O
as    O
its    O
‘    O
Book    O
of    O
the    O
Week’    O
in    O
March    O
2006    O
.    O

The    O
siddha    O
system    O
of    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
of    O
ancient    O
India    O
was    O
derived    O
by    O
Tamil    O
Siddhas    O
or    O
the    O
spiritual    O
scientists    O
of    O
Tamil    O
Nadu    O
.    O

He    O
was    O
also    O
famous    O
for    O
creating    O
a    O
jingle    O
called    O
"    O
Wes    O
Ewes    O
Ewes    O
Bablas    O
Angine    O
"    O
for    O
a    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
commercial    O
.    O

Boldo    O
and    O
plants    O
with    O
similar    O
properties    O
are    O
widely    O
used    O
as    O
mild    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
in    O
various    O
South    O
American    O
countries    O
in    O
both    O
urban    O
and    O
rural    O
areas    O
,    O
even    O
among    O
people    O
who    O
do    O
not    O
usually    O
drink    O
herbal    O
teas    O
other    O
than    O
mate    O
beverage    O
.    O

This    O
long    O
-    O
term    O
decline    O
had    O
a    O
number    O
of    O
causes    O
,    O
including    O
egg    O
collection    O
and    O
hunting    O
,    O
such    O
as    O
for    O
indigenous    B-Therapy100661091
medicine    I-Therapy100661091
.    O

Practitioners    O
of    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
have    O
used    O
black    O
elderberry    O
for    O
hundreds    O
of    O
years    O
,    O

The    O
bark    O
extract    O
is    O
also    O
used    O
in    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
as    O
an    O
astringent    O
,    O
purgative    O
,    O
antirheumatic    O
,    O
and    O
for    O
treating    O
gastrointestinal    O
ailments    O
like    O
diarrhea    O
and    O
dysentery    O
.    O

Romero    O
-    O
Daza    O
's    O
publications    O
address    O
several    O
areas    O
of    O
anthropological    O
inquiry    O
,    O
including    O
but    O
not    O
limited    O
to    O
HIV    O
/    O
AIDS    O
in    O
developing    O
countries    O
,    O
HIV    O
/    O
AIDS    O
among    O
minority    O
populations    O
,    O
traditional    B-Therapy100661091
healing    I-Therapy100661091
practices    I-Therapy100661091
,    O
maternal    O
and    O
child    O
health    O
,    O
reproductive    O
health    O
,    O
health    O
care    O
decision    O
making    O
,    O
cultural    O
competency    O
in    O
service    O
provision    O
,    O
political    O
economy    O
of    O
health    O
,    O
HIV    O
risk    O
among    O
sex    O
workers    O
and    O
injection    O
drug    O
users    O
,    O
and    O
medical    O
pluralism    O
.    O

The    O
fruits    O
are    O
processed    O
and    O
then    O
used    O
in    O
the    O
food    O
industry    O
,    O
in    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
,    O
as    O
part    O
of    O
drugs    O
or    O
in    O
the    O
cosmetic    O
industry    O
.    O

All    O
children    O
at    O
Nkosi    O
’s    O
Haven    O
Village    O
receive    O
various    O
forms    O
of    O
therapy    O
,    O
including    O
remedial    B-Therapy100661091
,    O
play    O
,    O
occupational    O
and    O
speech    O
.    O

E.    O
sinensis    O
"    O
has    O
been    O
used    O
as    O
a    O
folk    B-Therapy100661091
remedy    I-Therapy100661091
against    O
cancer    O
and    O
infection    O
in    O
Tibet    O
,    O
Yunnan    O
,    O
and    O
Sichuan    O
Provinces    O
.    O

The    O
plant    O
is    O
used    O
in    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
to    O
treat    O
a    O
variety    O
of    O
conditions    O
,    O
including    O
sexually    O
transmitted    O
diseases    O
,    O
impotency    O
,    O
back    O
pain    O
,    O
toothache    O
,    O
fever    O
,    O
dysentery    O
,    O
bleeding    O
,    O
and    O
liver    O
diseases    O
.    O

Yunani    O
or    O
Unani    O
medicine    O
(    O
Urdu    O
:    O
"    O
tibb    O
yūnānī    O
"    O
)    O
is    O
the    O
term    O
for    O
Perso    O
-    O
Arabic    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
as    O
practiced    O
in    O
Mughal    O
India    O
and    O
in    O
Muslim    O
culture    O
in    O
South    O
Asia    O
and    O
modern    O
day    O
Central    O
Asia    O
.    O

This    O
herb    O
used    O
in    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
of    O
East    O
Asia    O
for    O
its    O
purported    O
psychotropic    O
and    O
nootropic    O
properties    O
.    O
although    O
such    O
claims    O
are    O
not    O
medically    O
verified    O
.    O

Amber    O
has    O
been    O
used    O
since    O
prehistory    O
(    O
Solutrean    O
)    O
in    O
the    O
manufacture    O
of    O
jewelry    O
and    O
ornaments    O
,    O
and    O
also    O
in    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
.    O

Amber    O
has    O
long    O
been    O
used    O
in    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
for    O
its    O
purported    O
healing    O
properties    O
.    O

"    O
Acacia    O
"    O
species    O
have    O
possible    O
uses    O
in    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
.    O

Aloe    O
vera    O
"    O
is    O
used    O
both    O
internally    O
and    O
externally    O
on    O
humans    O
as    O
folk    B-Therapy100661091
or    O
alternative    O
medicine    O
.    O

Before    O
the    O
early    O
20th    O
century    O
,    O
treatments    O
for    O
infections    O
were    O
based    O
primarily    O
on    O
medicinal    B-Therapy100661091
folklore    I-Therapy100661091
.    O
Mixtures    O
with    O
antimicrobial    O
properties    O
that    O
were    O
used    O
in    O
treatments    O
of    O
infections    O
were    O
described    O
over    O
2000    O
years    O
ago    O
.    O

Alternative    O
treatments    O
are    O
not    O
the    O
same    O
as    O
experimental    O
medicine    O
or    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
,    O
although    O
much    O
of    O
the    O
latter    O
is    O
alternative    O
when    O
used    O
today    O
.    O

Alternative    O
medical    O
systems    O
may    O
be    O
based    O
on    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
practices    O
,    O
such    O
as    O
traditional    O
Chinese    O
medicine    O
(    O
TCM    O
)    O
,    O
Ayurveda    O
in    O
India    O
,    O
or    O
practices    O
of    O
other    O
cultures    O
around    O
the    O
world    O
.    O

Methods    O
may    O
incorporate    O
or    O
base    O
themselves    O
on    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
,    O
folk    B-Therapy100661091
knowledge    I-Therapy100661091
,    O
spiritual    O
beliefs    O
,    O
ignorance    O
or    O
misunderstanding    O
of    O
scientific    O
principles    O
,    O
errors    O
in    O
reasoning    O
,    O
or    O
newly    O
conceived    O
approaches    O
claiming    O
to    O
heal    O
.    O

Traditional    B-Therapy100661091
remedies    I-Therapy100661091
,    O
often    O
closely    O
resembling    O
or    O
forming    O
the    O
basis    O
for    O
alternative    O
remedies    O
,    O
may    O
comprise    O
primary    O
healthcare    O
or    O
be    O
integrated    O
into    O
the    O
healthcare    O
system    O
.    O

File    O
:    O
Market    O
Pharmacy    O
Tana    O
Traditional    B-Therapy100661091
medicine    I-Therapy100661091
in    O
Madagascar    O

The    O
brew    O
is    O
used    O
as    O
a    O
traditional    B-Therapy100661091
spiritual    I-Therapy100661091
medicine    I-Therapy100661091
in    O
ceremonies    O
among    O
the    O
Indigenous    O
peoples    O
of    O
the    O
Amazon    O
basin    O
.    O

Many    O
have    O
found    O
use    O
in    O
traditional    B-Therapy100661091
or    O
modern    O
medicine    O
,    O
or    O
as    O
starting    O
points    O
for    O
drug    O
discovery    O
.    O

The    O
antithesis    O
of    O
medicalization    O
is    O
the    O
process    O
of    O
paramedicalization    O
,    O
where    O
human    O
conditions    O
come    O
under    O
the    O
attention    O
of    O
alternative    O
medicine    O
,    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
or    O
any    O
of    O
numerous    O
non    O
-    O
medical    O
health    O
approaches    O
.    O

The    O
main    O
agricultural    O
products    O
in    O
the    O
country    O
are    O
tobacco    O
,    O
figs    O
,    O
olives    O
,    O
wheat    O
,    O
maize    O
,    O
potatoes    O
,    O
vegetables    O
,    O
fruits    O
,    O
sugar    O
beets    O
,    O
grapes    O
,    O
meat    O
,    O
honey    O
,    O
dairy    O
products    O
,    O
and    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
and    O
aromatic    O
plants    O
.    O

The    O
above    O
ground    O
parts    O
of    O
these    O
plants    O
are    O
used    O
for    O
spices    O
and    O
traditional    B-Therapy100661091
medicines    I-Therapy100661091
.    O

Dry    O
leaves    O
are    O
used    O
in    O
tea    O
in    O
Vietnamese    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
to    O
relieve    O
sleeping    O
problems    O
,    O
as    O
well    O
as    O
treatment    O
for    O
itching    O
and    O
coughs    O
.    O

Religious    O
pseudoscience    O
includes    O
witchcraft    O
that    O
is    O
beyond    O
traditional    O
midwifery    O
practices    O
and    O
sorcery    O
other    O
than    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
,    O
which    O
insists    O
on    O
supernatural    O
or    O
magical    O
or    O
miraculous    O
intervention    O
which    O
is    O
contrary    O
to    O
scientific    O
evidence    O
.    O

In    O
Ayurvedic    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
,    O
"    O
Coleus    O
"    O
has    O
been    O
used    O
to    O
treat    O
various    O
disorders    O
,    O
although    O
there    O
is    O
no    O
evidence    O
for    O
its    O
efficacy    O
confirmed    O
by    O
high    O
-    O
quality    O
clinical    O
research    O
in    O
any    O
of    O
those    O
conditions    O
.    O

"    O
Hypericum    O
mysorense    O
"    O
has    O
been    O
used    O
to    O
treat    O
wounds    O
as    O
part    O
of    O
the    O
Ayurvedic    O
system    O
of    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
.    O

There    O
is    O
also    O
a    O
vast    O
body    O
of    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
and    O
simple    O
quackery    O
.    O

"    O
Swertia    O
"    O
is    O
used    O
in    O
Indian    O
Ayurvedic    O
Herbal    O
System    O
to    O
cure    O
Fever    O
as    O
in    O
Laghu    O
sudarshana    O
churna    O
,    O
Maha    O
sudarshan    O
Churna    O
and    O
in    O
Tibetan    O
folk    B-Therapy100661091
medicine    I-Therapy100661091
.    O

In    O
1981    O
,    O
people    O
started    O
bathing    O
in    O
it    O
after    O
its    O
supposed    B-Therapy100661091
healing    I-Therapy100661091
powers    I-Therapy100661091
were    O
popularized    O
.    O

"    O
Balneotherapy    O
"    O
is    O
the    O
practice    O
of    O
immersing    O
a    O
subject    O
in    O
mineral    O
water    O
or    O
mineral    O
-    O
laden    O
mud    O
;    O
it    O
is    O
part    O
of    O
the    O
traditional    B-Therapy100661091
medicine    I-Therapy100661091
of    O
many    O
cultures    O
and    O
originated    O
in    O
hot    O
springs    O
,    O
cold    O
springs    O
,    O
or    O
other    O
sources    O
of    O
such    O
water    O
like    O
the    O
Dead    O
Sea    O
.    O

Serratia    O
E-15    O
protease    O
(    O
also    O
known    O
as    O
serratiopeptidase    B-Therapy100661091
or    O
serrapeptidase    O
)    O
is    O
another    O
protease    O
that    O
has    O
been    O
proposed    O
as    O
an    O
anti    O
-    O
inflammatory    O
agent    O
.    O

On    O
the    O
site    O
of    O
what    O
is    O
now    O
Camp    O
Twin    O
Creeks    O
warm    O
mineral    B-Therapy100661091
springs    I-Therapy100661091
can    O
still    O
be    O
found    O
.    O

Exceptional    O
properties    O
of    O
Świeradów    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
were    O
suspected    O
as    O
early    O
as    O
the    O
16th    O
century    O
.    O

There    O
are    O
no    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
in    O
the    O
municipality    O
.    O

The    O
sulphur    B-Therapy100661091
spring    I-Therapy100661091
at    O
Taubenkit    O
has    O
a    O
temperature    O
of    O
and    O
a    O
still    O
more    O
remarkable    O
example    O
is    O
found    O
at    O
Sayowang    O
on    O
the    O
east    O
coast    O
.    O
"    O
Amasing    O
Hill    O
"    O
on    O
the    O
northern    O
half    O
consists    O
of    O
three    O
small    O
andesitic    O
volcanoes    O
:    O
Cakasuanggi    O
,    O
Dua    O
Saudara    O
,    O
and    O
Mount    O
Sibela    O
.    O

Pancharevo    O
is    O
known    O
for    O
its    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
and    O
its    O
lake    O
,    O
Lake    O
Pancharevo    O
.    O

Helidon    O
is    O
also    O
the    O
location    O
of    O
a    O
natural    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
whose    O
products    O
were    O
sold    O
by    O
the    O
Helidon    O
Spa    O
Water    O
Company    O
,    O
now    O
known    O
as    O
Kirks    O
.    O

Obereisenbach    O
’s    O
inhabitants    O
lived    O
well    O
into    O
the    O
20th    O
century    O
mainly    O
from    O
agriculture    O
,    O
although    O
there    O
were    O
also    O
the    O
miller    O
families    O
,    O
innkeepers    O
,    O
distillers    O
,    O
workers    O
–    O
especially    O
at    O
the    O
stone    O
quarries    O
–    O
and    O
those    O
who    O
ran    O
the    O
mineral    O
water    O
spring    B-Therapy100661091
.    O

The    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
was    O
mentioned    O
as    O
early    O
as    O
the    O
early    O
16th    O
century    O
.    O

The    O
district    O
around    O
it    O
included    O
fertile    O
agricultural    O
valleys    O
but    O
also    O
sandy    O
desert    O
,    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
,    O
and    O
upwellings    O
of    O
naphtha    O
.    O

Thompson    O
's    O
Bromine    O
and    O
Arsenic    O
Springs    O
,    O
also    O
known    O
as    O
Healing    O
Springs    O
,    O
is    O
a    O
historic    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
resort    O
and    O
national    O
historic    O
district    O
located    O
near    O
Crumpler    O
,    O
Ashe    O
County    O
,    O
North    O
Carolina    O
.    O

Taytu    O
initially    O
built    O
a    O
house    O
for    O
herself    O
near    O
the    O
Filwoha    O
hot    O
mineral    B-Therapy100661091
springs    I-Therapy100661091
,    O
where    O
she    O
and    O
members    O
of    O
the    O
Shewan    O
royal    O
court    O
liked    O
to    O
take    O
mineral    O
baths    O
.    O

Though    O
little    O
remains    O
of    O
its    O
pre    O
-    O
spa    O
history    O
,    O
Cheltenham    O
has    O
been    O
a    O
health    O
and    O
holiday    O
spa    O
town    O
resort    O
since    O
the    O
discovery    O
of    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
there    O
in    O
1716    O
.    O

Seltzer    O
,    O
carbonated    O
water    O
,    O
a    O
genericized    O
trademark    O
that    O
derives    O
from    O
the    O
German    O
town    O
Selters    O
,    O
which    O
is    O
renowned    O
for    O
its    O
mineral    B-Therapy100661091
springs    I-Therapy100661091

As    O
a    O
result    O
of    O
former    O
volcanism    O
numerous    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
(    O
"    O
Sauerbrunnen    O
"    O
)    O
have    O
formed    O
.    O

Jan    O
Winterfeld    O
conducted    O
research    O
on    O
using    O
health    B-Therapy100661091
waters    I-Therapy100661091
to    O
treat    O
illness    O
in    O
1808    O
.    O

Banite    O
is    O
known    O
for    O
its    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
,    O
hydro    O
and    O
balneotherapy    O
centre    O
.    O

He    O
is    O
known    O
for    O
a    O
significant    O
work    O
on    O
the    O
chemistry    O
of    O
mineral    B-Therapy100661091
springs    I-Therapy100661091
,    O
and    O
as    O
an    O
editor    O
of    O
alchemical    O
tracts    O
.    O

A    O
number    O
of    O
settlements    O
at    O
the    O
foothills    O
of    O
Pirin    O
have    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
and    O
are    O
spa    O
resorts    O
—    O
Banya    O
,    O
Dobrinishte    O
,    O
Gotse    O
Delchev    O
,    O
Sandanski    O
,    O
etc    O
.    O

Pirin    O
has    O
abundant    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
,    O
being    O
among    O
Bulgaria    O
's    O
richest    O
areas    O
.    O

The    O
community    O
derives    O
its    O
name    O
from    O
Nathan    O
and    O
Daniel    O
Morgan    O
Boone    O
,    O
who    O
were    O
the    O
sons    O
of    O
Daniel    O
Boone    O
and    O
established    O
their    O
salt    O
business    O
near    O
the    O
community    O
in    O
the    O
early    O
1800s    O
by    O
delivering    O
the    O
salt    O
from    O
salt    B-Therapy100661091
lick    I-Therapy100661091
to    O
St.    O
Louis    O
.    O

The    O
present    O
name    O
is    O
after    O
a    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
near    O
the    O
original    O
town    O
site    O
.    O

A    O
spa    O
town    O
is    O
a    O
resort    O
town    O
based    O
on    O
a    O
mineral    O
spa    O
(    O
a    O
developed    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
)    O
.    O

The    O
town    O
is    O
home    O
to    O
a    O
number    O
of    O
balneological    B-Therapy100661091
resorts    O
,    O
where    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
and    O
silt    O
mud    O
from    O
the    O
Lake    O
Solyanoye    O
are    O
used    O
.    O

Exploitation    O
of    O
the    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
of    O
Fischau    O
took    O
a    O
rise    O
in    O
1872    O
,    O
when    O
the    O
spa    O
resort    O
(    O
"    O
Kristalltherme    O
"    O
)    O
was    O
opened    O
.    O

The    O
local    O
geography    O
includes    O
vernal    O
pools    O
to    O
the    O
west    O
(    O
Hog    O
Lake    O
)    O
and    O
just    O
north    O
of    O
the    O
Station    O
(    O
Dales    O
Lake    O
)    O
,    O
as    O
well    O
as    O
volcanic    O
buttes    O
(    O
Tuscan    O
Buttes    O
,    O
Soap    O
Butte    O
,    O
Inkskip    O
Hill    O
)    O
,    O
natural    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
,    O
rolling    O
hills    O
of    O
blue    O
oak    O
savannah    O
,    O
several    O
seasonal    O
gulches    O
and    O
the    O
anadromous    O
Payne    O
's    O
Creek    O
,    O
and    O
borders    O
the    O
Sacramento    O
River    O
Bend    O
area    O
.    O

The    O
location    O
has    O
been    O
inhabited    O
by    O
humans    O
since    O
the    O
Neolithic    O
era    O
,    O
about    O
5,000    O
years    O
ago    O
,    O
attracted    O
to    O
its    O
warm    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
.    O

Sulfur    B-Therapy100661091
springs    I-Therapy100661091
:    O
Soufrière    O
is    O
located    O
within    O
the    O
caldera    O
of    O
the    O
dormant    O
Qualibou    O
volcano    O
and    O
the    O
area    O
is    O
geothermally    O
active    O
.    O

He    O
is    O
best    O
remembered    O
for    O
establishing    O
the    O
first    O
French    O
Lick    O
Springs    O
Hotel    O
,    O
a    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
resort    O
hotel    O
in    O
the    O
1840s    O
,    O
and    O
platting    O
the    O
town    O
of    O
French    O
Lick    O
,    O
Indiana    O
,    O
in    O
1857    O
.    O

Among    O
the    O
springs    O
,    O
there    O
are    O
three    O
sulphur    B-Therapy100661091
springs    I-Therapy100661091
at    O
the    O
southern    O
side    O
of    O
the    O
lower    O
lake    O
,    O
with    O
extensive    O
mobile    O
sand    O
dunes    O
.    O

'    O
'    O
Füred    O
's    O
Mineralquellen    O
und    O
der    O
Plattensee    O
''    O
,    O
1837    O
–    O
Balatonfüred    O
's    O
mineral    B-Therapy100661091
springs    I-Therapy100661091
.    O

Bathing    O
tourism    O
is    O
based    O
on    O
the    O
healing    O
power    O
of    O
the    O
Vučkovec    O
mineral    B-Therapy100661091
spring    I-Therapy100661091
.    O

A    O
2009    O
review    O
found    O
"    O
methodological    O
flaws    O
"    O
in    O
research    O
studies    O
that    O
had    O
reported    O
"    O
small    O
successes    O
"    O
for    O
EFT    O
and    O
the    O
related    O
Tapas    B-Therapy100661091
Acupressure    I-Therapy100661091
Technique    I-Therapy100661091
.    O

Vega    B-Therapy100661091
machine    I-Therapy100661091
,    O
an    O
electrodiagnostic    O
device    O

Near    O
-    O
infrared    O
light    O
,    O
or    O
photobiomodulation    B-Therapy100661091
,    O
is    O
used    O
for    O
treatment    O
of    O
chemotherapy    O
-    O
induced    O
oral    O
ulceration    O
as    O
well    O
as    O
wound    O
healing    O
.    O

(    O
See    O
also    O
Photobiomodulation    B-Therapy100661091
)    O

Endre    O
Mester    O
invented    O
the    O
Low    B-Therapy100661091
level    I-Therapy100661091
laser    I-Therapy100661091
therapy    I-Therapy100661091
or    O
"    O
light    O
therapy    O
"    O

Low    B-Therapy100661091
level    I-Therapy100661091
laser    I-Therapy100661091
therapy    I-Therapy100661091
may    O
be    O
considered    O
for    O
relief    O
of    O
pain    O
and    O
stiffness    O
associated    O
with    O
arthritis    O
.    O

A    O
charcoal    B-Therapy100661091
biscuit    I-Therapy100661091
is    O
a    O
biscuit    O
based    O
on    O
a    O
powdered    O
willow    O
charcoal    O
or    O
activated    O
carbon    O
mixed    O
with    O
ordinary    O
flour    O
,    O
and    O
made    O
into    O
dough    O
with    O
butter    O
,    O
sugar    O
and    O
eggs    O
.    O

In    O
advance    O
of    O
confirmation    O
,    O
Gottlieb    O
expressed    O
his    O
intention    O
to    O
recuse    O
himself    O
"    O
for    O
one    O
year    O
from    O
any    O
agency    O
decisions    O
involving    O
about    O
20    O
health    O
care    O
companies    O
he    O
worked    O
with    O
"    O
under    O
an    O
ethics    O
agreement    O
,    O
including    O
such    O
companies    O
as    O
Vertex    O
Pharmaceuticals    O
,    O
Cell    O
Biotherapy    O
,    O
GSK    O
,    O
Bristol    O
-    O
Myers    O
Squibb    O
,    O
New    O
Enterprise    O
,    O
TR    O
Winston    O
,    O
MedAvante    O
and    O
Glytec    B-Therapy100661091
.    O

Pulsed    B-Therapy100661091
electromagnetic    I-Therapy100661091
field    I-Therapy100661091
therapy    I-Therapy100661091
(    O
PEMFT    B-Therapy100661091
)    O
uses    O
electromagnetic    O
fields    O
in    O
an    O
attempt    O
to    O
heal    O
non    O
-    O
union    O
fractures    O
and    O
depression    O
.    O

Pulsed    B-Therapy100661091
electromagnetic    I-Therapy100661091
field    I-Therapy100661091
therapy    I-Therapy100661091
has    O
tentative    O
evidence    O
supporting    O
improved    O
functioning    O
but    O
no    O
evidence    O
of    O
improved    O
pain    O
in    O
osteoarthritis    O
.    O

Intensive    B-Therapy100661091
insulinotherapy    I-Therapy100661091
is    O
a    O
therapeutic    O
regimen    O
for    O
diabetes    O
mellitus    O
treatment    O
.    O

In    O
North    O
America    O
in    O
2004    O
,    O
many    O
endocrinologists    O
prefer    O
the    O
term    O
flexible    B-Therapy100661091
insulin    I-Therapy100661091
therapy    I-Therapy100661091
(    O
FIT    B-Therapy100661091
)    O
to    O
"    O
intensive    O
therapy    O
"    O
and    O
use    O
it    O
to    O
refer    O
to    O
any    O
method    O
of    O
replacing    O
insulin    O
that    O
attempts    O
to    O
mimic    O
the    O
pattern    O
of    O
small    O
continuous    O
basal    O
insulin    O
secretion    O
of    O
a    O
working    O
pancreas    O
combined    O
with    O
larger    O
insulin    O
secretions    O
at    O
mealtimes    O
.    O

Interestingly    O
,    O
vanadium    O
compounds    O
such    O
as    O
vanadyl    O
sulfate    O
have    O
been    O
shown    O
to    O
inhibit    O
the    O
enzyme    O
,    O
and    O
thus    O
increase    O
the    O
insulin    O
sensitivity    O
"    O
in    O
vivo    O
"    O
in    O
diabetics    O
,    O
as    O
assessed    O
by    O
the    O
hyperinsulinemic    B-Therapy100661091
clamp    I-Therapy100661091
technique    I-Therapy100661091
,    O
which    O
may    O
have    O
potential    O
therapeutic    O
implications    O

1950    O
Nordisk    O
markets    O
NPH    B-Therapy100661091
insulin    I-Therapy100661091

The    O
long    O
-    O
acting    O
insulin    O
class    O
,    O
which    O
includes    O
insulin    O
glargine    O
,    O
do    O
not    O
appear    O
much    O
better    O
than    O
neutral    O
protamine    O
Hagedorn    O
(NPH)    B-Therapy100661091
insulin    I-Therapy100661091
but    O
have    O
a    O
significantly    O
greater    O
cost    O
making    O
them    O
,    O
as    O
of    O
2010    O
,    O
not    O
cost    O
effective    O
.    O

NPH    B-Therapy100661091
insulin    I-Therapy100661091
,    O
also    O
known    O
as    O
isophane    B-Therapy100661091
insulin    I-Therapy100661091
,    O
is    O
an    O
intermediate–acting    B-Therapy100661091
insulin    I-Therapy100661091
given    O
to    O
help    O
control    O
blood    O
sugar    O
levels    O
in    O
people    O
with    O
diabetes    O
.    O

Learning    B-Therapy100661091
styles    I-Therapy100661091

The    O
company    O
was    O
founded    O
on    O
the    O
knowledge    O
that    O
people    O
have    O
different    O
learning    B-Therapy100661091
styles    I-Therapy100661091
.    O

He    O
was    O
a    O
pioneer    O
of    O
the    O
theory    O
of    O
cognitive    O
styles    O
and    O
learning    B-Therapy100661091
styles    I-Therapy100661091
(    O
developed    O
in    O
cooperation    O
with    O
Solomon    O
Asch    O
,    O
Donald    O
Goodenough    O
etc    O
.    O
)    O
.    O

Learning    B-Therapy100661091
styles    I-Therapy100661091

Some    O
of    O
these    O
schools    O
become    O
"    O
GI    O
Model    O
Schools    O
"    O
and    O
aim    O
to    O
leverage    O
the    O
role    O
gender    O
plays    O
in    O
learning    B-Therapy100661091
styles    I-Therapy100661091
.    O

Learning    B-Therapy100661091
styles    I-Therapy100661091

Mind    B-Therapy100661091
Styles    I-Therapy100661091
Model    I-Therapy100661091
and    O
its    O
associated    O

Learning    B-Therapy100661091
styles    I-Therapy100661091

This    O
simplifies    O
record    O
keeping    O
and    O
can    O
be    O
interfaced    O
with    O
diabetes    B-Therapy100661091
management    I-Therapy100661091
software    I-Therapy100661091
.    O


